id	sid	tid	token	lemma	pos
aiua-8799	1	1	cop+ed+fisse	cop+ed+fisse	NOUN
aiua-8799	1	2	2006	2006	NUM
aiua-8799	1	3	177archivio	177archivio	PROPN
aiua-8799	1	4	italiano	italiano	NOUN
aiua-8799	1	5	di	di	NOUN
aiua-8799	1	6	urologia	urologia	PROPN
aiua-8799	1	7	e	e	PROPN
aiua-8799	1	8	andrologia	andrologia	NOUN
aiua-8799	1	9	2020	2020	NUM
aiua-8799	1	10	;	;	PUNCT
aiua-8799	1	11	92	92	NUM
aiua-8799	1	12	,	,	PUNCT
aiua-8799	1	13	3	3	NUM
aiua-8799	1	14	original	original	ADJ
aiua-8799	1	15	paper	paper	NOUN
aiua-8799	1	16	no	no	DET
aiua-8799	1	17	conflict	conflict	NOUN
aiua-8799	1	18	of	of	ADP
aiua-8799	1	19	interest	interest	NOUN
aiua-8799	1	20	declared	declare	VERB
aiua-8799	1	21	.	.	PUNCT
aiua-8799	2	1	doi	doi	NOUN
aiua-8799	2	2	:	:	PUNCT
aiua-8799	2	3	10.4081	10.4081	NUM
aiua-8799	2	4	/	/	SYM
aiua-8799	2	5	aiua.2020.3.177	aiua.2020.3.177	NOUN
aiua-8799	2	6	the	the	DET
aiua-8799	2	7	role	role	NOUN
aiua-8799	2	8	of	of	ADP
aiua-8799	2	9	protopine	protopine	NOUN
aiua-8799	2	10	associated	associate	VERB
aiua-8799	2	11	with	with	ADP
aiua-8799	2	12	nuciferine	nuciferine	NOUN
aiua-8799	2	13	in	in	ADP
aiua-8799	2	14	controlling	control	VERB
aiua-8799	2	15	adverse	adverse	ADJ
aiua-8799	2	16	events	event	NOUN
aiua-8799	2	17	during	during	ADP
aiua-8799	2	18	hyperthermic	hyperthermic	ADJ
aiua-8799	2	19	intravesical	intravesical	ADJ
aiua-8799	2	20	chemotherapy	chemotherapy	NOUN
aiua-8799	2	21	instillations	instillation	NOUN
aiua-8799	2	22	.	.	PUNCT
aiua-8799	3	1	a	a	DET
aiua-8799	3	2	nutraceutical	nutraceutical	ADJ
aiua-8799	3	3	approach	approach	NOUN
aiua-8799	3	4	to	to	PART
aiua-8799	3	5	control	control	VERB
aiua-8799	3	6	adverse	adverse	ADJ
aiua-8799	3	7	event	event	NOUN
aiua-8799	3	8	during	during	ADP
aiua-8799	3	9	intravesical	intravesical	ADJ
aiua-8799	3	10	instillations	instillation	NOUN
aiua-8799	3	11	francesco	francesco	PROPN
aiua-8799	3	12	chiancone	chiancone	PROPN
aiua-8799	3	13	,	,	PUNCT
aiua-8799	3	14	maurizio	maurizio	PROPN
aiua-8799	3	15	carrino	carrino	PROPN
aiua-8799	3	16	,	,	PUNCT
aiua-8799	3	17	maurizio	maurizio	PROPN
aiua-8799	3	18	fedelini	fedelini	PROPN
aiua-8799	3	19	,	,	PUNCT
aiua-8799	3	20	marco	marco	PROPN
aiua-8799	3	21	fabiano	fabiano	PROPN
aiua-8799	3	22	,	,	PUNCT
aiua-8799	3	23	francesco	francesco	PROPN
aiua-8799	3	24	persico	persico	PROPN
aiua-8799	3	25	,	,	PUNCT
aiua-8799	3	26	clemente	clemente	PROPN
aiua-8799	3	27	meccariello	meccariello	PROPN
aiua-8799	3	28	,	,	PUNCT
aiua-8799	3	29	paolo	paolo	PROPN
aiua-8799	3	30	fedelini	fedelini	PROPN
aiua-8799	3	31	department	department	PROPN
aiua-8799	3	32	of	of	ADP
aiua-8799	3	33	urology	urology	NOUN
aiua-8799	3	34	,	,	PUNCT
aiua-8799	3	35	a.	a.	PROPN
aiua-8799	3	36	cardarelli	cardarelli	PROPN
aiua-8799	3	37	hospital	hospital	PROPN
aiua-8799	3	38	,	,	PUNCT
aiua-8799	3	39	naples	naples	PROPN
aiua-8799	3	40	,	,	PUNCT
aiua-8799	3	41	italy	italy	PROPN
aiua-8799	3	42	.	.	PUNCT
aiua-8799	4	1	objectives	objective	VERB
aiua-8799	4	2	:	:	PUNCT
aiua-8799	4	3	the	the	DET
aiua-8799	4	4	aim	aim	NOUN
aiua-8799	4	5	of	of	ADP
aiua-8799	4	6	this	this	DET
aiua-8799	4	7	study	study	NOUN
aiua-8799	4	8	was	be	AUX
aiua-8799	4	9	to	to	PART
aiua-8799	4	10	analyse	analyse	VERB
aiua-8799	4	11	the	the	DET
aiua-8799	4	12	role	role	NOUN
aiua-8799	4	13	of	of	ADP
aiua-8799	4	14	two	two	NUM
aiua-8799	4	15	alkaloid	alkaloid	NOUN
aiua-8799	4	16	,	,	PUNCT
aiua-8799	4	17	protopine	protopine	NOUN
aiua-8799	4	18	and	and	CCONJ
aiua-8799	4	19	nuciferine	nuciferine	NOUN
aiua-8799	4	20	,	,	PUNCT
aiua-8799	4	21	in	in	ADP
aiua-8799	4	22	the	the	DET
aiua-8799	4	23	prevention	prevention	NOUN
aiua-8799	4	24	and	and	CCONJ
aiua-8799	4	25	the	the	DET
aiua-8799	4	26	treatment	treatment	NOUN
aiua-8799	4	27	of	of	ADP
aiua-8799	4	28	the	the	DET
aiua-8799	4	29	low	low	ADJ
aiua-8799	4	30	and	and	CCONJ
aiua-8799	4	31	mild	mild	ADJ
aiua-8799	4	32	grade	grade	NOUN
aiua-8799	4	33	adverse	adverse	ADJ
aiua-8799	4	34	events	event	NOUN
aiua-8799	4	35	related	relate	VERB
aiua-8799	4	36	to	to	ADP
aiua-8799	4	37	the	the	DET
aiua-8799	4	38	use	use	NOUN
aiua-8799	4	39	of	of	ADP
aiua-8799	4	40	hivec	hivec	NOUN
aiua-8799	4	41	®	®	NOUN
aiua-8799	4	42	(	(	PUNCT
aiua-8799	4	43	hyperthermic	hyperthermic	ADJ
aiua-8799	4	44	intravesical	intravesical	ADJ
aiua-8799	4	45	chemotherapy	chemotherapy	NOUN
aiua-8799	4	46	)	)	PUNCT
aiua-8799	4	47	instillations	instillation	NOUN
aiua-8799	4	48	.	.	PUNCT
aiua-8799	5	1	materials	material	NOUN
aiua-8799	5	2	and	and	CCONJ
aiua-8799	5	3	methods	method	NOUN
aiua-8799	5	4	:	:	PUNCT
aiua-8799	5	5	from	from	ADP
aiua-8799	5	6	september	september	PROPN
aiua-8799	5	7	2017	2017	NUM
aiua-8799	5	8	to	to	ADP
aiua-8799	5	9	september	september	PROPN
aiua-8799	5	10	2019	2019	NUM
aiua-8799	5	11	,	,	PUNCT
aiua-8799	5	12	100	100	NUM
aiua-8799	5	13	patients	patient	NOUN
aiua-8799	5	14	were	be	AUX
aiua-8799	5	15	prospectively	prospectively	ADV
aiua-8799	5	16	randomized	randomize	VERB
aiua-8799	5	17	into	into	ADP
aiua-8799	5	18	two	two	NUM
aiua-8799	5	19	groups	group	NOUN
aiua-8799	5	20	:	:	PUNCT
aiua-8799	5	21	group	group	NOUN
aiua-8799	5	22	a	a	DET
aiua-8799	5	23	=	=	X
aiua-8799	5	24	protopine	protopine	NOUN
aiua-8799	5	25	and	and	CCONJ
aiua-8799	5	26	nuciferine	nuciferine	NOUN
aiua-8799	5	27	syrup	syrup	NOUN
aiua-8799	5	28	,	,	PUNCT
aiua-8799	5	29	10	10	NUM
aiua-8799	5	30	ml	ml	NOUN
aiua-8799	5	31	,	,	PUNCT
aiua-8799	5	32	once	once	ADV
aiua-8799	5	33	a	a	DET
aiua-8799	5	34	day	day	NOUN
aiua-8799	5	35	,	,	PUNCT
aiua-8799	5	36	for	for	ADP
aiua-8799	5	37	8	8	NUM
aiua-8799	5	38	weeks	week	NOUN
aiua-8799	5	39	;	;	PUNCT
aiua-8799	5	40	group	group	NOUN
aiua-8799	5	41	b	b	NOUN
aiua-8799	5	42	=	=	NOUN
aiua-8799	5	43	placebo	placebo	NOUN
aiua-8799	5	44	(	(	PUNCT
aiua-8799	5	45	flavoured	flavoured	ADJ
aiua-8799	5	46	coloured	coloured	ADJ
aiua-8799	5	47	water	water	NOUN
aiua-8799	5	48	)	)	PUNCT
aiua-8799	5	49	,	,	PUNCT
aiua-8799	5	50	10	10	NUM
aiua-8799	5	51	ml	ml	NOUN
aiua-8799	5	52	,	,	PUNCT
aiua-8799	5	53	once	once	ADV
aiua-8799	5	54	a	a	DET
aiua-8799	5	55	day	day	NOUN
aiua-8799	5	56	,	,	PUNCT
aiua-8799	5	57	for	for	ADP
aiua-8799	5	58	8	8	NUM
aiua-8799	5	59	weeks	week	NOUN
aiua-8799	5	60	.	.	PUNCT
aiua-8799	6	1	the	the	DET
aiua-8799	6	2	primary	primary	ADJ
aiua-8799	6	3	endpoint	endpoint	NOUN
aiua-8799	6	4	was	be	AUX
aiua-8799	6	5	the	the	DET
aiua-8799	6	6	evaluation	evaluation	NOUN
aiua-8799	6	7	of	of	ADP
aiua-8799	6	8	the	the	DET
aiua-8799	6	9	efficacy	efficacy	NOUN
aiua-8799	6	10	of	of	ADP
aiua-8799	6	11	the	the	DET
aiua-8799	6	12	therapy	therapy	NOUN
aiua-8799	6	13	with	with	ADP
aiua-8799	6	14	protopine	protopine	NOUN
aiua-8799	6	15	and	and	CCONJ
aiua-8799	6	16	nuciferine	nuciferine	NOUN
aiua-8799	6	17	in	in	ADP
aiua-8799	6	18	controlling	controlling	NOUN
aiua-8799	6	19	of	of	ADP
aiua-8799	6	20	the	the	DET
aiua-8799	6	21	irritative	irritative	ADJ
aiua-8799	6	22	symptoms	symptom	NOUN
aiua-8799	6	23	.	.	PUNCT
aiua-8799	7	1	the	the	DET
aiua-8799	7	2	secondary	secondary	ADJ
aiua-8799	7	3	endpoint	endpoint	NOUN
aiua-8799	7	4	was	be	AUX
aiua-8799	7	5	the	the	DET
aiua-8799	7	6	evaluation	evaluation	NOUN
aiua-8799	7	7	of	of	ADP
aiua-8799	7	8	the	the	DET
aiua-8799	7	9	influences	influence	NOUN
aiua-8799	7	10	of	of	ADP
aiua-8799	7	11	the	the	DET
aiua-8799	7	12	treatment	treatment	NOUN
aiua-8799	7	13	on	on	ADP
aiua-8799	7	14	the	the	DET
aiua-8799	7	15	uroflowmetric	uroflowmetric	ADJ
aiua-8799	7	16	parameters	parameter	NOUN
aiua-8799	7	17	.	.	PUNCT
aiua-8799	8	1	results	result	NOUN
aiua-8799	8	2	:	:	PUNCT
aiua-8799	8	3	the	the	DET
aiua-8799	8	4	patients	patient	NOUN
aiua-8799	8	5	of	of	ADP
aiua-8799	8	6	group	group	PROPN
aiua-8799	8	7	a	a	PRON
aiua-8799	8	8	showed	show	VERB
aiua-8799	8	9	a	a	DET
aiua-8799	8	10	better	well	ADJ
aiua-8799	8	11	international	international	ADJ
aiua-8799	8	12	prostatic	prostatic	ADJ
aiua-8799	8	13	symptoms	symptom	NOUN
aiua-8799	8	14	score	score	VERB
aiua-8799	8	15	(	(	PUNCT
aiua-8799	8	16	ipss	ipss	PROPN
aiua-8799	8	17	)	)	PUNCT
aiua-8799	8	18	score	score	NOUN
aiua-8799	8	19	,	,	PUNCT
aiua-8799	8	20	a	a	DET
aiua-8799	8	21	better	well	ADJ
aiua-8799	8	22	control	control	NOUN
aiua-8799	8	23	of	of	ADP
aiua-8799	8	24	urgency	urgency	NOUN
aiua-8799	8	25	symptoms	symptom	NOUN
aiua-8799	8	26	(	(	PUNCT
aiua-8799	8	27	ppius	ppius	NOUN
aiua-8799	8	28	)	)	PUNCT
aiua-8799	8	29	and	and	CCONJ
aiua-8799	8	30	tolerate	tolerate	VERB
aiua-8799	8	31	well	well	INTJ
aiua-8799	8	32	the	the	DET
aiua-8799	8	33	pain	pain	NOUN
aiua-8799	8	34	(	(	PUNCT
aiua-8799	8	35	vas	vas	X
aiua-8799	8	36	score	score	NOUN
aiua-8799	8	37	)	)	PUNCT
aiua-8799	8	38	.	.	PUNCT
aiua-8799	9	1	the	the	DET
aiua-8799	9	2	treatment	treatment	NOUN
aiua-8799	9	3	does	do	AUX
aiua-8799	9	4	n’t	not	PART
aiua-8799	9	5	modify	modify	VERB
aiua-8799	9	6	uroflow	uroflow	NOUN
aiua-8799	9	7	-	-	PUNCT
aiua-8799	9	8	qmax	qmax	NOUN
aiua-8799	9	9	and	and	CCONJ
aiua-8799	9	10	seems	seem	VERB
aiua-8799	9	11	to	to	PART
aiua-8799	9	12	improve	improve	VERB
aiua-8799	9	13	the	the	DET
aiua-8799	9	14	uroflow	uroflow	NOUN
aiua-8799	9	15	-	-	PUNCT
aiua-8799	9	16	voided	void	VERB
aiua-8799	9	17	volume	volume	NOUN
aiua-8799	9	18	(	(	PUNCT
aiua-8799	9	19	ml	ml	NOUN
aiua-8799	9	20	)	)	PUNCT
aiua-8799	9	21	without	without	ADP
aiua-8799	9	22	influencing	influence	VERB
aiua-8799	9	23	the	the	DET
aiua-8799	9	24	uroflow	uroflow	ADJ
aiua-8799	9	25	-	-	PUNCT
aiua-8799	9	26	post	post	NOUN
aiua-8799	9	27	void	void	ADJ
aiua-8799	9	28	residual	residual	ADJ
aiua-8799	9	29	volume	volume	NOUN
aiua-8799	9	30	(	(	PUNCT
aiua-8799	9	31	pvr	pvr	NOUN
aiua-8799	9	32	)	)	PUNCT
aiua-8799	9	33	.	.	PUNCT
aiua-8799	10	1	moreover	moreover	ADV
aiua-8799	10	2	,	,	PUNCT
aiua-8799	10	3	the	the	DET
aiua-8799	10	4	treatment	treatment	NOUN
aiua-8799	10	5	with	with	ADP
aiua-8799	10	6	protopine	protopine	NOUN
aiua-8799	10	7	and	and	CCONJ
aiua-8799	10	8	nuciferine	nuciferine	NOUN
aiua-8799	10	9	has	have	AUX
aiua-8799	10	10	been	be	AUX
aiua-8799	10	11	proven	prove	VERB
aiua-8799	10	12	to	to	PART
aiua-8799	10	13	be	be	AUX
aiua-8799	10	14	effective	effective	ADJ
aiua-8799	10	15	in	in	ADP
aiua-8799	10	16	the	the	DET
aiua-8799	10	17	treatment	treatment	NOUN
aiua-8799	10	18	of	of	ADP
aiua-8799	10	19	overactive	overactive	ADJ
aiua-8799	10	20	bladder	bladder	NOUN
aiua-8799	10	21	(	(	PUNCT
aiua-8799	10	22	oab	oab	NOUN
aiua-8799	10	23	)	)	PUNCT
aiua-8799	10	24	symptoms	symptom	NOUN
aiua-8799	10	25	.	.	PUNCT
aiua-8799	11	1	patients	patient	NOUN
aiua-8799	11	2	’	'	PUNCT
aiua-8799	11	3	evaluation	evaluation	NOUN
aiua-8799	11	4	of	of	ADP
aiua-8799	11	5	the	the	DET
aiua-8799	11	6	two	two	NUM
aiua-8799	11	7	different	different	ADJ
aiua-8799	11	8	treatments	treatment	NOUN
aiua-8799	11	9	assessed	assess	VERB
aiua-8799	11	10	with	with	ADP
aiua-8799	11	11	patient	patient	ADJ
aiua-8799	11	12	global	global	ADJ
aiua-8799	11	13	impression	impression	NOUN
aiua-8799	11	14	of	of	ADP
aiua-8799	11	15	improvement	improvement	NOUN
aiua-8799	11	16	questionnaire	questionnaire	NOUN
aiua-8799	11	17	(	(	PUNCT
aiua-8799	11	18	pgi	pgi	PROPN
aiua-8799	11	19	-	-	PUNCT
aiua-8799	11	20	i	i	PROPN
aiua-8799	11	21	)	)	PUNCT
aiua-8799	11	22	,	,	PUNCT
aiua-8799	11	23	demonstrated	demonstrate	VERB
aiua-8799	11	24	improvements	improvement	NOUN
aiua-8799	11	25	in	in	ADP
aiua-8799	11	26	the	the	DET
aiua-8799	11	27	group	group	NOUN
aiua-8799	11	28	a	a	NOUN
aiua-8799	11	29	,	,	PUNCT
aiua-8799	11	30	while	while	SCONJ
aiua-8799	11	31	the	the	DET
aiua-8799	11	32	group	group	NOUN
aiua-8799	11	33	b	b	PROPN
aiua-8799	11	34	showed	show	VERB
aiua-8799	11	35	a	a	DET
aiua-8799	11	36	lower	low	ADJ
aiua-8799	11	37	satisfaction	satisfaction	NOUN
aiua-8799	11	38	.	.	PUNCT
aiua-8799	12	1	conclusions	conclusion	NOUN
aiua-8799	12	2	:	:	PUNCT
aiua-8799	12	3	protopine	protopine	NOUN
aiua-8799	12	4	and	and	CCONJ
aiua-8799	12	5	nuciferine	nuciferine	NOUN
aiua-8799	12	6	can	can	AUX
aiua-8799	12	7	be	be	AUX
aiua-8799	12	8	interesting	interesting	ADJ
aiua-8799	12	9	nutraceutical	nutraceutical	ADJ
aiua-8799	12	10	compounds	compound	NOUN
aiua-8799	12	11	useful	useful	ADJ
aiua-8799	12	12	to	to	PART
aiua-8799	12	13	control	control	VERB
aiua-8799	12	14	irritative	irritative	ADJ
aiua-8799	12	15	and	and	CCONJ
aiua-8799	12	16	pain	pain	NOUN
aiua-8799	12	17	related	relate	VERB
aiua-8799	12	18	symptoms	symptom	NOUN
aiua-8799	12	19	of	of	ADP
aiua-8799	12	20	intravesical	intravesical	ADJ
aiua-8799	12	21	chemo	chemo	NOUN
aiua-8799	12	22	/	/	SYM
aiua-8799	12	23	immunotherapy	immunotherapy	NOUN
aiua-8799	12	24	.	.	PUNCT
aiua-8799	13	1	key	key	ADJ
aiua-8799	13	2	words	word	NOUN
aiua-8799	13	3	:	:	PUNCT
aiua-8799	13	4	complementary	complementary	ADJ
aiua-8799	13	5	medicine	medicine	NOUN
aiua-8799	13	6	;	;	PUNCT
aiua-8799	13	7	bladder	bladder	NOUN
aiua-8799	13	8	cancer	cancer	NOUN
aiua-8799	13	9	;	;	PUNCT
aiua-8799	13	10	luts	luts	PROPN
aiua-8799	13	11	;	;	PUNCT
aiua-8799	13	12	chemotherapy	chemotherapy	NOUN
aiua-8799	13	13	;	;	PUNCT
aiua-8799	13	14	overactive	overactive	ADJ
aiua-8799	13	15	bladder	bladder	NOUN
aiua-8799	13	16	;	;	PUNCT
aiua-8799	13	17	urodynamics	urodynamic	NOUN
aiua-8799	13	18	.	.	PUNCT
aiua-8799	13	19	submitted	submit	VERB
aiua-8799	13	20	6	6	NUM
aiua-8799	13	21	january	january	NOUN
aiua-8799	13	22	2020	2020	NUM
aiua-8799	13	23	;	;	PUNCT
aiua-8799	13	24	accepted	accept	VERB
aiua-8799	13	25	13	13	NUM
aiua-8799	13	26	march	march	NOUN
aiua-8799	13	27	2020	2020	NUM
aiua-8799	13	28	introduction	introduction	NOUN
aiua-8799	13	29	in	in	ADP
aiua-8799	13	30	recent	recent	ADJ
aiua-8799	13	31	times	time	NOUN
aiua-8799	13	32	,	,	PUNCT
aiua-8799	13	33	hyperthermic	hyperthermic	ADJ
aiua-8799	13	34	intravesical	intravesical	ADJ
aiua-8799	13	35	chemotherapy	chemotherapy	NOUN
aiua-8799	13	36	(	(	PUNCT
aiua-8799	13	37	hivec	hivec	PROPN
aiua-8799	13	38	®	®	NOUN
aiua-8799	13	39	)	)	PUNCT
aiua-8799	13	40	instillations	instillation	NOUN
aiua-8799	13	41	has	have	AUX
aiua-8799	13	42	been	be	AUX
aiua-8799	13	43	added	add	VERB
aiua-8799	13	44	to	to	ADP
aiua-8799	13	45	the	the	DET
aiua-8799	13	46	existing	exist	VERB
aiua-8799	13	47	regimens	regimen	NOUN
aiua-8799	13	48	as	as	ADP
aiua-8799	13	49	adjuvant	adjuvant	ADJ
aiua-8799	13	50	and	and	CCONJ
aiua-8799	13	51	neoadjuvant	neoadjuvant	ADJ
aiua-8799	13	52	treatment	treatment	NOUN
aiua-8799	13	53	of	of	ADP
aiua-8799	13	54	bladder	bladder	NOUN
aiua-8799	13	55	cancer	cancer	NOUN
aiua-8799	13	56	(	(	PUNCT
aiua-8799	13	57	1	1	NUM
aiua-8799	13	58	)	)	PUNCT
aiua-8799	13	59	.	.	PUNCT
aiua-8799	14	1	most	most	ADJ
aiua-8799	14	2	of	of	ADP
aiua-8799	14	3	the	the	DET
aiua-8799	14	4	side	side	NOUN
aiua-8799	14	5	effects	effect	NOUN
aiua-8799	14	6	were	be	AUX
aiua-8799	14	7	low	low	ADJ
aiua-8799	14	8	grade	grade	NOUN
aiua-8799	14	9	and	and	CCONJ
aiua-8799	14	10	97	97	NUM
aiua-8799	14	11	%	%	NOUN
aiua-8799	14	12	of	of	ADP
aiua-8799	14	13	patients	patient	NOUN
aiua-8799	14	14	completed	complete	VERB
aiua-8799	14	15	the	the	DET
aiua-8799	14	16	hivec	hivec	NOUN
aiua-8799	14	17	®	®	NOUN
aiua-8799	14	18	protocol	protocol	NOUN
aiua-8799	14	19	(	(	PUNCT
aiua-8799	14	20	2	2	NUM
aiua-8799	14	21	)	)	PUNCT
aiua-8799	14	22	.	.	PUNCT
aiua-8799	15	1	in	in	ADP
aiua-8799	15	2	a	a	DET
aiua-8799	15	3	population	population	NOUN
aiua-8799	15	4	of	of	ADP
aiua-8799	15	5	55	55	NUM
aiua-8799	15	6	bcg	bcg	NOUN
aiua-8799	15	7	(	(	PUNCT
aiua-8799	15	8	bacillus	bacillus	NOUN
aiua-8799	15	9	calmetteguérin	calmetteguérin	NOUN
aiua-8799	15	10	)	)	PUNCT
aiua-8799	15	11	unresponsive	unresponsive	ADJ
aiua-8799	15	12	non	non	ADJ
aiua-8799	15	13	-	-	ADJ
aiua-8799	15	14	muscle	muscle	ADJ
aiua-8799	15	15	invasive	invasive	ADJ
aiua-8799	15	16	bladder	bladder	NOUN
aiua-8799	15	17	cancer	cancer	NOUN
aiua-8799	15	18	(	(	PUNCT
aiua-8799	15	19	nmibc	nmibc	ADJ
aiua-8799	15	20	)	)	PUNCT
aiua-8799	15	21	patients	patient	NOUN
aiua-8799	15	22	,	,	PUNCT
aiua-8799	15	23	5	5	NUM
aiua-8799	15	24	%	%	NOUN
aiua-8799	15	25	of	of	ADP
aiua-8799	15	26	the	the	DET
aiua-8799	15	27	patients	patient	NOUN
aiua-8799	15	28	did	do	AUX
aiua-8799	15	29	not	not	PART
aiua-8799	15	30	complete	complete	VERB
aiua-8799	15	31	at	at	ADV
aiua-8799	15	32	least	least	ADV
aiua-8799	15	33	5	5	NUM
aiua-8799	15	34	hivec	hivec	NOUN
aiua-8799	15	35	®	®	NOUN
aiua-8799	15	36	instillations	instillation	NOUN
aiua-8799	15	37	because	because	SCONJ
aiua-8799	15	38	of	of	ADP
aiua-8799	15	39	facial	facial	ADJ
aiua-8799	15	40	swelling	swelling	NOUN
aiua-8799	15	41	,	,	PUNCT
aiua-8799	15	42	urticaria	urticaria	NOUN
aiua-8799	15	43	and	and	CCONJ
aiua-8799	15	44	urinary	urinary	ADJ
aiua-8799	15	45	tract	tract	NOUN
aiua-8799	15	46	pain	pain	NOUN
aiua-8799	15	47	grade	grade	NOUN
aiua-8799	15	48	3	3	NUM
aiua-8799	15	49	according	accord	VERB
aiua-8799	15	50	to	to	ADP
aiua-8799	15	51	common	common	ADJ
aiua-8799	15	52	terminology	terminology	NOUN
aiua-8799	15	53	criteria	criterion	NOUN
aiua-8799	15	54	for	for	ADP
aiua-8799	15	55	adverse	adverse	ADJ
aiua-8799	15	56	events	event	NOUN
aiua-8799	15	57	(	(	PUNCT
aiua-8799	15	58	ctcae	ctcae	NOUN
aiua-8799	15	59	)	)	PUNCT
aiua-8799	15	60	.	.	PUNCT
aiua-8799	16	1	despite	despite	SCONJ
aiua-8799	16	2	this	this	PRON
aiua-8799	16	3	,	,	PUNCT
aiua-8799	16	4	7	7	NUM
aiua-8799	16	5	%	%	NOUN
aiua-8799	16	6	of	of	ADP
aiua-8799	16	7	patients	patient	NOUN
aiua-8799	16	8	reported	report	VERB
aiua-8799	16	9	ctcae	ctcae	NOUN
aiua-8799	16	10	grade	grade	NOUN
aiua-8799	16	11	1	1	NUM
aiua-8799	16	12	bladder	bladder	NOUN
aiua-8799	16	13	spams	spam	NOUN
aiua-8799	16	14	,	,	PUNCT
aiua-8799	16	15	11	11	NUM
aiua-8799	16	16	%	%	NOUN
aiua-8799	16	17	ctcae	ctcae	NOUN
aiua-8799	16	18	grade	grade	NOUN
aiua-8799	16	19	1	1	NUM
aiua-8799	16	20	urinary	urinary	ADJ
aiua-8799	16	21	frequency	frequency	NOUN
aiua-8799	16	22	/	/	SYM
aiua-8799	16	23	urgency	urgency	NOUN
aiua-8799	16	24	,	,	PUNCT
aiua-8799	16	25	24	24	NUM
aiua-8799	16	26	%	%	NOUN
aiua-8799	16	27	ctcae	ctcae	NOUN
aiua-8799	16	28	grade	grade	NOUN
aiua-8799	16	29	2	2	NUM
aiua-8799	16	30	urinary	urinary	ADJ
aiua-8799	16	31	frequency	frequency	NOUN
aiua-8799	16	32	/	/	SYM
aiua-8799	16	33	urgency	urgency	NOUN
aiua-8799	16	34	,	,	PUNCT
aiua-8799	16	35	4	4	NUM
aiua-8799	16	36	%	%	NOUN
aiua-8799	16	37	ctcae	ctcae	NOUN
aiua-8799	16	38	grade	grade	NOUN
aiua-8799	16	39	1	1	NUM
aiua-8799	16	40	urinary	urinary	ADJ
aiua-8799	16	41	tract	tract	NOUN
aiua-8799	16	42	pain	pain	NOUN
aiua-8799	16	43	,	,	PUNCT
aiua-8799	16	44	9	9	NUM
aiua-8799	16	45	%	%	NOUN
aiua-8799	16	46	ctcae	ctcae	NOUN
aiua-8799	16	47	grade	grade	NOUN
aiua-8799	16	48	2	2	NUM
aiua-8799	16	49	urinary	urinary	ADJ
aiua-8799	16	50	tract	tract	NOUN
aiua-8799	16	51	pain	pain	NOUN
aiua-8799	16	52	and	and	CCONJ
aiua-8799	16	53	2	2	NUM
aiua-8799	16	54	%	%	NOUN
aiua-8799	16	55	ctcae	ctcae	NOUN
aiua-8799	16	56	grade	grade	NOUN
aiua-8799	16	57	3	3	NUM
aiua-8799	16	58	urinary	urinary	ADJ
aiua-8799	16	59	tract	tract	NOUN
aiua-8799	16	60	pain	pain	NOUN
aiua-8799	16	61	(	(	PUNCT
aiua-8799	16	62	3	3	NUM
aiua-8799	16	63	)	)	PUNCT
aiua-8799	16	64	.	.	PUNCT
aiua-8799	17	1	despite	despite	SCONJ
aiua-8799	17	2	the	the	DET
aiua-8799	17	3	low	low	ADJ
aiua-8799	17	4	number	number	NOUN
aiua-8799	17	5	of	of	ADP
aiua-8799	17	6	adverse	adverse	ADJ
aiua-8799	17	7	events	event	NOUN
aiua-8799	17	8	,	,	PUNCT
aiua-8799	17	9	the	the	DET
aiua-8799	17	10	patients	patient	NOUN
aiua-8799	17	11	treated	treat	VERB
aiua-8799	17	12	with	with	ADP
aiua-8799	17	13	hivec	hivec	NOUN
aiua-8799	17	14	®	®	NOUN
aiua-8799	17	15	were	be	AUX
aiua-8799	17	16	significantly	significantly	ADV
aiua-8799	17	17	more	more	ADV
aiua-8799	17	18	likely	likely	ADJ
aiua-8799	17	19	to	to	PART
aiua-8799	17	20	develop	develop	VERB
aiua-8799	17	21	urinary	urinary	ADJ
aiua-8799	17	22	frequency	frequency	NOUN
aiua-8799	17	23	,	,	PUNCT
aiua-8799	17	24	haematuria	haematuria	NOUN
aiua-8799	17	25	and	and	CCONJ
aiua-8799	17	26	bladder	bladder	NOUN
aiua-8799	17	27	spasm	spasm	NOUN
aiua-8799	17	28	than	than	ADP
aiua-8799	17	29	passive	passive	ADJ
aiua-8799	17	30	mitomycin	mitomycin	NOUN
aiua-8799	17	31	-	-	PUNCT
aiua-8799	17	32	c	c	NOUN
aiua-8799	17	33	(	(	PUNCT
aiua-8799	17	34	4	4	NUM
aiua-8799	17	35	)	)	PUNCT
aiua-8799	17	36	.	.	PUNCT
aiua-8799	18	1	the	the	DET
aiua-8799	18	2	aim	aim	NOUN
aiua-8799	18	3	of	of	ADP
aiua-8799	18	4	this	this	DET
aiua-8799	18	5	study	study	NOUN
aiua-8799	18	6	was	be	AUX
aiua-8799	18	7	to	to	PART
aiua-8799	18	8	analyse	analyse	VERB
aiua-8799	18	9	the	the	DET
aiua-8799	18	10	role	role	NOUN
aiua-8799	18	11	of	of	ADP
aiua-8799	18	12	two	two	NUM
aiua-8799	18	13	alkaloid	alkaloid	NOUN
aiua-8799	18	14	,	,	PUNCT
aiua-8799	18	15	protopine	protopine	NOUN
aiua-8799	18	16	and	and	CCONJ
aiua-8799	18	17	nuciferinein	nuciferinein	VERB
aiua-8799	18	18	the	the	DET
aiua-8799	18	19	prevention	prevention	NOUN
aiua-8799	18	20	and	and	CCONJ
aiua-8799	18	21	the	the	DET
aiua-8799	18	22	treatment	treatment	NOUN
aiua-8799	18	23	of	of	ADP
aiua-8799	18	24	the	the	DET
aiua-8799	18	25	low	low	ADJ
aiua-8799	18	26	and	and	CCONJ
aiua-8799	18	27	mild	mild	ADJ
aiua-8799	18	28	grade	grade	NOUN
aiua-8799	18	29	adverse	adverse	ADJ
aiua-8799	18	30	events	event	NOUN
aiua-8799	18	31	related	relate	VERB
aiua-8799	18	32	to	to	ADP
aiua-8799	18	33	the	the	DET
aiua-8799	18	34	use	use	NOUN
aiua-8799	18	35	of	of	ADP
aiua-8799	18	36	hivec	hivec	NOUN
aiua-8799	18	37	®	®	NOUN
aiua-8799	18	38	instillations	instillation	NOUN
aiua-8799	18	39	.	.	PUNCT
aiua-8799	19	1	materials	material	NOUN
aiua-8799	19	2	and	and	CCONJ
aiua-8799	19	3	methods	method	NOUN
aiua-8799	19	4	from	from	ADP
aiua-8799	19	5	september	september	PROPN
aiua-8799	19	6	2017	2017	NUM
aiua-8799	19	7	to	to	ADP
aiua-8799	19	8	september	september	PROPN
aiua-8799	19	9	2019	2019	NUM
aiua-8799	19	10	,	,	PUNCT
aiua-8799	19	11	100	100	NUM
aiua-8799	19	12	patients	patient	NOUN
aiua-8799	19	13	with	with	ADP
aiua-8799	19	14	bacillus	bacillus	NOUN
aiua-8799	19	15	of	of	ADP
aiua-8799	19	16	calmette	calmette	PROPN
aiua-8799	19	17	guerin	guerin	PROPN
aiua-8799	19	18	(	(	PUNCT
aiua-8799	19	19	bcg)-failure	bcg)-failure	PROPN
aiua-8799	19	20	(	(	PUNCT
aiua-8799	19	21	including	include	VERB
aiua-8799	19	22	bcg	bcg	NOUN
aiua-8799	19	23	-	-	PUNCT
aiua-8799	19	24	refractory	refractory	NOUN
aiua-8799	19	25	tumour	tumour	NOUN
aiua-8799	19	26	,	,	PUNCT
aiua-8799	19	27	bcg	bcg	NOUN
aiua-8799	19	28	-	-	PUNCT
aiua-8799	19	29	relapsing	relapse	VERB
aiua-8799	19	30	tumour	tumour	NOUN
aiua-8799	19	31	and	and	CCONJ
aiua-8799	19	32	bcg	bcg	PROPN
aiua-8799	19	33	unresponsive	unresponsive	ADJ
aiua-8799	19	34	tumour	tumour	NOUN
aiua-8799	19	35	)	)	PUNCT
aiua-8799	19	36	nmibc	nmibc	ADP
aiua-8799	19	37	whose	whose	DET
aiua-8799	19	38	underwent	underwent	ADJ
aiua-8799	19	39	hivec	hivec	NOUN
aiua-8799	19	40	®	®	NOUN
aiua-8799	19	41	chemotherapy	chemotherapy	NOUN
aiua-8799	19	42	were	be	AUX
aiua-8799	19	43	prospectively	prospectively	ADV
aiua-8799	19	44	enrolled	enrol	VERB
aiua-8799	19	45	in	in	ADP
aiua-8799	19	46	this	this	DET
aiua-8799	19	47	study	study	NOUN
aiua-8799	19	48	.	.	PUNCT
aiua-8799	20	1	the	the	DET
aiua-8799	20	2	patients	patient	NOUN
aiua-8799	20	3	(	(	PUNCT
aiua-8799	20	4	pts	pt	NOUN
aiua-8799	20	5	)	)	PUNCT
aiua-8799	20	6	were	be	AUX
aiua-8799	20	7	randomized	randomize	VERB
aiua-8799	20	8	into	into	ADP
aiua-8799	20	9	two	two	NUM
aiua-8799	20	10	groups	group	NOUN
aiua-8799	20	11	using	use	VERB
aiua-8799	20	12	block	block	NOUN
aiua-8799	20	13	randomization	randomization	NOUN
aiua-8799	20	14	in	in	ADP
aiua-8799	20	15	order	order	NOUN
aiua-8799	20	16	to	to	PART
aiua-8799	20	17	obtain	obtain	VERB
aiua-8799	20	18	two	two	NUM
aiua-8799	20	19	groups	group	NOUN
aiua-8799	20	20	of	of	ADP
aiua-8799	20	21	equal	equal	ADJ
aiua-8799	20	22	sample	sample	NOUN
aiua-8799	20	23	size	size	NOUN
aiua-8799	20	24	.	.	PUNCT
aiua-8799	21	1	in	in	ADP
aiua-8799	21	2	group	group	PROPN
aiua-8799	21	3	a	a	NOUN
aiua-8799	21	4	,	,	PUNCT
aiua-8799	21	5	we	we	PRON
aiua-8799	21	6	enrolled	enrol	VERB
aiua-8799	21	7	50	50	NUM
aiua-8799	21	8	patients	patient	NOUN
aiua-8799	21	9	who	who	PRON
aiua-8799	21	10	received	receive	VERB
aiua-8799	21	11	protoves	protove	NOUN
aiua-8799	21	12	m1	m1	PROPN
aiua-8799	21	13	®	®	PROPN
aiua-8799	21	14	(	(	PUNCT
aiua-8799	21	15	protopine	protopine	NOUN
aiua-8799	21	16	and	and	CCONJ
aiua-8799	21	17	nuciferine	nuciferine	ADJ
aiua-8799	21	18	)	)	PUNCT
aiua-8799	21	19	syrup	syrup	NOUN
aiua-8799	21	20	,	,	PUNCT
aiua-8799	21	21	10	10	NUM
aiua-8799	21	22	ml	ml	NOUN
aiua-8799	21	23	,	,	PUNCT
aiua-8799	21	24	once	once	ADV
aiua-8799	21	25	a	a	DET
aiua-8799	21	26	day	day	NOUN
aiua-8799	21	27	,	,	PUNCT
aiua-8799	21	28	for	for	ADP
aiua-8799	21	29	8	8	NUM
aiua-8799	21	30	weeks	week	NOUN
aiua-8799	21	31	.	.	PUNCT
aiua-8799	22	1	in	in	ADP
aiua-8799	22	2	group	group	PROPN
aiua-8799	22	3	b	b	PROPN
aiua-8799	22	4	,	,	PUNCT
aiua-8799	22	5	we	we	PRON
aiua-8799	22	6	enrolled	enrol	VERB
aiua-8799	22	7	50	50	NUM
aiua-8799	22	8	patients	patient	NOUN
aiua-8799	22	9	who	who	PRON
aiua-8799	22	10	received	receive	VERB
aiua-8799	22	11	placebo	placebo	NOUN
aiua-8799	22	12	(	(	PUNCT
aiua-8799	22	13	flavoured	flavoured	ADJ
aiua-8799	22	14	coloured	coloured	ADJ
aiua-8799	22	15	water	water	NOUN
aiua-8799	22	16	)	)	PUNCT
aiua-8799	22	17	,	,	PUNCT
aiua-8799	22	18	10	10	NUM
aiua-8799	22	19	ml	ml	NOUN
aiua-8799	22	20	,	,	PUNCT
aiua-8799	22	21	once	once	ADV
aiua-8799	22	22	a	a	DET
aiua-8799	22	23	day	day	NOUN
aiua-8799	22	24	,	,	PUNCT
aiua-8799	22	25	for	for	ADP
aiua-8799	22	26	8	8	NUM
aiua-8799	22	27	weeks	week	NOUN
aiua-8799	22	28	.	.	PUNCT
aiua-8799	23	1	they	they	PRON
aiua-8799	23	2	started	start	VERB
aiua-8799	23	3	the	the	DET
aiua-8799	23	4	therapy	therapy	NOUN
aiua-8799	23	5	two	two	NUM
aiua-8799	23	6	weeks	week	NOUN
aiua-8799	23	7	before	before	ADP
aiua-8799	23	8	the	the	DET
aiua-8799	23	9	beginning	beginning	NOUN
aiua-8799	23	10	of	of	ADP
aiua-8799	23	11	hivec	hivec	NOUN
aiua-8799	23	12	®	®	NOUN
aiua-8799	23	13	treatment	treatment	NOUN
aiua-8799	23	14	.	.	PUNCT
aiua-8799	24	1	inclusion	inclusion	NOUN
aiua-8799	24	2	criteria	criterion	NOUN
aiua-8799	24	3	covered	cover	VERB
aiua-8799	24	4	all	all	DET
aiua-8799	24	5	the	the	DET
aiua-8799	24	6	patients	patient	NOUN
aiua-8799	24	7	with	with	ADP
aiua-8799	24	8	intermediate	intermediate	ADJ
aiua-8799	24	9	-	-	PUNCT
aiua-8799	24	10	and	and	CCONJ
aiua-8799	24	11	high	high	ADJ
aiua-8799	24	12	-	-	PUNCT
aiua-8799	24	13	risk	risk	NOUN
aiua-8799	24	14	nmibc	nmibc	ADJ
aiua-8799	24	15	patients	patient	NOUN
aiua-8799	24	16	who	who	PRON
aiua-8799	24	17	were	be	AUX
aiua-8799	24	18	planned	plan	VERB
aiua-8799	24	19	to	to	PART
aiua-8799	24	20	receive	receive	VERB
aiua-8799	24	21	hivec	hivec	NOUN
aiua-8799	24	22	®	®	NOUN
aiua-8799	24	23	treatment	treatment	NOUN
aiua-8799	24	24	.	.	PUNCT
aiua-8799	25	1	patients	patient	NOUN
aiua-8799	25	2	with	with	ADP
aiua-8799	25	3	uncontrolled	uncontrolled	ADJ
aiua-8799	25	4	underlying	underlying	ADJ
aiua-8799	25	5	diseases	disease	NOUN
aiua-8799	25	6	(	(	PUNCT
aiua-8799	25	7	asa	asa	PROPN
aiua-8799	25	8	iii	iii	PROPN
aiua-8799	25	9	or	or	CCONJ
aiua-8799	25	10	iv	iv	NUM
aiua-8799	25	11	)	)	PUNCT
aiua-8799	25	12	,	,	PUNCT
aiua-8799	25	13	post	post	VERB
aiua-8799	25	14	void	void	VERB
aiua-8799	25	15	residual	residual	ADJ
aiua-8799	25	16	urine	urine	NOUN
aiua-8799	25	17	≥	≥	NUM
aiua-8799	25	18	100	100	NUM
aiua-8799	25	19	ml	ml	ADP
aiua-8799	25	20	,	,	PUNCT
aiua-8799	25	21	bleeding	bleed	VERB
aiua-8799	25	22	tendency	tendency	NOUN
aiua-8799	25	23	,	,	PUNCT
aiua-8799	25	24	drug	drug	NOUN
aiua-8799	25	25	abuse	abuse	NOUN
aiua-8799	25	26	,	,	PUNCT
aiua-8799	25	27	chronic	chronic	ADJ
aiua-8799	25	28	pelvic	pelvic	ADJ
aiua-8799	25	29	pain	pain	NOUN
aiua-8799	25	30	,	,	PUNCT
aiua-8799	25	31	urinary	urinary	ADJ
aiua-8799	25	32	tract	tract	NOUN
aiua-8799	25	33	infection	infection	NOUN
aiua-8799	25	34	,	,	PUNCT
aiua-8799	25	35	neurological	neurological	ADJ
aiua-8799	25	36	disease	disease	NOUN
aiua-8799	25	37	,	,	PUNCT
aiua-8799	25	38	bladder	bladder	NOUN
aiua-8799	25	39	lithiasis	lithiasis	NOUN
aiua-8799	25	40	,	,	PUNCT
aiua-8799	25	41	renal	renal	ADJ
aiua-8799	25	42	or	or	CCONJ
aiua-8799	25	43	liver	liver	NOUN
aiua-8799	25	44	failure	failure	NOUN
aiua-8799	25	45	,	,	PUNCT
aiua-8799	25	46	tachycardia	tachycardia	NOUN
aiua-8799	25	47	and	and	CCONJ
aiua-8799	25	48	heart	heart	NOUN
aiua-8799	25	49	failure	failure	NOUN
aiua-8799	25	50	were	be	AUX
aiua-8799	25	51	summary	summary	NOUN
aiua-8799	25	52	04chiancone_stesura	04chiancone_stesura	ADJ
aiua-8799	25	53	seveso	seveso	PROPN
aiua-8799	25	54	24/09/20	24/09/20	PROPN
aiua-8799	25	55	14:13	14:13	NUM
aiua-8799	25	56	pagina	pagina	NOUN
aiua-8799	25	57	177	177	NUM
aiua-8799	25	58	archivio	archivio	NOUN
aiua-8799	25	59	italiano	italiano	X
aiua-8799	25	60	di	di	X
aiua-8799	25	61	urologia	urologia	PROPN
aiua-8799	25	62	e	e	PROPN
aiua-8799	25	63	andrologia	andrologia	NOUN
aiua-8799	25	64	2020	2020	NUM
aiua-8799	25	65	;	;	PUNCT
aiua-8799	25	66	92	92	NUM
aiua-8799	25	67	,	,	PUNCT
aiua-8799	25	68	3	3	NUM
aiua-8799	25	69	f.	f.	PROPN
aiua-8799	25	70	chiancone	chiancone	PROPN
aiua-8799	25	71	,	,	PUNCT
aiua-8799	25	72	m.	m.	NOUN
aiua-8799	25	73	carrino	carrino	PROPN
aiua-8799	25	74	,	,	PUNCT
aiua-8799	25	75	m.	m.	NOUN
aiua-8799	25	76	fedelini	fedelini	PROPN
aiua-8799	25	77	,	,	PUNCT
aiua-8799	25	78	m.	m.	NOUN
aiua-8799	25	79	fabiano	fabiano	PROPN
aiua-8799	25	80	,	,	PUNCT
aiua-8799	25	81	f.	f.	PROPN
aiua-8799	25	82	persico	persico	PROPN
aiua-8799	25	83	,	,	PUNCT
aiua-8799	25	84	c.	c.	PROPN
aiua-8799	25	85	meccariello	meccariello	PROPN
aiua-8799	25	86	,	,	PUNCT
aiua-8799	25	87	p.	p.	NOUN
aiua-8799	25	88	fedelini	fedelini	PROPN
aiua-8799	26	1	178	178	NUM
aiua-8799	26	2	excluded	exclude	VERB
aiua-8799	26	3	from	from	ADP
aiua-8799	26	4	the	the	DET
aiua-8799	26	5	study	study	NOUN
aiua-8799	26	6	.	.	PUNCT
aiua-8799	27	1	male	male	ADJ
aiua-8799	27	2	patients	patient	NOUN
aiua-8799	27	3	with	with	ADP
aiua-8799	27	4	lower	low	ADJ
aiua-8799	27	5	urinary	urinary	ADJ
aiua-8799	27	6	tract	tract	NOUN
aiua-8799	27	7	symptoms	symptom	NOUN
aiua-8799	27	8	(	(	PUNCT
aiua-8799	27	9	luts	luts	PROPN
aiua-8799	27	10	)	)	PUNCT
aiua-8799	27	11	and	and	CCONJ
aiua-8799	27	12	benign	benign	ADJ
aiua-8799	27	13	prostatic	prostatic	ADJ
aiua-8799	27	14	hyperplasia	hyperplasia	NOUN
aiua-8799	27	15	(	(	PUNCT
aiua-8799	27	16	bph	bph	NOUN
aiua-8799	27	17	)	)	PUNCT
aiua-8799	27	18	were	be	AUX
aiua-8799	27	19	not	not	PART
aiua-8799	27	20	excluded	exclude	VERB
aiua-8799	27	21	from	from	ADP
aiua-8799	27	22	the	the	DET
aiua-8799	27	23	study	study	NOUN
aiua-8799	27	24	if	if	SCONJ
aiua-8799	27	25	they	they	PRON
aiua-8799	27	26	had	have	VERB
aiua-8799	27	27	normal	normal	ADJ
aiua-8799	27	28	values	value	NOUN
aiua-8799	27	29	of	of	ADP
aiua-8799	27	30	uroflowmetry	uroflowmetry	NOUN
aiua-8799	27	31	and	and	CCONJ
aiua-8799	27	32	they	they	PRON
aiua-8799	27	33	did	do	AUX
aiua-8799	27	34	not	not	PART
aiua-8799	27	35	assume	assume	VERB
aiua-8799	27	36	any	any	DET
aiua-8799	27	37	medical	medical	ADJ
aiua-8799	27	38	treatment	treatment	NOUN
aiua-8799	27	39	for	for	ADP
aiua-8799	27	40	bph	bph	NOUN
aiua-8799	27	41	.	.	PUNCT
aiua-8799	28	1	at	at	ADP
aiua-8799	28	2	the	the	DET
aiua-8799	28	3	baseline	baseline	NOUN
aiua-8799	28	4	,	,	PUNCT
aiua-8799	28	5	data	datum	NOUN
aiua-8799	28	6	on	on	ADP
aiua-8799	28	7	demographic	demographic	ADJ
aiua-8799	28	8	and	and	CCONJ
aiua-8799	28	9	anthropometric	anthropometric	ADJ
aiua-8799	28	10	features	feature	NOUN
aiua-8799	28	11	(	(	PUNCT
aiua-8799	28	12	age	age	NOUN
aiua-8799	28	13	,	,	PUNCT
aiua-8799	28	14	weight	weight	NOUN
aiua-8799	28	15	,	,	PUNCT
aiua-8799	28	16	height	height	NOUN
aiua-8799	28	17	,	,	PUNCT
aiua-8799	28	18	bmi	bmi	X
aiua-8799	29	1	[	[	X
aiua-8799	29	2	body	body	NOUN
aiua-8799	29	3	mass	mass	PROPN
aiua-8799	29	4	index	index	NOUN
aiua-8799	29	5	]	]	PUNCT
aiua-8799	29	6	)	)	PUNCT
aiua-8799	29	7	,	,	PUNCT
aiua-8799	29	8	lifestyle	lifestyle	NOUN
aiua-8799	29	9	characteristics	characteristic	NOUN
aiua-8799	29	10	(	(	PUNCT
aiua-8799	29	11	smoke	smoke	NOUN
aiua-8799	29	12	,	,	PUNCT
aiua-8799	29	13	alcohol	alcohol	NOUN
aiua-8799	29	14	)	)	PUNCT
aiua-8799	29	15	,	,	PUNCT
aiua-8799	29	16	any	any	DET
aiua-8799	29	17	comorbidities	comorbiditie	NOUN
aiua-8799	29	18	(	(	PUNCT
aiua-8799	29	19	hypertension	hypertension	NOUN
aiua-8799	29	20	,	,	PUNCT
aiua-8799	29	21	diabetes	diabetes	NOUN
aiua-8799	29	22	mellitus	mellitus	NOUN
aiua-8799	29	23	,	,	PUNCT
aiua-8799	29	24	etc	etc	X
aiua-8799	29	25	.	.	X
aiua-8799	29	26	)	)	PUNCT
aiua-8799	29	27	were	be	AUX
aiua-8799	29	28	collected	collect	VERB
aiua-8799	29	29	.	.	PUNCT
aiua-8799	30	1	all	all	DET
aiua-8799	30	2	patients	patient	NOUN
aiua-8799	30	3	underwent	undergo	VERB
aiua-8799	30	4	a	a	DET
aiua-8799	30	5	clinical	clinical	ADJ
aiua-8799	30	6	evaluation	evaluation	NOUN
aiua-8799	30	7	(	(	PUNCT
aiua-8799	30	8	comprised	comprise	VERB
aiua-8799	30	9	general	general	ADJ
aiua-8799	30	10	,	,	PUNCT
aiua-8799	30	11	genital	genital	ADJ
aiua-8799	30	12	and	and	CCONJ
aiua-8799	30	13	urologic	urologic	ADJ
aiua-8799	30	14	examination	examination	NOUN
aiua-8799	30	15	)	)	PUNCT
aiua-8799	30	16	.	.	PUNCT
aiua-8799	31	1	before	before	ADP
aiua-8799	31	2	starting	start	VERB
aiua-8799	31	3	the	the	DET
aiua-8799	31	4	treatment	treatment	NOUN
aiua-8799	31	5	,	,	PUNCT
aiua-8799	31	6	the	the	DET
aiua-8799	31	7	following	follow	VERB
aiua-8799	31	8	measurements	measurement	NOUN
aiua-8799	31	9	were	be	AUX
aiua-8799	31	10	collected	collect	VERB
aiua-8799	31	11	:	:	PUNCT
aiua-8799	31	12	prostate	prostate	NOUN
aiua-8799	31	13	volume	volume	NOUN
aiua-8799	31	14	by	by	ADP
aiua-8799	31	15	transrectal	transrectal	ADJ
aiua-8799	31	16	ultrasound	ultrasound	PROPN
aiua-8799	31	17	,	,	PUNCT
aiua-8799	31	18	prostate	prostate	NOUN
aiua-8799	31	19	specific	specific	ADJ
aiua-8799	31	20	antigen	antigen	NOUN
aiua-8799	31	21	(	(	PUNCT
aiua-8799	31	22	psa	psa	NOUN
aiua-8799	31	23	)	)	PUNCT
aiua-8799	31	24	,	,	PUNCT
aiua-8799	31	25	uroflowmetry	uroflowmetry	NOUN
aiua-8799	31	26	parameters	parameter	NOUN
aiua-8799	31	27	(	(	PUNCT
aiua-8799	31	28	uroflow	uroflow	NOUN
aiua-8799	31	29	-	-	PUNCT
aiua-8799	31	30	qmax	qmax	NOUN
aiua-8799	31	31	,	,	PUNCT
aiua-8799	31	32	uroflowvoided	uroflowvoided	ADJ
aiua-8799	31	33	volume	volume	NOUN
aiua-8799	31	34	,	,	PUNCT
aiua-8799	31	35	uroflow	uroflow	ADJ
aiua-8799	31	36	-	-	PUNCT
aiua-8799	31	37	pvr	pvr	NOUN
aiua-8799	32	1	[	[	X
aiua-8799	32	2	post	post	ADJ
aiua-8799	32	3	-	-	ADJ
aiua-8799	32	4	void	void	ADJ
aiua-8799	32	5	residual	residual	ADJ
aiua-8799	32	6	]	]	X
aiua-8799	32	7	)	)	PUNCT
aiua-8799	32	8	,	,	PUNCT
aiua-8799	32	9	international	international	ADJ
aiua-8799	32	10	prostatic	prostatic	ADJ
aiua-8799	32	11	symptoms	symptom	NOUN
aiua-8799	32	12	score	score	VERB
aiua-8799	32	13	(	(	PUNCT
aiua-8799	32	14	ipss	ipss	PROPN
aiua-8799	32	15	)	)	PUNCT
aiua-8799	32	16	questionnaire	questionnaire	NOUN
aiua-8799	32	17	,	,	PUNCT
aiua-8799	32	18	overactive	overactive	ADJ
aiua-8799	32	19	bladder	bladder	NOUN
aiua-8799	32	20	questionnaire	questionnaire	NOUN
aiua-8799	32	21	-	-	PUNCT
aiua-8799	32	22	short	short	ADJ
aiua-8799	32	23	form	form	NOUN
aiua-8799	32	24	(	(	PUNCT
aiua-8799	32	25	oabqsf	oabqsf	PROPN
aiua-8799	32	26	)	)	PUNCT
aiua-8799	32	27	6	6	NUM
aiua-8799	32	28	and	and	CCONJ
aiua-8799	32	29	13	13	NUM
aiua-8799	32	30	,	,	PUNCT
aiua-8799	32	31	patient	patient	ADJ
aiua-8799	32	32	perception	perception	NOUN
aiua-8799	32	33	of	of	ADP
aiua-8799	32	34	intensity	intensity	NOUN
aiua-8799	32	35	of	of	ADP
aiua-8799	32	36	urgency	urgency	NOUN
aiua-8799	32	37	scale	scale	NOUN
aiua-8799	32	38	(	(	PUNCT
aiua-8799	32	39	ppius	ppius	NOUN
aiua-8799	32	40	)	)	PUNCT
aiua-8799	32	41	,	,	PUNCT
aiua-8799	32	42	and	and	CCONJ
aiua-8799	32	43	visual	visual	ADJ
aiua-8799	32	44	analogue	analogue	NOUN
aiua-8799	32	45	scale	scale	NOUN
aiua-8799	32	46	(	(	PUNCT
aiua-8799	32	47	vas	vas	NOUN
aiua-8799	32	48	)	)	PUNCT
aiua-8799	32	49	.	.	PUNCT
aiua-8799	33	1	psa	psa	VERB
aiua-8799	33	2	and	and	CCONJ
aiua-8799	33	3	ipss	ipss	PROPN
aiua-8799	33	4	were	be	AUX
aiua-8799	33	5	investigated	investigate	VERB
aiua-8799	33	6	only	only	ADV
aiua-8799	33	7	in	in	ADP
aiua-8799	33	8	male	male	ADJ
aiua-8799	33	9	pts	pt	NOUN
aiua-8799	33	10	.	.	PUNCT
aiua-8799	34	1	in	in	ADP
aiua-8799	34	2	addition	addition	NOUN
aiua-8799	34	3	,	,	PUNCT
aiua-8799	34	4	the	the	DET
aiua-8799	34	5	patient	patient	ADJ
aiua-8799	34	6	impression	impression	NOUN
aiua-8799	34	7	of	of	ADP
aiua-8799	34	8	improvement	improvement	NOUN
aiua-8799	34	9	was	be	AUX
aiua-8799	34	10	assessed	assess	VERB
aiua-8799	34	11	.	.	PUNCT
aiua-8799	35	1	improvement	improvement	NOUN
aiua-8799	35	2	was	be	AUX
aiua-8799	35	3	evaluated	evaluate	VERB
aiua-8799	35	4	with	with	ADP
aiua-8799	35	5	the	the	DET
aiua-8799	35	6	patient	patient	ADJ
aiua-8799	35	7	global	global	ADJ
aiua-8799	35	8	impression	impression	NOUN
aiua-8799	35	9	of	of	ADP
aiua-8799	35	10	improvement	improvement	NOUN
aiua-8799	35	11	questionnaire	questionnaire	NOUN
aiua-8799	35	12	(	(	PUNCT
aiua-8799	35	13	pgi	pgi	PROPN
aiua-8799	35	14	-	-	PUNCT
aiua-8799	35	15	i	i	PROPN
aiua-8799	35	16	)	)	PUNCT
aiua-8799	35	17	,	,	PUNCT
aiua-8799	35	18	a	a	DET
aiua-8799	35	19	validated	validate	VERB
aiua-8799	35	20	tool	tool	NOUN
aiua-8799	35	21	to	to	PART
aiua-8799	35	22	estimate	estimate	VERB
aiua-8799	35	23	the	the	DET
aiua-8799	35	24	improvement	improvement	NOUN
aiua-8799	35	25	or	or	CCONJ
aiua-8799	35	26	the	the	DET
aiua-8799	35	27	deterioration	deterioration	NOUN
aiua-8799	35	28	associated	associate	VERB
aiua-8799	35	29	to	to	ADP
aiua-8799	35	30	the	the	DET
aiua-8799	35	31	treatment	treatment	NOUN
aiua-8799	35	32	.	.	PUNCT
aiua-8799	36	1	the	the	DET
aiua-8799	36	2	primary	primary	ADJ
aiua-8799	36	3	endpoint	endpoint	NOUN
aiua-8799	36	4	was	be	AUX
aiua-8799	36	5	the	the	DET
aiua-8799	36	6	evaluation	evaluation	NOUN
aiua-8799	36	7	of	of	ADP
aiua-8799	36	8	the	the	DET
aiua-8799	36	9	efficacy	efficacy	NOUN
aiua-8799	36	10	of	of	ADP
aiua-8799	36	11	the	the	DET
aiua-8799	36	12	therapy	therapy	NOUN
aiua-8799	36	13	with	with	ADP
aiua-8799	36	14	protopine	protopine	NOUN
aiua-8799	36	15	and	and	CCONJ
aiua-8799	36	16	nuciferine	nuciferine	NOUN
aiua-8799	36	17	in	in	ADP
aiua-8799	36	18	controlling	control	VERB
aiua-8799	36	19	irritative	irritative	ADJ
aiua-8799	36	20	symptoms	symptom	NOUN
aiua-8799	36	21	,	,	PUNCT
aiua-8799	36	22	including	include	VERB
aiua-8799	36	23	nocturia	nocturia	ADJ
aiua-8799	36	24	,	,	PUNCT
aiua-8799	36	25	urinary	urinary	ADJ
aiua-8799	36	26	frequency	frequency	NOUN
aiua-8799	36	27	,	,	PUNCT
aiua-8799	36	28	bladder	bladder	NOUN
aiua-8799	36	29	pain	pain	NOUN
aiua-8799	36	30	,	,	PUNCT
aiua-8799	36	31	urgency	urgency	NOUN
aiua-8799	36	32	and	and	CCONJ
aiua-8799	36	33	urge	urge	VERB
aiua-8799	36	34	incontinence	incontinence	NOUN
aiua-8799	36	35	related	relate	VERB
aiua-8799	36	36	to	to	ADP
aiua-8799	36	37	the	the	DET
aiua-8799	36	38	chemo	chemo	NOUN
aiua-8799	36	39	-	-	PUNCT
aiua-8799	36	40	hypertermia	hypertermia	NOUN
aiua-8799	36	41	treatment	treatment	NOUN
aiua-8799	36	42	.	.	PUNCT
aiua-8799	37	1	the	the	DET
aiua-8799	37	2	secondary	secondary	ADJ
aiua-8799	37	3	endpoint	endpoint	NOUN
aiua-8799	37	4	we	we	PRON
aiua-8799	37	5	evaluated	evaluate	VERB
aiua-8799	37	6	was	be	AUX
aiua-8799	37	7	the	the	DET
aiua-8799	37	8	influence	influence	NOUN
aiua-8799	37	9	of	of	ADP
aiua-8799	37	10	the	the	DET
aiua-8799	37	11	treatment	treatment	NOUN
aiua-8799	37	12	on	on	ADP
aiua-8799	37	13	the	the	DET
aiua-8799	37	14	uroflowmetric	uroflowmetric	ADJ
aiua-8799	37	15	parameters	parameter	NOUN
aiua-8799	37	16	.	.	PUNCT
aiua-8799	38	1	evaluation	evaluation	NOUN
aiua-8799	38	2	was	be	AUX
aiua-8799	38	3	performed	perform	VERB
aiua-8799	38	4	after	after	ADP
aiua-8799	38	5	1	1	NUM
aiua-8799	38	6	week	week	NOUN
aiua-8799	38	7	and	and	CCONJ
aiua-8799	38	8	after	after	ADP
aiua-8799	38	9	6	6	NUM
aiua-8799	38	10	weeks	week	NOUN
aiua-8799	38	11	of	of	ADP
aiua-8799	38	12	therapy	therapy	NOUN
aiua-8799	38	13	.	.	PUNCT
aiua-8799	39	1	statistical	statistical	ADJ
aiua-8799	39	2	analyses	analysis	NOUN
aiua-8799	39	3	were	be	AUX
aiua-8799	39	4	conducted	conduct	VERB
aiua-8799	39	5	using	use	VERB
aiua-8799	39	6	sas	sas	PROPN
aiua-8799	39	7	version	version	PROPN
aiua-8799	39	8	9.3	9.3	NUM
aiua-8799	39	9	software	software	NOUN
aiua-8799	39	10	(	(	PUNCT
aiua-8799	39	11	sas	sas	PROPN
aiua-8799	39	12	institute	institute	PROPN
aiua-8799	39	13	,	,	PUNCT
aiua-8799	39	14	inc	inc	PROPN
aiua-8799	39	15	.	.	PROPN
aiua-8799	39	16	,	,	PUNCT
aiua-8799	39	17	nc	nc	PROPN
aiua-8799	39	18	)	)	PUNCT
aiua-8799	39	19	.	.	PUNCT
aiua-8799	40	1	mean	mean	VERB
aiua-8799	40	2	values	value	NOUN
aiua-8799	40	3	with	with	ADP
aiua-8799	40	4	standard	standard	ADJ
aiua-8799	40	5	deviations	deviation	NOUN
aiua-8799	40	6	(	(	PUNCT
aiua-8799	40	7	±	±	NOUN
aiua-8799	40	8	sd	sd	NOUN
aiua-8799	40	9	)	)	PUNCT
aiua-8799	40	10	were	be	AUX
aiua-8799	40	11	computed	compute	VERB
aiua-8799	40	12	and	and	CCONJ
aiua-8799	40	13	reported	report	VERB
aiua-8799	40	14	for	for	ADP
aiua-8799	40	15	all	all	DET
aiua-8799	40	16	items	item	NOUN
aiua-8799	40	17	.	.	PUNCT
aiua-8799	41	1	statistical	statistical	ADJ
aiua-8799	41	2	significance	significance	NOUN
aiua-8799	41	3	was	be	AUX
aiua-8799	41	4	achieved	achieve	VERB
aiua-8799	41	5	if	if	SCONJ
aiua-8799	41	6	p	p	NOUN
aiua-8799	41	7	-	-	PUNCT
aiua-8799	41	8	value	value	NOUN
aiua-8799	41	9	was	be	AUX
aiua-8799	41	10	≤	≤	NUM
aiua-8799	41	11	0.05	0.05	NUM
aiua-8799	41	12	(	(	PUNCT
aiua-8799	41	13	two	two	NUM
aiua-8799	41	14	-	-	PUNCT
aiua-8799	41	15	sides	side	NOUN
aiua-8799	41	16	)	)	PUNCT
aiua-8799	41	17	.	.	PUNCT
aiua-8799	42	1	results	result	NOUN
aiua-8799	42	2	table	table	VERB
aiua-8799	42	3	1	1	NUM
aiua-8799	42	4	depicts	depict	VERB
aiua-8799	42	5	patients	patient	NOUN
aiua-8799	42	6	’	'	PUNCT
aiua-8799	42	7	demographics	demographic	NOUN
aiua-8799	42	8	and	and	CCONJ
aiua-8799	42	9	baseline	baseline	PROPN
aiua-8799	42	10	characteristics	characteristic	NOUN
aiua-8799	42	11	.	.	PUNCT
aiua-8799	43	1	the	the	DET
aiua-8799	43	2	two	two	NUM
aiua-8799	43	3	groups	group	NOUN
aiua-8799	43	4	showed	show	VERB
aiua-8799	43	5	no	no	DET
aiua-8799	43	6	difference	difference	NOUN
aiua-8799	43	7	in	in	ADP
aiua-8799	43	8	terms	term	NOUN
aiua-8799	43	9	of	of	ADP
aiua-8799	43	10	patients	patient	NOUN
aiua-8799	43	11	’	'	PUNCT
aiua-8799	43	12	demographics	demographic	NOUN
aiua-8799	43	13	as	as	ADV
aiua-8799	43	14	well	well	ADV
aiua-8799	43	15	as	as	ADP
aiua-8799	43	16	tumour	tumour	ADJ
aiua-8799	43	17	characteristics	characteristic	NOUN
aiua-8799	43	18	in	in	ADP
aiua-8799	43	19	all	all	DET
aiua-8799	43	20	variables	variable	NOUN
aiua-8799	43	21	.	.	PUNCT
aiua-8799	44	1	of	of	ADP
aiua-8799	44	2	all	all	DET
aiua-8799	44	3	100	100	NUM
aiua-8799	44	4	patients	patient	NOUN
aiua-8799	44	5	enrolled	enrol	VERB
aiua-8799	44	6	,	,	PUNCT
aiua-8799	44	7	2/50	2/50	NUM
aiua-8799	44	8	(	(	PUNCT
aiua-8799	44	9	4	4	NUM
aiua-8799	44	10	%	%	NOUN
aiua-8799	44	11	)	)	PUNCT
aiua-8799	44	12	of	of	ADP
aiua-8799	44	13	group	group	PROPN
aiua-8799	44	14	b	b	PROPN
aiua-8799	44	15	withdrew	withdraw	VERB
aiua-8799	44	16	the	the	DET
aiua-8799	44	17	study	study	NOUN
aiua-8799	44	18	for	for	ADP
aiua-8799	44	19	adverse	adverse	ADJ
aiua-8799	44	20	events	event	NOUN
aiua-8799	44	21	of	of	ADP
aiua-8799	44	22	hivec	hivec	NOUN
aiua-8799	44	23	treatment	treatment	NOUN
aiua-8799	44	24	.	.	PUNCT
aiua-8799	45	1	in	in	ADP
aiua-8799	45	2	table	table	NOUN
aiua-8799	45	3	2	2	NUM
aiua-8799	45	4	and	and	CCONJ
aiua-8799	45	5	3	3	NUM
aiua-8799	45	6	we	we	PRON
aiua-8799	45	7	show	show	VERB
aiua-8799	45	8	a	a	DET
aiua-8799	45	9	comparison	comparison	NOUN
aiua-8799	45	10	of	of	ADP
aiua-8799	45	11	uroflowmetric	uroflowmetric	ADJ
aiua-8799	45	12	parameters	parameter	NOUN
aiua-8799	45	13	and	and	CCONJ
aiua-8799	45	14	questionnaires	questionnaire	NOUN
aiua-8799	45	15	from	from	ADP
aiua-8799	45	16	baseline	baseline	NOUN
aiua-8799	45	17	and	and	CCONJ
aiua-8799	45	18	one	one	NUM
aiua-8799	45	19	and	and	CCONJ
aiua-8799	45	20	six	six	NUM
aiua-8799	45	21	weeks	week	NOUN
aiua-8799	45	22	follow	follow	VERB
aiua-8799	45	23	up	up	ADP
aiua-8799	45	24	of	of	ADP
aiua-8799	45	25	treatment	treatment	NOUN
aiua-8799	45	26	in	in	ADP
aiua-8799	45	27	the	the	DET
aiua-8799	45	28	cases	case	NOUN
aiua-8799	45	29	(	(	PUNCT
aiua-8799	45	30	group	group	NOUN
aiua-8799	45	31	a	a	NOUN
aiua-8799	45	32	)	)	PUNCT
aiua-8799	45	33	and	and	CCONJ
aiua-8799	45	34	in	in	ADP
aiua-8799	45	35	the	the	DET
aiua-8799	45	36	controls	control	NOUN
aiua-8799	45	37	(	(	PUNCT
aiua-8799	45	38	group	group	NOUN
aiua-8799	45	39	b	b	NOUN
aiua-8799	45	40	)	)	PUNCT
aiua-8799	45	41	.	.	PUNCT
aiua-8799	46	1	the	the	DET
aiua-8799	46	2	uroflow	uroflow	ADJ
aiua-8799	46	3	parameters	parameter	NOUN
aiua-8799	46	4	(	(	PUNCT
aiua-8799	46	5	uroflow	uroflow	NOUN
aiua-8799	46	6	-	-	PUNCT
aiua-8799	46	7	qmax	qmax	NOUN
aiua-8799	46	8	,	,	PUNCT
aiua-8799	46	9	uroflow	uroflow	NOUN
aiua-8799	46	10	-	-	PUNCT
aiua-8799	46	11	voided	void	VERB
aiua-8799	46	12	volume	volume	NOUN
aiua-8799	46	13	,	,	PUNCT
aiua-8799	46	14	uroflow	uroflow	ADJ
aiua-8799	46	15	-	-	PUNCT
aiua-8799	46	16	pvr	pvr	NOUN
aiua-8799	46	17	)	)	PUNCT
aiua-8799	46	18	did	do	AUX
aiua-8799	46	19	not	not	PART
aiua-8799	46	20	show	show	VERB
aiua-8799	46	21	statistical	statistical	ADJ
aiua-8799	46	22	significant	significant	ADJ
aiua-8799	46	23	difference	difference	NOUN
aiua-8799	46	24	from	from	ADP
aiua-8799	46	25	baseline	baseline	NOUN
aiua-8799	46	26	in	in	ADP
aiua-8799	46	27	the	the	DET
aiua-8799	46	28	group	group	NOUN
aiua-8799	46	29	a	a	PRON
aiua-8799	46	30	and	and	CCONJ
aiua-8799	46	31	one	one	NUM
aiua-8799	46	32	and	and	CCONJ
aiua-8799	46	33	six	six	NUM
aiua-8799	46	34	weeks	week	NOUN
aiua-8799	46	35	follow	follow	NOUN
aiua-8799	46	36	-	-	PUNCT
aiua-8799	46	37	up	up	NOUN
aiua-8799	46	38	.	.	PUNCT
aiua-8799	47	1	otherwise	otherwise	ADV
aiua-8799	47	2	ipss	ipss	PROPN
aiua-8799	47	3	total	total	NOUN
aiua-8799	47	4	significantly	significantly	ADV
aiua-8799	47	5	increase	increase	VERB
aiua-8799	47	6	at	at	ADP
aiua-8799	47	7	one	one	NUM
aiua-8799	47	8	week	week	NOUN
aiua-8799	47	9	from	from	ADP
aiua-8799	47	10	baseline	baseline	PROPN
aiua-8799	47	11	(	(	PUNCT
aiua-8799	47	12	p	p	X
aiua-8799	47	13	<	<	X
aiua-8799	47	14	0.001	0.001	NUM
aiua-8799	47	15	)	)	PUNCT
aiua-8799	47	16	,	,	PUNCT
aiua-8799	47	17	but	but	CCONJ
aiua-8799	47	18	this	this	DET
aiua-8799	47	19	difference	difference	NOUN
aiua-8799	47	20	was	be	AUX
aiua-8799	47	21	not	not	PART
aiua-8799	47	22	significant	significant	ADJ
aiua-8799	47	23	at	at	ADP
aiua-8799	47	24	six	six	NUM
aiua-8799	47	25	weeks	week	NOUN
aiua-8799	47	26	when	when	SCONJ
aiua-8799	47	27	ipss	ipss	PROPN
aiua-8799	47	28	total	total	NOUN
aiua-8799	47	29	was	be	AUX
aiua-8799	47	30	not	not	PART
aiua-8799	47	31	significantly	significantly	ADV
aiua-8799	47	32	worse	bad	ADJ
aiua-8799	47	33	from	from	ADP
aiua-8799	47	34	baseline	baseline	PROPN
aiua-8799	47	35	(	(	PUNCT
aiua-8799	47	36	p	p	NOUN
aiua-8799	47	37	=	=	NOUN
aiua-8799	47	38	0.09	0.09	NUM
aiua-8799	47	39	)	)	PUNCT
aiua-8799	47	40	.	.	PUNCT
aiua-8799	48	1	in	in	ADP
aiua-8799	48	2	group	group	PROPN
aiua-8799	48	3	a	a	PRON
aiua-8799	48	4	the	the	DET
aiua-8799	48	5	quality	quality	NOUN
aiua-8799	48	6	of	of	ADP
aiua-8799	48	7	life	life	NOUN
aiua-8799	48	8	showed	show	VERB
aiua-8799	48	9	a	a	DET
aiua-8799	48	10	significant	significant	ADJ
aiua-8799	48	11	worsening	worsening	NOUN
aiua-8799	48	12	from	from	ADP
aiua-8799	48	13	baseline	baseline	NOUN
aiua-8799	48	14	after	after	ADP
aiua-8799	48	15	one	one	NUM
aiua-8799	48	16	week	week	NOUN
aiua-8799	48	17	and	and	CCONJ
aiua-8799	48	18	six	six	NUM
aiua-8799	48	19	weeks	week	NOUN
aiua-8799	48	20	of	of	ADP
aiua-8799	48	21	treatment	treatment	NOUN
aiua-8799	48	22	in	in	ADP
aiua-8799	48	23	all	all	DET
aiua-8799	48	24	parameters	parameter	NOUN
aiua-8799	48	25	and	and	CCONJ
aiua-8799	48	26	questionnaires	questionnaire	NOUN
aiua-8799	48	27	analyzed	analyze	VERB
aiua-8799	48	28	(	(	PUNCT
aiua-8799	48	29	oab	oab	PROPN
aiua-8799	48	30	-	-	PROPN
aiua-8799	48	31	q	q	PROPN
aiua-8799	48	32	sf6	sf6	PROPN
aiua-8799	48	33	,	,	PUNCT
aiua-8799	48	34	oab	oab	PROPN
aiua-8799	48	35	-	-	PROPN
aiua-8799	48	36	q	q	PROPN
aiua-8799	48	37	sf13	sf13	PROPN
aiua-8799	48	38	,	,	PUNCT
aiua-8799	48	39	ppius	ppius	NOUN
aiua-8799	48	40	,	,	PUNCT
aiua-8799	48	41	vas	vas	X
aiua-8799	48	42	scale	scale	NOUN
aiua-8799	48	43	)	)	PUNCT
aiua-8799	48	44	but	but	CCONJ
aiua-8799	48	45	after	after	ADP
aiua-8799	48	46	six	six	NUM
aiua-8799	48	47	weeks	week	NOUN
aiua-8799	48	48	of	of	ADP
aiua-8799	48	49	treatment	treatment	NOUN
aiua-8799	48	50	a	a	DET
aiua-8799	48	51	significanttable	significanttable	ADJ
aiua-8799	48	52	1	1	NUM
aiua-8799	48	53	.	.	PUNCT
aiua-8799	48	54	demographics	demographic	NOUN
aiua-8799	48	55	and	and	CCONJ
aiua-8799	48	56	baseline	baseline	PROPN
aiua-8799	48	57	characteristics	characteristic	NOUN
aiua-8799	48	58	of	of	ADP
aiua-8799	48	59	the	the	DET
aiua-8799	48	60	50	50	NUM
aiua-8799	48	61	cases	case	NOUN
aiua-8799	48	62	and	and	CCONJ
aiua-8799	48	63	50	50	NUM
aiua-8799	48	64	controls	control	NOUN
aiua-8799	48	65	.	.	PUNCT
aiua-8799	49	1	variable	variable	ADJ
aiua-8799	49	2	value	value	NOUN
aiua-8799	49	3	(	(	PUNCT
aiua-8799	49	4	cases	case	NOUN
aiua-8799	49	5	)	)	PUNCT
aiua-8799	49	6	value	value	NOUN
aiua-8799	49	7	(	(	PUNCT
aiua-8799	49	8	controls	control	NOUN
aiua-8799	49	9	)	)	PUNCT
aiua-8799	49	10	p	p	NOUN
aiua-8799	49	11	n	n	CCONJ
aiua-8799	49	12	°	°	NUM
aiua-8799	49	13	(	(	PUNCT
aiua-8799	49	14	%	%	INTJ
aiua-8799	49	15	)	)	PUNCT
aiua-8799	49	16	males	male	NOUN
aiua-8799	49	17	40	40	NUM
aiua-8799	49	18	(	(	PUNCT
aiua-8799	49	19	80	80	NUM
aiua-8799	49	20	%	%	NOUN
aiua-8799	49	21	)	)	PUNCT
aiua-8799	49	22	39	39	NUM
aiua-8799	49	23	(	(	PUNCT
aiua-8799	49	24	78	78	NUM
aiua-8799	49	25	%	%	NOUN
aiua-8799	49	26	)	)	PUNCT
aiua-8799	50	1	p	p	X
aiua-8799	50	2	=	=	PUNCT
aiua-8799	50	3	0.8061	0.8061	NUM
aiua-8799	50	4	females	female	NOUN
aiua-8799	50	5	10	10	NUM
aiua-8799	50	6	(	(	PUNCT
aiua-8799	50	7	20	20	NUM
aiua-8799	50	8	%	%	NOUN
aiua-8799	50	9	)	)	PUNCT
aiua-8799	50	10	11	11	NUM
aiua-8799	50	11	(	(	PUNCT
aiua-8799	50	12	22	22	NUM
aiua-8799	50	13	%	%	NOUN
aiua-8799	50	14	)	)	PUNCT
aiua-8799	51	1	p	p	X
aiua-8799	52	1	=	=	PUNCT
aiua-8799	52	2	0.8061	0.8061	NUM
aiua-8799	52	3	smokers	smoker	NOUN
aiua-8799	52	4	12	12	NUM
aiua-8799	52	5	(	(	PUNCT
aiua-8799	52	6	24	24	NUM
aiua-8799	52	7	%	%	NOUN
aiua-8799	52	8	)	)	PUNCT
aiua-8799	52	9	11	11	NUM
aiua-8799	52	10	(	(	PUNCT
aiua-8799	52	11	22	22	NUM
aiua-8799	52	12	%	%	NOUN
aiua-8799	52	13	)	)	PUNCT
aiua-8799	53	1	p	p	X
aiua-8799	54	1	=	=	PUNCT
aiua-8799	54	2	0.8122	0.8122	NUM
aiua-8799	54	3	non	non	NOUN
aiua-8799	54	4	-	-	NOUN
aiua-8799	54	5	smokers	smoker	NOUN
aiua-8799	54	6	38	38	NUM
aiua-8799	54	7	(	(	PUNCT
aiua-8799	54	8	76	76	NUM
aiua-8799	54	9	%	%	NOUN
aiua-8799	54	10	)	)	PUNCT
aiua-8799	54	11	39	39	NUM
aiua-8799	54	12	(	(	PUNCT
aiua-8799	54	13	78	78	NUM
aiua-8799	54	14	%	%	NOUN
aiua-8799	54	15	)	)	PUNCT
aiua-8799	54	16	p	p	X
aiua-8799	54	17	=	=	NOUN
aiua-8799	54	18	0.8122	0.8122	NUM
aiua-8799	54	19	diabetes	diabetes	NOUN
aiua-8799	54	20	(	(	PUNCT
aiua-8799	54	21	yes	yes	INTJ
aiua-8799	54	22	)	)	PUNCT
aiua-8799	54	23	5	5	NUM
aiua-8799	54	24	(	(	PUNCT
aiua-8799	54	25	10	10	NUM
aiua-8799	54	26	%	%	NOUN
aiua-8799	54	27	)	)	PUNCT
aiua-8799	54	28	7	7	NUM
aiua-8799	54	29	(	(	PUNCT
aiua-8799	54	30	14	14	NUM
aiua-8799	54	31	%	%	NOUN
aiua-8799	54	32	)	)	PUNCT
aiua-8799	55	1	p	p	X
aiua-8799	55	2	=	=	SYM
aiua-8799	55	3	0.5383	0.5383	NUM
aiua-8799	55	4	diabetes	diabetes	NOUN
aiua-8799	55	5	(	(	PUNCT
aiua-8799	55	6	no	no	NOUN
aiua-8799	55	7	)	)	PUNCT
aiua-8799	55	8	45	45	NUM
aiua-8799	55	9	(	(	PUNCT
aiua-8799	55	10	90	90	NUM
aiua-8799	55	11	%	%	NOUN
aiua-8799	55	12	)	)	PUNCT
aiua-8799	55	13	43	43	NUM
aiua-8799	55	14	(	(	PUNCT
aiua-8799	55	15	86	86	NUM
aiua-8799	55	16	%	%	NOUN
aiua-8799	55	17	)	)	PUNCT
aiua-8799	56	1	p	p	X
aiua-8799	56	2	=	=	PUNCT
aiua-8799	56	3	0.5383	0.5383	NUM
aiua-8799	56	4	c.i.s	c.i.s	NOUN
aiua-8799	56	5	.	.	PUNCT
aiua-8799	57	1	(	(	PUNCT
aiua-8799	57	2	yes	yes	INTJ
aiua-8799	57	3	)	)	PUNCT
aiua-8799	57	4	11	11	NUM
aiua-8799	57	5	(	(	PUNCT
aiua-8799	57	6	22	22	NUM
aiua-8799	57	7	%	%	NOUN
aiua-8799	57	8	)	)	PUNCT
aiua-8799	57	9	8	8	NUM
aiua-8799	57	10	(	(	PUNCT
aiua-8799	57	11	16	16	NUM
aiua-8799	57	12	%	%	NOUN
aiua-8799	57	13	)	)	PUNCT
aiua-8799	58	1	p	p	X
aiua-8799	58	2	=	=	SYM
aiua-8799	58	3	0.4444	0.4444	NUM
aiua-8799	58	4	c.i.s	c.i.s	NOUN
aiua-8799	58	5	.	.	PUNCT
aiua-8799	59	1	(	(	PUNCT
aiua-8799	59	2	no	no	INTJ
aiua-8799	59	3	)	)	PUNCT
aiua-8799	59	4	39	39	NUM
aiua-8799	59	5	(	(	PUNCT
aiua-8799	59	6	78	78	NUM
aiua-8799	59	7	%	%	NOUN
aiua-8799	59	8	)	)	PUNCT
aiua-8799	59	9	42	42	NUM
aiua-8799	59	10	(	(	PUNCT
aiua-8799	59	11	84	84	NUM
aiua-8799	59	12	%	%	NOUN
aiua-8799	59	13	)	)	PUNCT
aiua-8799	60	1	p	p	NOUN
aiua-8799	60	2	=	=	PUNCT
aiua-8799	60	3	0.4444	0.4444	NUM
aiua-8799	60	4	mean	mean	NOUN
aiua-8799	60	5	±	±	NUM
aiua-8799	60	6	sd	sd	ADP
aiua-8799	60	7	age	age	NOUN
aiua-8799	60	8	at	at	ADP
aiua-8799	60	9	surgery	surgery	NOUN
aiua-8799	60	10	(	(	PUNCT
aiua-8799	60	11	years	year	NOUN
aiua-8799	60	12	)	)	PUNCT
aiua-8799	60	13	58.52	58.52	NUM
aiua-8799	60	14	±	±	NUM
aiua-8799	60	15	5.28	5.28	NUM
aiua-8799	60	16	57.64	57.64	NUM
aiua-8799	60	17	±	±	NUM
aiua-8799	60	18	5.38	5.38	NUM
aiua-8799	60	19	p	p	NOUN
aiua-8799	60	20	=	=	PUNCT
aiua-8799	60	21	0.4138	0.4138	NUM
aiua-8799	60	22	bmi	bmi	NOUN
aiua-8799	60	23	(	(	PUNCT
aiua-8799	60	24	kg	kg	NOUN
aiua-8799	60	25	/	/	SYM
aiua-8799	60	26	m2	m2	PROPN
aiua-8799	60	27	)	)	PUNCT
aiua-8799	60	28	26.754	26.754	NUM
aiua-8799	60	29	±	±	NUM
aiua-8799	60	30	1.96	1.96	NUM
aiua-8799	60	31	26.916	26.916	NUM
aiua-8799	60	32	±	±	NUM
aiua-8799	60	33	1.91	1.91	NUM
aiua-8799	60	34	p	p	NOUN
aiua-8799	60	35	=	=	PUNCT
aiua-8799	60	36	0.6764	0.6764	NUM
aiua-8799	60	37	t.u.r.b	t.u.r.b	PROPN
aiua-8799	60	38	.	.	PROPN
aiua-8799	60	39	(	(	PUNCT
aiua-8799	60	40	n	n	CCONJ
aiua-8799	60	41	°	°	PROPN
aiua-8799	60	42	)	)	PUNCT
aiua-8799	60	43	1.86	1.86	NUM
aiua-8799	60	44	±	±	NUM
aiua-8799	60	45	1.18	1.18	NUM
aiua-8799	60	46	2.08	2.08	NUM
aiua-8799	60	47	±	±	NUM
aiua-8799	61	1	1.16	1.16	NUM
aiua-8799	61	2	p	p	NOUN
aiua-8799	61	3	=	=	PUNCT
aiua-8799	61	4	0.3495	0.3495	NUM
aiua-8799	61	5	tumors	tumor	NOUN
aiua-8799	61	6	(	(	PUNCT
aiua-8799	61	7	last	last	ADJ
aiua-8799	61	8	t.u.r.b	t.u.r.b	PROPN
aiua-8799	61	9	.	.	PROPN
aiua-8799	61	10	)	)	PUNCT
aiua-8799	61	11	(	(	PUNCT
aiua-8799	61	12	n	n	X
aiua-8799	61	13	°	°	PROPN
aiua-8799	61	14	)	)	PUNCT
aiua-8799	61	15	3.5	3.5	NUM
aiua-8799	61	16	±	±	NUM
aiua-8799	61	17	2.44	2.44	NUM
aiua-8799	61	18	4.08	4.08	NUM
aiua-8799	61	19	±	±	NOUN
aiua-8799	61	20	2.25	2.25	NUM
aiua-8799	61	21	p	p	NOUN
aiua-8799	61	22	=	=	SYM
aiua-8799	61	23	0.2195	0.2195	NUM
aiua-8799	61	24	psa	psa	NOUN
aiua-8799	61	25	(	(	PUNCT
aiua-8799	61	26	ng	ng	PROPN
aiua-8799	61	27	/	/	SYM
aiua-8799	61	28	ml	ml	NOUN
aiua-8799	61	29	)	)	PUNCT
aiua-8799	61	30	2.33	2.33	NUM
aiua-8799	61	31	±	±	NUM
aiua-8799	61	32	0.95	0.95	NUM
aiua-8799	61	33	2.13	2.13	NUM
aiua-8799	61	34	±	±	NUM
aiua-8799	61	35	0.95	0.95	NUM
aiua-8799	61	36	p	p	NOUN
aiua-8799	61	37	=	=	NOUN
aiua-8799	61	38	0.2951	0.2951	NUM
aiua-8799	61	39	prostate	prostate	NOUN
aiua-8799	61	40	volume	volume	NOUN
aiua-8799	61	41	(	(	PUNCT
aiua-8799	61	42	cc	cc	NOUN
aiua-8799	61	43	)	)	PUNCT
aiua-8799	61	44	42.43	42.43	NUM
aiua-8799	61	45	±	±	NUM
aiua-8799	61	46	13.39	13.39	NUM
aiua-8799	61	47	41.38	41.38	NUM
aiua-8799	61	48	±	±	NOUN
aiua-8799	61	49	13.56	13.56	NUM
aiua-8799	61	50	p	p	NOUN
aiua-8799	61	51	=	=	SYM
aiua-8799	61	52	0.6977	0.6977	NUM
aiua-8799	61	53	uroflow	uroflow	NOUN
aiua-8799	61	54	-	-	PUNCT
aiua-8799	61	55	qmax	qmax	NOUN
aiua-8799	61	56	(	(	PUNCT
aiua-8799	61	57	ml	ml	PROPN
aiua-8799	61	58	/	/	SYM
aiua-8799	61	59	s	s	NOUN
aiua-8799	61	60	)	)	PUNCT
aiua-8799	61	61	17.49	17.49	NUM
aiua-8799	61	62	±	±	NUM
aiua-8799	61	63	2.39	2.39	NUM
aiua-8799	61	64	17.39	17.39	NUM
aiua-8799	61	65	±	±	NUM
aiua-8799	61	66	2.21	2.21	NUM
aiua-8799	61	67	p	p	NOUN
aiua-8799	61	68	=	=	SYM
aiua-8799	61	69	0.8285	0.8285	NUM
aiua-8799	61	70	uroflow	uroflow	NOUN
aiua-8799	61	71	-	-	PUNCT
aiua-8799	61	72	voided	void	VERB
aiua-8799	61	73	volume	volume	NOUN
aiua-8799	61	74	(	(	PUNCT
aiua-8799	61	75	ml	ml	NOUN
aiua-8799	61	76	)	)	PUNCT
aiua-8799	61	77	250.6	250.6	NUM
aiua-8799	61	78	±	±	NUM
aiua-8799	61	79	39.8	39.8	NUM
aiua-8799	61	80	242.2	242.2	NUM
aiua-8799	61	81	±	±	NUM
aiua-8799	61	82	41.2	41.2	NUM
aiua-8799	61	83	p	p	NOUN
aiua-8799	61	84	=	=	SYM
aiua-8799	61	85	0.3023	0.3023	NUM
aiua-8799	61	86	uroflow	uroflow	ADJ
aiua-8799	61	87	-	-	PUNCT
aiua-8799	61	88	pvr	pvr	NOUN
aiua-8799	61	89	(	(	PUNCT
aiua-8799	61	90	ml	ml	NOUN
aiua-8799	61	91	)	)	PUNCT
aiua-8799	61	92	15.4	15.4	NUM
aiua-8799	61	93	±	±	NUM
aiua-8799	61	94	10.6	10.6	NUM
aiua-8799	61	95	14.9	14.9	NUM
aiua-8799	61	96	±	±	NUM
aiua-8799	61	97	10.1	10.1	NUM
aiua-8799	61	98	p	p	NOUN
aiua-8799	61	99	=	=	PUNCT
aiua-8799	61	100	0.8097	0.8097	NUM
aiua-8799	61	101	ipss	ipss	PROPN
aiua-8799	61	102	total	total	NOUN
aiua-8799	61	103	7.05	7.05	NUM
aiua-8799	61	104	±	±	NUM
aiua-8799	61	105	3.88	3.88	NUM
aiua-8799	61	106	7.79	7.79	NUM
aiua-8799	61	107	±	±	NUM
aiua-8799	61	108	4.55	4.55	NUM
aiua-8799	61	109	p	p	NOUN
aiua-8799	61	110	=	=	SYM
aiua-8799	61	111	0.3837	0.3837	NUM
aiua-8799	61	112	qol	qol	NOUN
aiua-8799	61	113	score	score	VERB
aiua-8799	61	114	2.22	2.22	NUM
aiua-8799	61	115	±	±	NUM
aiua-8799	61	116	1.23	1.23	NUM
aiua-8799	61	117	2.34	2.34	NUM
aiua-8799	61	118	±	±	NUM
aiua-8799	61	119	1.26	1.26	NUM
aiua-8799	61	120	p	p	NOUN
aiua-8799	61	121	=	=	SYM
aiua-8799	61	122	0.6310	0.6310	NUM
aiua-8799	61	123	oab	oab	PROPN
aiua-8799	61	124	-	-	PROPN
aiua-8799	61	125	q	q	PROPN
aiua-8799	61	126	sf	sf	PROPN
aiua-8799	61	127	6	6	NUM
aiua-8799	61	128	11.48	11.48	NUM
aiua-8799	61	129	±	±	NUM
aiua-8799	61	130	5.18	5.18	NUM
aiua-8799	61	131	11.92	11.92	NUM
aiua-8799	61	132	±	±	NUM
aiua-8799	61	133	5.30	5.30	NUM
aiua-8799	61	134	p	p	NOUN
aiua-8799	61	135	=	=	SYM
aiua-8799	61	136	0,6755	0,6755	PROPN
aiua-8799	62	1	oab	oab	PROPN
aiua-8799	62	2	-	-	PROPN
aiua-8799	62	3	q	q	PROPN
aiua-8799	62	4	sf	sf	PROPN
aiua-8799	62	5	13	13	NUM
aiua-8799	62	6	25.12	25.12	NUM
aiua-8799	62	7	±	±	NUM
aiua-8799	62	8	11.50	11.50	NUM
aiua-8799	62	9	26.02	26.02	NUM
aiua-8799	62	10	±	±	NUM
aiua-8799	62	11	11.39	11.39	NUM
aiua-8799	62	12	p	p	NOUN
aiua-8799	62	13	=	=	X
aiua-8799	62	14	0.6950	0.6950	NUM
aiua-8799	62	15	ppius	ppius	NOUN
aiua-8799	62	16	0.94	0.94	NUM
aiua-8799	62	17	±	±	NUM
aiua-8799	62	18	0.79	0.79	NUM
aiua-8799	62	19	0.96	0.96	NUM
aiua-8799	62	20	±	±	NUM
aiua-8799	62	21	0.78	0.78	NUM
aiua-8799	62	22	p	p	NOUN
aiua-8799	62	23	=	=	SYM
aiua-8799	62	24	0.8989	0.8989	NUM
aiua-8799	62	25	vas	vas	NOUN
aiua-8799	62	26	scale	scale	NOUN
aiua-8799	62	27	0.08	0.08	NUM
aiua-8799	62	28	±	±	NUM
aiua-8799	62	29	0.27	0.27	NUM
aiua-8799	62	30	0.18	0.18	NUM
aiua-8799	62	31	±	±	NUM
aiua-8799	62	32	0.87	0.87	NUM
aiua-8799	62	33	p	p	NOUN
aiua-8799	62	34	=	=	PUNCT
aiua-8799	62	35	0.4395	0.4395	NUM
aiua-8799	62	36	cis	cis	NOUN
aiua-8799	62	37	:	:	PUNCT
aiua-8799	62	38	in	in	ADP
aiua-8799	62	39	situ	situ	ADJ
aiua-8799	62	40	carcinoma	carcinoma	NOUN
aiua-8799	62	41	;	;	PUNCT
aiua-8799	62	42	bmi	bmi	PROPN
aiua-8799	62	43	:	:	PUNCT
aiua-8799	62	44	body	body	NOUN
aiua-8799	62	45	max	max	PROPN
aiua-8799	62	46	index	index	PROPN
aiua-8799	62	47	;	;	PUNCT
aiua-8799	62	48	turb	turb	NOUN
aiua-8799	62	49	:	:	PUNCT
aiua-8799	62	50	trans	trans	X
aiua-8799	62	51	urethral	urethral	ADJ
aiua-8799	62	52	bladder	bladder	NOUN
aiua-8799	62	53	resection	resection	NOUN
aiua-8799	62	54	;	;	PUNCT
aiua-8799	62	55	psa	psa	VERB
aiua-8799	62	56	:	:	PUNCT
aiua-8799	62	57	prostate	prostate	NOUN
aiua-8799	62	58	specific	specific	ADJ
aiua-8799	62	59	antigen	antigen	NOUN
aiua-8799	62	60	;	;	PUNCT
aiua-8799	62	61	pvr	pvr	NOUN
aiua-8799	62	62	:	:	PUNCT
aiua-8799	62	63	post	post	ADJ
aiua-8799	62	64	-	-	ADJ
aiua-8799	62	65	void	void	ADJ
aiua-8799	62	66	residual	residual	NOUN
aiua-8799	62	67	;	;	PUNCT
aiua-8799	62	68	ipss	ipss	PROPN
aiua-8799	62	69	:	:	PUNCT
aiua-8799	62	70	international	international	ADJ
aiua-8799	62	71	prostatic	prostatic	ADJ
aiua-8799	62	72	symptoms	symptom	NOUN
aiua-8799	62	73	score	score	VERB
aiua-8799	62	74	;	;	PUNCT
aiua-8799	62	75	qol	qol	PRON
aiua-8799	62	76	:	:	PUNCT
aiua-8799	62	77	quality	quality	NOUN
aiua-8799	62	78	of	of	ADP
aiua-8799	62	79	life	life	NOUN
aiua-8799	62	80	;	;	PUNCT
aiua-8799	62	81	oab	oab	PROPN
aiua-8799	62	82	:	:	PUNCT
aiua-8799	62	83	overactive	overactive	ADJ
aiua-8799	62	84	bladder	bladder	NOUN
aiua-8799	62	85	;	;	PUNCT
aiua-8799	62	86	ppius	ppius	NOUN
aiua-8799	62	87	:	:	PUNCT
aiua-8799	62	88	patient	patient	ADJ
aiua-8799	62	89	perception	perception	NOUN
aiua-8799	62	90	of	of	ADP
aiua-8799	62	91	intensity	intensity	NOUN
aiua-8799	62	92	of	of	ADP
aiua-8799	62	93	urgency	urgency	NOUN
aiua-8799	62	94	scale	scale	NOUN
aiua-8799	62	95	;	;	PUNCT
aiua-8799	62	96	vas	vas	X
aiua-8799	62	97	:	:	PUNCT
aiua-8799	62	98	visual	visual	ADJ
aiua-8799	62	99	analogue	analogue	NOUN
aiua-8799	62	100	scale	scale	NOUN
aiua-8799	62	101	.	.	PUNCT
aiua-8799	62	102	table	table	NOUN
aiua-8799	63	1	2	2	NUM
aiua-8799	63	2	.	.	PUNCT
aiua-8799	63	3	comparison	comparison	NOUN
aiua-8799	63	4	of	of	ADP
aiua-8799	63	5	uroflowmetry	uroflowmetry	NOUN
aiua-8799	63	6	parameters	parameter	NOUN
aiua-8799	63	7	and	and	CCONJ
aiua-8799	63	8	questionnaires	questionnaire	NOUN
aiua-8799	63	9	from	from	ADP
aiua-8799	63	10	baseline	baseline	NOUN
aiua-8799	63	11	and	and	CCONJ
aiua-8799	63	12	between	between	ADP
aiua-8799	63	13	one	one	NUM
aiua-8799	63	14	and	and	CCONJ
aiua-8799	63	15	six	six	NUM
aiua-8799	63	16	weeks	week	NOUN
aiua-8799	63	17	of	of	ADP
aiua-8799	63	18	treatment	treatment	NOUN
aiua-8799	63	19	(	(	PUNCT
aiua-8799	63	20	cases	case	NOUN
aiua-8799	63	21	)	)	PUNCT
aiua-8799	63	22	.	.	PUNCT
aiua-8799	64	1	variable	variable	ADJ
aiua-8799	64	2	value	value	NOUN
aiua-8799	64	3	(	(	PUNCT
aiua-8799	64	4	baseline	baseline	NOUN
aiua-8799	64	5	)	)	PUNCT
aiua-8799	64	6	value	value	NOUN
aiua-8799	64	7	(	(	PUNCT
aiua-8799	64	8	one	one	NUM
aiua-8799	64	9	-	-	PUNCT
aiua-8799	64	10	week	week	NOUN
aiua-8799	64	11	)	)	PUNCT
aiua-8799	64	12	value	value	NOUN
aiua-8799	64	13	(	(	PUNCT
aiua-8799	64	14	six	six	NUM
aiua-8799	64	15	-	-	PUNCT
aiua-8799	64	16	weeks	week	NOUN
aiua-8799	64	17	)	)	PUNCT
aiua-8799	64	18	uroflow	uroflow	NOUN
aiua-8799	64	19	-	-	PUNCT
aiua-8799	64	20	qmax	qmax	NOUN
aiua-8799	64	21	(	(	PUNCT
aiua-8799	64	22	ml	ml	PROPN
aiua-8799	64	23	/	/	SYM
aiua-8799	64	24	s	s	NOUN
aiua-8799	64	25	)	)	PUNCT
aiua-8799	64	26	17.49	17.49	NUM
aiua-8799	64	27	±	±	NUM
aiua-8799	64	28	2.39	2.39	NUM
aiua-8799	64	29	16.99	16.99	NUM
aiua-8799	64	30	±	±	NUM
aiua-8799	64	31	2.55	2.55	NUM
aiua-8799	64	32	16.62	16.62	NUM
aiua-8799	64	33	±	±	NUM
aiua-8799	64	34	2.43	2.43	NUM
aiua-8799	64	35	p	p	NOUN
aiua-8799	64	36	(	(	PUNCT
aiua-8799	64	37	from	from	ADP
aiua-8799	64	38	baseline	baseline	NOUN
aiua-8799	64	39	)	)	PUNCT
aiua-8799	64	40	p	p	NOUN
aiua-8799	64	41	=	=	PUNCT
aiua-8799	64	42	0.3142	0.3142	NUM
aiua-8799	64	43	p	p	NOUN
aiua-8799	64	44	=	=	NOUN
aiua-8799	64	45	0.0742	0.0742	NUM
aiua-8799	64	46	variable	variable	ADJ
aiua-8799	64	47	value	value	NOUN
aiua-8799	64	48	(	(	PUNCT
aiua-8799	64	49	baseline	baseline	NOUN
aiua-8799	64	50	)	)	PUNCT
aiua-8799	64	51	value	value	NOUN
aiua-8799	64	52	(	(	PUNCT
aiua-8799	64	53	one	one	NUM
aiua-8799	64	54	-	-	PUNCT
aiua-8799	64	55	week	week	NOUN
aiua-8799	64	56	)	)	PUNCT
aiua-8799	64	57	value	value	NOUN
aiua-8799	64	58	(	(	PUNCT
aiua-8799	64	59	six	six	NUM
aiua-8799	64	60	-	-	PUNCT
aiua-8799	64	61	weeks	week	NOUN
aiua-8799	64	62	)	)	PUNCT
aiua-8799	64	63	uroflow	uroflow	NOUN
aiua-8799	64	64	-	-	PUNCT
aiua-8799	64	65	voided	void	VERB
aiua-8799	64	66	volume	volume	NOUN
aiua-8799	64	67	(	(	PUNCT
aiua-8799	64	68	ml	ml	NOUN
aiua-8799	64	69	)	)	PUNCT
aiua-8799	64	70	250.6	250.6	NUM
aiua-8799	64	71	±	±	NUM
aiua-8799	64	72	39.8	39.8	NUM
aiua-8799	64	73	239.7	239.7	NUM
aiua-8799	64	74	±	±	NUM
aiua-8799	64	75	40.10	40.10	NUM
aiua-8799	64	76	250.9	250.9	NUM
aiua-8799	64	77	±	±	NOUN
aiua-8799	64	78	39.22	39.22	NUM
aiua-8799	64	79	p	p	NOUN
aiua-8799	64	80	(	(	PUNCT
aiua-8799	64	81	from	from	ADP
aiua-8799	64	82	baseline	baseline	NOUN
aiua-8799	64	83	)	)	PUNCT
aiua-8799	65	1	p	p	X
aiua-8799	65	2	=	=	PUNCT
aiua-8799	65	3	0.1756	0.1756	NUM
aiua-8799	65	4	p	p	X
aiua-8799	65	5	=	=	PUNCT
aiua-8799	65	6	0.9698	0.9698	NUM
aiua-8799	65	7	p	p	NOUN
aiua-8799	65	8	(	(	PUNCT
aiua-8799	65	9	from	from	ADP
aiua-8799	65	10	1	1	NUM
aiua-8799	65	11	and	and	CCONJ
aiua-8799	65	12	6	6	NUM
aiua-8799	65	13	weeks	week	NOUN
aiua-8799	65	14	)	)	PUNCT
aiua-8799	65	15	p	p	X
aiua-8799	65	16	=	=	PUNCT
aiua-8799	65	17	0.1611	0.1611	NUM
aiua-8799	65	18	uroflow	uroflow	ADJ
aiua-8799	65	19	-	-	PUNCT
aiua-8799	65	20	pvr	pvr	NOUN
aiua-8799	65	21	(	(	PUNCT
aiua-8799	65	22	ml	ml	NOUN
aiua-8799	65	23	)	)	PUNCT
aiua-8799	65	24	15.4	15.4	NUM
aiua-8799	65	25	±	±	NUM
aiua-8799	65	26	10.6	10.6	NUM
aiua-8799	65	27	18.18	18.18	NUM
aiua-8799	65	28	±	±	NUM
aiua-8799	65	29	12.46	12.46	NUM
aiua-8799	65	30	19.7	19.7	NUM
aiua-8799	65	31	±	±	NUM
aiua-8799	65	32	12.01	12.01	NUM
aiua-8799	65	33	p	p	NOUN
aiua-8799	65	34	(	(	PUNCT
aiua-8799	65	35	from	from	ADP
aiua-8799	65	36	baseline	baseline	NOUN
aiua-8799	65	37	)	)	PUNCT
aiua-8799	66	1	p	p	X
aiua-8799	66	2	=	=	PUNCT
aiua-8799	66	3	0.2324	0.2324	NUM
aiua-8799	66	4	p	p	X
aiua-8799	66	5	=	=	X
aiua-8799	66	6	0.0606	0.0606	NUM
aiua-8799	66	7	p	p	NOUN
aiua-8799	66	8	(	(	PUNCT
aiua-8799	66	9	from	from	ADP
aiua-8799	66	10	1	1	NUM
aiua-8799	66	11	and	and	CCONJ
aiua-8799	66	12	6	6	NUM
aiua-8799	66	13	weeks	week	NOUN
aiua-8799	66	14	)	)	PUNCT
aiua-8799	67	1	p	p	X
aiua-8799	67	2	=	=	PUNCT
aiua-8799	67	3	0.5360	0.5360	NUM
aiua-8799	67	4	ipss	ipss	PROPN
aiua-8799	67	5	total	total	ADJ
aiua-8799	67	6	7.05	7.05	NUM
aiua-8799	67	7	±	±	NUM
aiua-8799	67	8	3.88	3.88	NUM
aiua-8799	67	9	11.18	11.18	NUM
aiua-8799	67	10	±	±	NUM
aiua-8799	67	11	4.84	4.84	NUM
aiua-8799	67	12	8.35	8.35	NUM
aiua-8799	67	13	±	±	NUM
aiua-8799	67	14	3.81	3.81	NUM
aiua-8799	67	15	p	p	NOUN
aiua-8799	67	16	(	(	PUNCT
aiua-8799	67	17	from	from	ADP
aiua-8799	67	18	baseline	baseline	NOUN
aiua-8799	67	19	)	)	PUNCT
aiua-8799	68	1	p	p	X
aiua-8799	68	2	<	<	X
aiua-8799	68	3	0.001	0.001	NUM
aiua-8799	68	4	p	p	NOUN
aiua-8799	68	5	=	=	PUNCT
aiua-8799	68	6	0.0941	0.0941	NUM
aiua-8799	68	7	p	p	NOUN
aiua-8799	68	8	(	(	PUNCT
aiua-8799	68	9	from	from	ADP
aiua-8799	68	10	1	1	NUM
aiua-8799	68	11	and	and	CCONJ
aiua-8799	68	12	6	6	NUM
aiua-8799	68	13	weeks	week	NOUN
aiua-8799	68	14	)	)	PUNCT
aiua-8799	69	1	p	p	NOUN
aiua-8799	69	2	=	=	PUNCT
aiua-8799	69	3	0.0016	0.0016	NUM
aiua-8799	69	4	oab	oab	PROPN
aiua-8799	69	5	-	-	PROPN
aiua-8799	69	6	q	q	PROPN
aiua-8799	69	7	sf	sf	PROPN
aiua-8799	69	8	6	6	NUM
aiua-8799	69	9	11.48	11.48	NUM
aiua-8799	69	10	±	±	NUM
aiua-8799	69	11	5.18	5.18	NUM
aiua-8799	69	12	17.16	17.16	NUM
aiua-8799	69	13	±	±	NUM
aiua-8799	69	14	4.82	4.82	NUM
aiua-8799	69	15	14.46	14.46	NUM
aiua-8799	69	16	±	±	NUM
aiua-8799	69	17	5.60	5.60	NUM
aiua-8799	69	18	p	p	NOUN
aiua-8799	69	19	(	(	PUNCT
aiua-8799	69	20	from	from	ADP
aiua-8799	69	21	baseline	baseline	NOUN
aiua-8799	69	22	)	)	PUNCT
aiua-8799	69	23	p	p	X
aiua-8799	69	24	<	<	X
aiua-8799	69	25	0.001	0.001	NUM
aiua-8799	69	26	p	p	NOUN
aiua-8799	69	27	=	=	PROPN
aiua-8799	69	28	0.0069	0.0069	NUM
aiua-8799	69	29	p	p	NOUN
aiua-8799	69	30	(	(	PUNCT
aiua-8799	69	31	from	from	ADP
aiua-8799	69	32	1	1	NUM
aiua-8799	69	33	and	and	CCONJ
aiua-8799	69	34	6	6	NUM
aiua-8799	69	35	weeks	week	NOUN
aiua-8799	69	36	)	)	PUNCT
aiua-8799	70	1	p	p	X
aiua-8799	71	1	=	=	PUNCT
aiua-8799	72	1	0.0112	0.0112	NUM
aiua-8799	72	2	oab	oab	PROPN
aiua-8799	72	3	-	-	PROPN
aiua-8799	72	4	q	q	PROPN
aiua-8799	72	5	sf	sf	PROPN
aiua-8799	72	6	13	13	NUM
aiua-8799	72	7	25.12	25.12	NUM
aiua-8799	72	8	±	±	NUM
aiua-8799	72	9	11.50	11.50	NUM
aiua-8799	72	10	36.42	36.42	NUM
aiua-8799	72	11	±	±	NUM
aiua-8799	72	12	10.67	10.67	NUM
aiua-8799	72	13	31.16	31.16	NUM
aiua-8799	72	14	±	±	NUM
aiua-8799	72	15	11.57	11.57	NUM
aiua-8799	72	16	p	p	NOUN
aiua-8799	72	17	(	(	PUNCT
aiua-8799	72	18	from	from	ADP
aiua-8799	72	19	baseline	baseline	NOUN
aiua-8799	72	20	)	)	PUNCT
aiua-8799	73	1	p	p	X
aiua-8799	73	2	<	<	X
aiua-8799	73	3	0.001	0.001	NUM
aiua-8799	73	4	p	p	NOUN
aiua-8799	73	5	=	=	NOUN
aiua-8799	73	6	0.0102	0.0102	NUM
aiua-8799	73	7	p	p	NOUN
aiua-8799	73	8	(	(	PUNCT
aiua-8799	73	9	from	from	ADP
aiua-8799	73	10	1	1	NUM
aiua-8799	73	11	and	and	CCONJ
aiua-8799	73	12	6	6	NUM
aiua-8799	73	13	weeks	week	NOUN
aiua-8799	73	14	)	)	PUNCT
aiua-8799	73	15	p	p	X
aiua-8799	73	16	=	=	PUNCT
aiua-8799	73	17	0.0201	0.0201	NUM
aiua-8799	73	18	ppius	ppius	NOUN
aiua-8799	73	19	0.94	0.94	NUM
aiua-8799	73	20	±	±	NUM
aiua-8799	73	21	0.79	0.79	NUM
aiua-8799	73	22	2.26	2.26	NUM
aiua-8799	73	23	±	±	NUM
aiua-8799	73	24	0.88	0.88	NUM
aiua-8799	73	25	1.66	1.66	NUM
aiua-8799	73	26	±	±	NUM
aiua-8799	73	27	0.66	0.66	NUM
aiua-8799	73	28	p	p	NOUN
aiua-8799	73	29	(	(	PUNCT
aiua-8799	73	30	from	from	ADP
aiua-8799	73	31	baseline	baseline	NOUN
aiua-8799	73	32	)	)	PUNCT
aiua-8799	74	1	p	p	X
aiua-8799	74	2	<	<	X
aiua-8799	74	3	0.001	0.001	NUM
aiua-8799	74	4	p	p	X
aiua-8799	74	5	<	<	X
aiua-8799	74	6	0.001	0.001	NUM
aiua-8799	74	7	p	p	NOUN
aiua-8799	74	8	(	(	PUNCT
aiua-8799	74	9	from	from	ADP
aiua-8799	74	10	1	1	NUM
aiua-8799	74	11	and	and	CCONJ
aiua-8799	74	12	6	6	NUM
aiua-8799	74	13	weeks	week	NOUN
aiua-8799	74	14	)	)	PUNCT
aiua-8799	75	1	p	p	X
aiua-8799	75	2	=	=	PUNCT
aiua-8799	75	3	0.0002	0.0002	NUM
aiua-8799	75	4	pgi	pgi	PROPN
aiua-8799	75	5	-	-	PUNCT
aiua-8799	75	6	i	i	PROPN
aiua-8799	75	7	4	4	NUM
aiua-8799	75	8	±	±	NUM
aiua-8799	75	9	0	0	NUM
aiua-8799	75	10	4.2	4.2	NUM
aiua-8799	75	11	±	±	NUM
aiua-8799	75	12	0.60	0.60	NUM
aiua-8799	75	13	2.46	2.46	NUM
aiua-8799	75	14	±	±	NUM
aiua-8799	75	15	0.86	0.86	NUM
aiua-8799	75	16	p	p	NOUN
aiua-8799	75	17	(	(	PUNCT
aiua-8799	75	18	from	from	ADP
aiua-8799	75	19	baseline	baseline	NOUN
aiua-8799	75	20	)	)	PUNCT
aiua-8799	76	1	p	p	NOUN
aiua-8799	76	2	=	=	PUNCT
aiua-8799	76	3	0.1161	0.1161	NUM
aiua-8799	76	4	p	p	X
aiua-8799	76	5	<	<	X
aiua-8799	76	6	0.001	0.001	NUM
aiua-8799	76	7	p	p	NOUN
aiua-8799	76	8	(	(	PUNCT
aiua-8799	76	9	from	from	ADP
aiua-8799	76	10	1	1	NUM
aiua-8799	76	11	and	and	CCONJ
aiua-8799	76	12	6	6	NUM
aiua-8799	76	13	weeks	week	NOUN
aiua-8799	76	14	)	)	PUNCT
aiua-8799	76	15	p	p	X
aiua-8799	76	16	<	<	X
aiua-8799	76	17	0.001	0.001	NUM
aiua-8799	76	18	vas	vas	NOUN
aiua-8799	76	19	scale	scale	NOUN
aiua-8799	76	20	0.08	0.08	NUM
aiua-8799	76	21	±	±	NUM
aiua-8799	76	22	0.27	0.27	NUM
aiua-8799	76	23	3.38	3.38	NUM
aiua-8799	76	24	±	±	NUM
aiua-8799	76	25	1.35	1.35	NUM
aiua-8799	76	26	2.34	2.34	NUM
aiua-8799	76	27	±	±	NUM
aiua-8799	76	28	0.96	0.96	NUM
aiua-8799	76	29	p	p	NOUN
aiua-8799	76	30	(	(	PUNCT
aiua-8799	76	31	from	from	ADP
aiua-8799	76	32	baseline	baseline	NOUN
aiua-8799	76	33	)	)	PUNCT
aiua-8799	76	34	p	p	X
aiua-8799	76	35	<	<	X
aiua-8799	76	36	0.001	0.001	NUM
aiua-8799	76	37	p	p	X
aiua-8799	76	38	<	<	X
aiua-8799	76	39	0.001	0.001	NUM
aiua-8799	76	40	p	p	NOUN
aiua-8799	76	41	(	(	PUNCT
aiua-8799	76	42	from	from	ADP
aiua-8799	76	43	1	1	NUM
aiua-8799	76	44	and	and	CCONJ
aiua-8799	76	45	6	6	NUM
aiua-8799	76	46	weeks	week	NOUN
aiua-8799	76	47	)	)	PUNCT
aiua-8799	77	1	p	p	X
aiua-8799	77	2	<	<	X
aiua-8799	77	3	0.001	0.001	NUM
aiua-8799	77	4	pvr	pvr	NOUN
aiua-8799	77	5	:	:	PUNCT
aiua-8799	77	6	post	post	ADJ
aiua-8799	77	7	-	-	ADJ
aiua-8799	77	8	void	void	ADJ
aiua-8799	77	9	residual	residual	NOUN
aiua-8799	77	10	;	;	PUNCT
aiua-8799	77	11	ipss	ipss	PROPN
aiua-8799	77	12	:	:	PUNCT
aiua-8799	77	13	international	international	ADJ
aiua-8799	77	14	prostatic	prostatic	ADJ
aiua-8799	77	15	symptoms	symptom	NOUN
aiua-8799	77	16	score	score	VERB
aiua-8799	77	17	;	;	PUNCT
aiua-8799	77	18	oab	oab	PROPN
aiua-8799	77	19	:	:	PUNCT
aiua-8799	77	20	overactive	overactive	ADJ
aiua-8799	77	21	bladder	bladder	NOUN
aiua-8799	77	22	;	;	PUNCT
aiua-8799	77	23	ppius	ppius	NOUN
aiua-8799	77	24	:	:	PUNCT
aiua-8799	77	25	patient	patient	ADJ
aiua-8799	77	26	perception	perception	NOUN
aiua-8799	77	27	of	of	ADP
aiua-8799	77	28	intensity	intensity	NOUN
aiua-8799	77	29	of	of	ADP
aiua-8799	77	30	urgency	urgency	NOUN
aiua-8799	77	31	scale	scale	NOUN
aiua-8799	77	32	;	;	PUNCT
aiua-8799	77	33	pgi	pgi	PROPN
aiua-8799	77	34	-	-	PUNCT
aiua-8799	77	35	i	i	PROPN
aiua-8799	77	36	:	:	PUNCT
aiua-8799	77	37	patient	patient	ADJ
aiua-8799	77	38	global	global	ADJ
aiua-8799	77	39	impression	impression	NOUN
aiua-8799	77	40	of	of	ADP
aiua-8799	77	41	improvement	improvement	NOUN
aiua-8799	77	42	questionnaire	questionnaire	NOUN
aiua-8799	77	43	;	;	PUNCT
aiua-8799	77	44	vas	vas	X
aiua-8799	77	45	:	:	PUNCT
aiua-8799	77	46	visual	visual	ADJ
aiua-8799	77	47	analogue	analogue	NOUN
aiua-8799	77	48	scale	scale	NOUN
aiua-8799	77	49	.	.	PUNCT
aiua-8799	78	1	04chiancone_stesura	04chiancone_stesura	ADJ
aiua-8799	78	2	seveso	seveso	PROPN
aiua-8799	78	3	24/09/20	24/09/20	PROPN
aiua-8799	78	4	14:13	14:13	NUM
aiua-8799	78	5	pagina	pagina	NOUN
aiua-8799	78	6	178	178	NUM
aiua-8799	78	7	ly	ly	ADP
aiua-8799	78	8	improvement	improvement	NOUN
aiua-8799	78	9	of	of	ADP
aiua-8799	78	10	quality	quality	NOUN
aiua-8799	78	11	of	of	ADP
aiua-8799	78	12	life	life	NOUN
aiua-8799	78	13	was	be	AUX
aiua-8799	78	14	demonstrated	demonstrate	VERB
aiua-8799	78	15	with	with	ADP
aiua-8799	78	16	respect	respect	NOUN
aiua-8799	78	17	of	of	ADP
aiua-8799	78	18	the	the	DET
aiua-8799	78	19	values	value	NOUN
aiua-8799	78	20	at	at	ADP
aiua-8799	78	21	one	one	NUM
aiua-8799	78	22	week	week	NOUN
aiua-8799	78	23	.	.	PUNCT
aiua-8799	79	1	pgi-1	pgi-1	PRON
aiua-8799	79	2	did	do	AUX
aiua-8799	79	3	not	not	PART
aiua-8799	79	4	significantly	significantly	ADV
aiua-8799	79	5	show	show	VERB
aiua-8799	79	6	any	any	DET
aiua-8799	79	7	change	change	NOUN
aiua-8799	79	8	at	at	ADP
aiua-8799	79	9	one	one	NUM
aiua-8799	79	10	week	week	NOUN
aiua-8799	79	11	but	but	CCONJ
aiua-8799	79	12	showed	show	VERB
aiua-8799	79	13	a	a	DET
aiua-8799	79	14	significant	significant	ADJ
aiua-8799	79	15	decrease	decrease	NOUN
aiua-8799	79	16	at	at	ADP
aiua-8799	79	17	six	six	NUM
aiua-8799	79	18	weeks	week	NOUN
aiua-8799	79	19	follow	follow	NOUN
aiua-8799	79	20	-	-	PUNCT
aiua-8799	79	21	up	up	NOUN
aiua-8799	79	22	with	with	ADP
aiua-8799	79	23	a	a	DET
aiua-8799	79	24	greater	great	ADJ
aiua-8799	79	25	satisfaction	satisfaction	NOUN
aiua-8799	79	26	for	for	ADP
aiua-8799	79	27	the	the	DET
aiua-8799	79	28	treatment	treatment	NOUN
aiua-8799	79	29	.	.	PUNCT
aiua-8799	80	1	in	in	ADP
aiua-8799	80	2	the	the	DET
aiua-8799	80	3	group	group	NOUN
aiua-8799	80	4	b	b	PROPN
aiua-8799	80	5	the	the	DET
aiua-8799	80	6	uroflow	uroflow	ADJ
aiua-8799	80	7	parameters	parameter	NOUN
aiua-8799	80	8	did	do	AUX
aiua-8799	80	9	not	not	PART
aiua-8799	80	10	show	show	VERB
aiua-8799	80	11	a	a	DET
aiua-8799	80	12	statistical	statistical	ADJ
aiua-8799	80	13	significant	significant	ADJ
aiua-8799	80	14	difference	difference	NOUN
aiua-8799	80	15	from	from	ADP
aiua-8799	80	16	baseline	baseline	NOUN
aiua-8799	80	17	at	at	ADP
aiua-8799	80	18	one	one	NUM
aiua-8799	80	19	and	and	CCONJ
aiua-8799	80	20	six	six	NUM
aiua-8799	80	21	weeks	week	NOUN
aiua-8799	80	22	follow	follow	NOUN
aiua-8799	80	23	-	-	PUNCT
aiua-8799	80	24	up	up	NOUN
aiua-8799	80	25	except	except	SCONJ
aiua-8799	80	26	for	for	ADP
aiua-8799	80	27	a	a	DET
aiua-8799	80	28	significant	significant	ADJ
aiua-8799	80	29	reduction	reduction	NOUN
aiua-8799	80	30	of	of	ADP
aiua-8799	80	31	uroflow	uroflow	NOUN
aiua-8799	80	32	-	-	PUNCT
aiua-8799	80	33	voided	void	VERB
aiua-8799	80	34	volume	volume	NOUN
aiua-8799	80	35	(	(	PUNCT
aiua-8799	80	36	p	p	X
aiua-8799	80	37	=	=	NOUN
aiua-8799	80	38	0.0118	0.0118	NUM
aiua-8799	80	39	)	)	PUNCT
aiua-8799	80	40	at	at	ADP
aiua-8799	80	41	one	one	NUM
aiua-8799	80	42	week	week	NOUN
aiua-8799	80	43	.	.	PUNCT
aiua-8799	81	1	a	a	DET
aiua-8799	81	2	significant	significant	ADJ
aiua-8799	81	3	worsening	worsening	NOUN
aiua-8799	81	4	of	of	ADP
aiua-8799	81	5	ipss	ipss	PROPN
aiua-8799	81	6	score	score	NOUN
aiua-8799	81	7	was	be	AUX
aiua-8799	81	8	seen	see	VERB
aiua-8799	81	9	at	at	ADP
aiua-8799	81	10	one	one	NUM
aiua-8799	81	11	and	and	CCONJ
aiua-8799	81	12	six	six	NUM
aiua-8799	81	13	weeks	week	NOUN
aiua-8799	81	14	of	of	ADP
aiua-8799	81	15	follow	follow	NOUN
aiua-8799	81	16	-	-	PUNCT
aiua-8799	81	17	up	up	NOUN
aiua-8799	81	18	(	(	PUNCT
aiua-8799	81	19	p	p	X
aiua-8799	81	20	<	<	X
aiua-8799	81	21	0.001	0.001	NUM
aiua-8799	81	22	)	)	PUNCT
aiua-8799	81	23	.	.	PUNCT
aiua-8799	82	1	in	in	ADP
aiua-8799	82	2	this	this	DET
aiua-8799	82	3	group	group	NOUN
aiua-8799	82	4	the	the	DET
aiua-8799	82	5	quality	quality	NOUN
aiua-8799	82	6	of	of	ADP
aiua-8799	82	7	life	life	NOUN
aiua-8799	82	8	showed	show	VERB
aiua-8799	82	9	a	a	DET
aiua-8799	82	10	significant	significant	ADJ
aiua-8799	82	11	worsening	worsening	NOUN
aiua-8799	82	12	after	after	ADP
aiua-8799	82	13	one	one	NUM
aiua-8799	82	14	week	week	NOUN
aiua-8799	82	15	and	and	CCONJ
aiua-8799	82	16	six	six	NUM
aiua-8799	82	17	weeks	week	NOUN
aiua-8799	82	18	of	of	ADP
aiua-8799	82	19	treatment	treatment	NOUN
aiua-8799	82	20	from	from	ADP
aiua-8799	82	21	baseline	baseline	NOUN
aiua-8799	82	22	in	in	ADP
aiua-8799	82	23	all	all	DET
aiua-8799	82	24	parameters	parameter	NOUN
aiua-8799	82	25	and	and	CCONJ
aiua-8799	82	26	questionnaires	questionnaire	NOUN
aiua-8799	82	27	analyzed	analyze	VERB
aiua-8799	82	28	(	(	PUNCT
aiua-8799	82	29	oab	oab	PROPN
aiua-8799	82	30	-	-	PROPN
aiua-8799	82	31	q	q	PROPN
aiua-8799	82	32	sf6	sf6	PROPN
aiua-8799	82	33	,	,	PUNCT
aiua-8799	82	34	oab	oab	PROPN
aiua-8799	82	35	-	-	PROPN
aiua-8799	82	36	q	q	PROPN
aiua-8799	82	37	sf13	sf13	PROPN
aiua-8799	82	38	,	,	PUNCT
aiua-8799	82	39	ppius	ppius	NOUN
aiua-8799	82	40	,	,	PUNCT
aiua-8799	82	41	vas	vas	X
aiua-8799	82	42	scale	scale	NOUN
aiua-8799	82	43	)	)	PUNCT
aiua-8799	82	44	.	.	PUNCT
aiua-8799	83	1	at	at	ADP
aiua-8799	83	2	six	six	NUM
aiua-8799	83	3	weeks	week	NOUN
aiua-8799	83	4	follow	follow	VERB
aiua-8799	83	5	-	-	PUNCT
aiua-8799	83	6	up	up	NOUN
aiua-8799	83	7	a	a	DET
aiua-8799	83	8	significantly	significantly	ADV
aiua-8799	83	9	worsening	worsen	VERB
aiua-8799	83	10	of	of	ADP
aiua-8799	83	11	quality	quality	NOUN
aiua-8799	83	12	of	of	ADP
aiua-8799	83	13	life	life	NOUN
aiua-8799	83	14	was	be	AUX
aiua-8799	83	15	demonstrated	demonstrate	VERB
aiua-8799	83	16	from	from	ADP
aiua-8799	83	17	the	the	DET
aiua-8799	83	18	values	value	NOUN
aiua-8799	83	19	at	at	ADP
aiua-8799	83	20	one	one	NUM
aiua-8799	83	21	week	week	NOUN
aiua-8799	83	22	.	.	PUNCT
aiua-8799	84	1	pgi-1	pgi-1	NUM
aiua-8799	84	2	showed	show	VERB
aiua-8799	84	3	a	a	DET
aiua-8799	84	4	significantly	significantly	ADV
aiua-8799	84	5	increase	increase	NOUN
aiua-8799	84	6	from	from	ADP
aiua-8799	84	7	baseline	baseline	NOUN
aiua-8799	84	8	at	at	ADP
aiua-8799	84	9	one	one	NUM
aiua-8799	84	10	and	and	CCONJ
aiua-8799	84	11	six	six	NUM
aiua-8799	84	12	weeks	week	NOUN
aiua-8799	84	13	of	of	ADP
aiua-8799	84	14	follow	follow	NOUN
aiua-8799	84	15	-	-	PUNCT
aiua-8799	84	16	up	up	NOUN
aiua-8799	84	17	with	with	ADP
aiua-8799	84	18	a	a	DET
aiua-8799	84	19	worse	bad	ADJ
aiua-8799	84	20	perception	perception	NOUN
aiua-8799	84	21	of	of	ADP
aiua-8799	84	22	the	the	DET
aiua-8799	84	23	response	response	NOUN
aiua-8799	84	24	to	to	ADP
aiua-8799	84	25	the	the	DET
aiua-8799	84	26	therapy	therapy	NOUN
aiua-8799	84	27	.	.	PUNCT
aiua-8799	85	1	vas	vas	X
aiua-8799	85	2	scale	scale	PROPN
aiua-8799	85	3	also	also	ADV
aiua-8799	85	4	showed	show	VERB
aiua-8799	85	5	a	a	DET
aiua-8799	85	6	significantly	significantly	ADV
aiua-8799	85	7	increase	increase	NOUN
aiua-8799	85	8	from	from	ADP
aiua-8799	85	9	baseline	baseline	NOUN
aiua-8799	85	10	at	at	ADP
aiua-8799	85	11	one	one	NUM
aiua-8799	85	12	and	and	CCONJ
aiua-8799	85	13	six	six	NUM
aiua-8799	85	14	weeks	week	NOUN
aiua-8799	85	15	of	of	ADP
aiua-8799	85	16	follow	follow	NOUN
aiua-8799	85	17	-	-	PUNCT
aiua-8799	85	18	up	up	NOUN
aiua-8799	85	19	.	.	PUNCT
aiua-8799	86	1	in	in	ADP
aiua-8799	86	2	both	both	DET
aiua-8799	86	3	cases	case	NOUN
aiua-8799	86	4	an	an	DET
aiua-8799	86	5	increase	increase	NOUN
aiua-8799	86	6	of	of	ADP
aiua-8799	86	7	values	value	NOUN
aiua-8799	86	8	was	be	AUX
aiua-8799	86	9	seen	see	VERB
aiua-8799	86	10	from	from	ADP
aiua-8799	86	11	the	the	DET
aiua-8799	86	12	one	one	NUM
aiua-8799	86	13	and	and	CCONJ
aiua-8799	86	14	six	six	NUM
aiua-8799	86	15	weeks	week	NOUN
aiua-8799	86	16	of	of	ADP
aiua-8799	86	17	follow	follow	VERB
aiua-8799	86	18	-	-	PUNCT
aiua-8799	86	19	up	up	NOUN
aiua-8799	86	20	without	without	ADP
aiua-8799	86	21	reaching	reach	VERB
aiua-8799	86	22	a	a	DET
aiua-8799	86	23	significant	significant	ADJ
aiua-8799	86	24	difference	difference	NOUN
aiua-8799	86	25	.	.	PUNCT
aiua-8799	87	1	table	table	NOUN
aiua-8799	87	2	4	4	NUM
aiua-8799	87	3	shows	show	VERB
aiua-8799	87	4	a	a	DET
aiua-8799	87	5	comparison	comparison	NOUN
aiua-8799	87	6	of	of	ADP
aiua-8799	87	7	uroflowmetric	uroflowmetric	ADJ
aiua-8799	87	8	parameters	parameter	NOUN
aiua-8799	87	9	and	and	CCONJ
aiua-8799	87	10	results	result	NOUN
aiua-8799	87	11	of	of	ADP
aiua-8799	87	12	questionnaires	questionnaire	NOUN
aiua-8799	87	13	between	between	ADP
aiua-8799	87	14	cases	case	NOUN
aiua-8799	87	15	and	and	CCONJ
aiua-8799	87	16	controls	control	NOUN
aiua-8799	87	17	at	at	ADP
aiua-8799	87	18	one	one	NUM
aiua-8799	87	19	and	and	CCONJ
aiua-8799	87	20	six	six	NUM
aiua-8799	87	21	weeks	week	NOUN
aiua-8799	87	22	.	.	PUNCT
aiua-8799	88	1	no	no	DET
aiua-8799	88	2	differences	difference	NOUN
aiua-8799	88	3	were	be	AUX
aiua-8799	88	4	seen	see	VERB
aiua-8799	88	5	in	in	ADP
aiua-8799	88	6	the	the	DET
aiua-8799	88	7	uroflow	uroflow	NOUN
aiua-8799	88	8	-	-	PUNCT
aiua-8799	88	9	qmax	qmax	NOUN
aiua-8799	88	10	and	and	CCONJ
aiua-8799	88	11	in	in	ADP
aiua-8799	88	12	the	the	DET
aiua-8799	88	13	uroflow	uroflow	ADJ
aiua-8799	88	14	-	-	PUNCT
aiua-8799	88	15	pvr	pvr	NOUN
aiua-8799	88	16	at	at	ADP
aiua-8799	88	17	one	one	NUM
aiua-8799	88	18	(	(	PUNCT
aiua-8799	88	19	p	p	NOUN
aiua-8799	88	20	=	=	NOUN
aiua-8799	88	21	0.8846	0.8846	NUM
aiua-8799	88	22	)	)	PUNCT
aiua-8799	88	23	and	and	CCONJ
aiua-8799	88	24	six	six	NUM
aiua-8799	88	25	weeks	week	NOUN
aiua-8799	88	26	(	(	PUNCT
aiua-8799	88	27	0.3951	0.3951	NUM
aiua-8799	88	28	)	)	PUNCT
aiua-8799	88	29	while	while	SCONJ
aiua-8799	88	30	the	the	DET
aiua-8799	88	31	uroflowvoided	uroflowvoided	ADJ
aiua-8799	88	32	volume	volume	NOUN
aiua-8799	88	33	was	be	AUX
aiua-8799	88	34	significantly	significantly	ADV
aiua-8799	88	35	reduced	reduce	VERB
aiua-8799	88	36	in	in	ADP
aiua-8799	88	37	the	the	DET
aiua-8799	88	38	controls	control	NOUN
aiua-8799	88	39	at	at	ADP
aiua-8799	88	40	one	one	NUM
aiua-8799	88	41	(	(	PUNCT
aiua-8799	88	42	p	p	X
aiua-8799	88	43	=	=	NOUN
aiua-8799	88	44	0.0234	0.0234	NUM
aiua-8799	88	45	)	)	PUNCT
aiua-8799	88	46	and	and	CCONJ
aiua-8799	88	47	six	six	NUM
aiua-8799	88	48	(	(	PUNCT
aiua-8799	88	49	p	p	X
aiua-8799	88	50	=	=	NOUN
aiua-8799	88	51	0.0002	0.0002	NUM
aiua-8799	88	52	)	)	PUNCT
aiua-8799	88	53	weeks	week	NOUN
aiua-8799	88	54	followup	followup	NOUN
aiua-8799	88	55	.	.	PUNCT
aiua-8799	89	1	the	the	DET
aiua-8799	89	2	ipss	ipss	PROPN
aiua-8799	89	3	questionnaire	questionnaire	NOUN
aiua-8799	89	4	significantly	significantly	ADV
aiua-8799	89	5	get	get	VERB
aiua-8799	89	6	worse	bad	ADJ
aiua-8799	89	7	in	in	ADP
aiua-8799	89	8	the	the	DET
aiua-8799	89	9	group	group	NOUN
aiua-8799	89	10	b	b	PROPN
aiua-8799	89	11	instead	instead	ADV
aiua-8799	89	12	of	of	ADP
aiua-8799	89	13	group	group	NOUN
aiua-8799	89	14	a	a	PRON
aiua-8799	89	15	at	at	ADP
aiua-8799	89	16	one	one	NOUN
aiua-8799	89	17	(	(	PUNCT
aiua-8799	89	18	p	p	X
aiua-8799	89	19	=	=	NOUN
aiua-8799	89	20	0.0222	0.0222	NUM
aiua-8799	89	21	)	)	PUNCT
aiua-8799	89	22	and	and	CCONJ
aiua-8799	89	23	six	six	NUM
aiua-8799	89	24	(	(	PUNCT
aiua-8799	89	25	p	p	X
aiua-8799	89	26	<	<	X
aiua-8799	89	27	0.001	0.001	NUM
aiua-8799	89	28	)	)	PUNCT
aiua-8799	89	29	weeks	week	NOUN
aiua-8799	89	30	of	of	ADP
aiua-8799	89	31	treatment	treatment	NOUN
aiua-8799	89	32	.	.	PUNCT
aiua-8799	90	1	group	group	PROPN
aiua-8799	90	2	a	a	PRON
aiua-8799	90	3	showed	show	VERB
aiua-8799	90	4	a	a	DET
aiua-8799	90	5	significantly	significantly	ADV
aiua-8799	90	6	better	well	ADJ
aiua-8799	90	7	oab	oab	PROPN
aiua-8799	90	8	-	-	PROPN
aiua-8799	90	9	q	q	PROPN
aiua-8799	90	10	sf	sf	PROPN
aiua-8799	90	11	6	6	NUM
aiua-8799	90	12	and	and	CCONJ
aiua-8799	90	13	oab	oab	PROPN
aiua-8799	90	14	-	-	PROPN
aiua-8799	90	15	q	q	PROPN
aiua-8799	90	16	sf	sf	PROPN
aiua-8799	90	17	13	13	NUM
aiua-8799	90	18	at	at	ADP
aiua-8799	90	19	one	one	NUM
aiua-8799	90	20	and	and	CCONJ
aiua-8799	90	21	six	six	NUM
aiua-8799	90	22	weeks	week	NOUN
aiua-8799	90	23	of	of	ADP
aiua-8799	90	24	follow	follow	NOUN
aiua-8799	90	25	-	-	PUNCT
aiua-8799	90	26	up	up	NOUN
aiua-8799	90	27	,	,	PUNCT
aiua-8799	90	28	while	while	SCONJ
aiua-8799	90	29	the	the	DET
aiua-8799	90	30	ppius	ppius	NOUN
aiua-8799	90	31	and	and	CCONJ
aiua-8799	90	32	the	the	DET
aiua-8799	90	33	vas	vas	NOUN
aiua-8799	90	34	scale	scale	NOUN
aiua-8799	90	35	were	be	AUX
aiua-8799	90	36	significantly	significantly	ADV
aiua-8799	90	37	worse	bad	ADJ
aiua-8799	90	38	in	in	ADP
aiua-8799	90	39	the	the	DET
aiua-8799	90	40	group	group	NOUN
aiua-8799	90	41	b	b	PROPN
aiua-8799	90	42	only	only	ADV
aiua-8799	90	43	at	at	ADP
aiua-8799	90	44	six	six	NUM
aiua-8799	90	45	weeks	week	NOUN
aiua-8799	90	46	.	.	PUNCT
aiua-8799	91	1	pgi-1	pgi-1	NUM
aiua-8799	91	2	showed	show	VERB
aiua-8799	91	3	a	a	DET
aiua-8799	91	4	worst	bad	ADJ
aiua-8799	91	5	perception	perception	NOUN
aiua-8799	91	6	of	of	ADP
aiua-8799	91	7	the	the	DET
aiua-8799	91	8	condition	condition	NOUN
aiua-8799	91	9	post	post	NOUN
aiua-8799	91	10	-	-	NOUN
aiua-8799	91	11	therapy	therapy	NOUN
aiua-8799	91	12	in	in	ADP
aiua-8799	91	13	the	the	DET
aiua-8799	91	14	group	group	NOUN
aiua-8799	91	15	b	b	PROPN
aiua-8799	91	16	both	both	PRON
aiua-8799	91	17	after	after	ADP
aiua-8799	91	18	one	one	NUM
aiua-8799	91	19	and	and	CCONJ
aiua-8799	91	20	six	six	NUM
aiua-8799	91	21	weeks	week	NOUN
aiua-8799	91	22	of	of	ADP
aiua-8799	91	23	treatment	treatment	NOUN
aiua-8799	91	24	.	.	PUNCT
aiua-8799	92	1	no	no	DET
aiua-8799	92	2	adverse	adverse	ADJ
aiua-8799	92	3	events	event	NOUN
aiua-8799	92	4	were	be	AUX
aiua-8799	92	5	reported	report	VERB
aiua-8799	92	6	in	in	ADP
aiua-8799	92	7	both	both	DET
aiua-8799	92	8	groups	group	NOUN
aiua-8799	92	9	.	.	PUNCT
aiua-8799	93	1	discussion	discussion	NOUN
aiua-8799	93	2	several	several	ADJ
aiua-8799	93	3	clinical	clinical	ADJ
aiua-8799	93	4	trials	trial	NOUN
aiua-8799	93	5	have	have	AUX
aiua-8799	93	6	demonstrated	demonstrate	VERB
aiua-8799	93	7	a	a	DET
aiua-8799	93	8	benefit	benefit	NOUN
aiua-8799	93	9	for	for	ADP
aiua-8799	93	10	chemo	chemo	NOUN
aiua-8799	93	11	-	-	PUNCT
aiua-8799	93	12	hyperthermia	hyperthermia	NOUN
aiua-8799	93	13	over	over	ADP
aiua-8799	93	14	intravesical	intravesical	ADJ
aiua-8799	93	15	chemotherapy	chemotherapy	NOUN
aiua-8799	93	16	alone	alone	ADV
aiua-8799	93	17	for	for	ADP
aiua-8799	93	18	treating	treat	VERB
aiua-8799	93	19	nmibc	nmibc	ADP
aiua-8799	93	20	(	(	PUNCT
aiua-8799	93	21	5	5	NUM
aiua-8799	93	22	-	-	SYM
aiua-8799	93	23	6	6	NUM
aiua-8799	93	24	)	)	PUNCT
aiua-8799	93	25	.	.	PUNCT
aiua-8799	94	1	neoadjuvant	neoadjuvant	ADJ
aiua-8799	94	2	hivec	hivec	PROPN
aiua-8799	94	3	consisted	consist	VERB
aiua-8799	94	4	of	of	ADP
aiua-8799	94	5	intravesical	intravesical	ADJ
aiua-8799	94	6	chemotherapy	chemotherapy	NOUN
aiua-8799	94	7	with	with	ADP
aiua-8799	94	8	mitomycin	mitomycin	PROPN
aiua-8799	94	9	-	-	PUNCT
aiua-8799	94	10	c	c	PROPN
aiua-8799	94	11	(	(	PUNCT
aiua-8799	94	12	mmc	mmc	PROPN
aiua-8799	94	13	)	)	PUNCT
aiua-8799	94	14	combined	combine	VERB
aiua-8799	94	15	with	with	ADP
aiua-8799	94	16	bladder	bladder	NOUN
aiua-8799	94	17	hyperthermia	hyperthermia	NOUN
aiua-8799	94	18	,	,	PUNCT
aiua-8799	94	19	which	which	PRON
aiua-8799	94	20	was	be	AUX
aiua-8799	94	21	achieved	achieve	VERB
aiua-8799	94	22	in	in	ADP
aiua-8799	94	23	our	our	PRON
aiua-8799	94	24	cases	case	NOUN
aiua-8799	94	25	with	with	ADP
aiua-8799	94	26	the	the	DET
aiua-8799	94	27	bladder	bladder	NOUN
aiua-8799	94	28	recirculation	recirculation	NOUN
aiua-8799	94	29	system	system	NOUN
aiua-8799	94	30	(	(	PUNCT
aiua-8799	94	31	brs	brs	NOUN
aiua-8799	94	32	)	)	PUNCT
aiua-8799	94	33	system	system	NOUN
aiua-8799	94	34	from	from	ADP
aiua-8799	94	35	combat	combat	NOUN
aiua-8799	94	36	medical	medical	NOUN
aiua-8799	94	37	.	.	PUNCT
aiua-8799	95	1	the	the	DET
aiua-8799	95	2	combat	combat	NOUN
aiua-8799	95	3	brs	brs	NOUN
aiua-8799	95	4	device	device	NOUN
aiua-8799	95	5	is	be	AUX
aiua-8799	95	6	an	an	DET
aiua-8799	95	7	external	external	ADJ
aiua-8799	95	8	device	device	NOUN
aiua-8799	95	9	that	that	PRON
aiua-8799	95	10	heats	heat	VERB
aiua-8799	95	11	fluid	fluid	NOUN
aiua-8799	95	12	(	(	PUNCT
aiua-8799	95	13	mmc	mmc	NOUN
aiua-8799	95	14	in	in	ADP
aiua-8799	95	15	this	this	DET
aiua-8799	95	16	case	case	NOUN
aiua-8799	95	17	)	)	PUNCT
aiua-8799	95	18	in	in	ADP
aiua-8799	95	19	a	a	DET
aiua-8799	95	20	sterile	sterile	ADJ
aiua-8799	95	21	disposable	disposable	ADJ
aiua-8799	95	22	bag	bag	NOUN
aiua-8799	95	23	and	and	CCONJ
aiua-8799	95	24	recirculates	recirculate	VERB
aiua-8799	95	25	it	it	PRON
aiua-8799	95	26	to	to	ADP
aiua-8799	95	27	the	the	DET
aiua-8799	95	28	urinary	urinary	ADJ
aiua-8799	95	29	bladder	bladder	NOUN
aiua-8799	95	30	at	at	ADP
aiua-8799	95	31	a	a	DET
aiua-8799	95	32	constant	constant	ADJ
aiua-8799	95	33	and	and	CCONJ
aiua-8799	95	34	controllable	controllable	ADJ
aiua-8799	95	35	temperature	temperature	NOUN
aiua-8799	95	36	and	and	CCONJ
aiua-8799	95	37	flow	flow	NOUN
aiua-8799	95	38	rate	rate	NOUN
aiua-8799	95	39	through	through	ADP
aiua-8799	95	40	a	a	DET
aiua-8799	95	41	three	three	NUM
aiua-8799	95	42	-	-	PUNCT
aiua-8799	95	43	way	way	NOUN
aiua-8799	95	44	foley	foley	NOUN
aiua-8799	95	45	catheter	catheter	NOUN
aiua-8799	95	46	.	.	PUNCT
aiua-8799	96	1	hyperthermia	hyperthermia	NOUN
aiua-8799	96	2	increases	increase	VERB
aiua-8799	96	3	drug	drug	NOUN
aiua-8799	96	4	uptake	uptake	ADJ
aiua-8799	96	5	into	into	ADP
aiua-8799	96	6	the	the	DET
aiua-8799	96	7	cancer	cancer	NOUN
aiua-8799	96	8	cells	cell	NOUN
aiua-8799	96	9	,	,	PUNCT
aiua-8799	96	10	affects	affect	VERB
aiua-8799	96	11	drug	drug	NOUN
aiua-8799	96	12	metabolism	metabolism	NOUN
aiua-8799	96	13	,	,	PUNCT
aiua-8799	96	14	and	and	CCONJ
aiua-8799	96	15	impairs	impair	VERB
aiua-8799	96	16	cellular	cellular	ADJ
aiua-8799	96	17	dna	dna	PROPN
aiua-8799	96	18	repair	repair	NOUN
aiua-8799	96	19	mechanisms	mechanism	NOUN
aiua-8799	96	20	that	that	PRON
aiua-8799	96	21	normally	normally	ADV
aiua-8799	96	22	counteract	counteract	VERB
aiua-8799	96	23	drug	drug	NOUN
aiua-8799	96	24	effect	effect	NOUN
aiua-8799	96	25	(	(	PUNCT
aiua-8799	96	26	7	7	NUM
aiua-8799	96	27	-	-	SYM
aiua-8799	96	28	9	9	NUM
aiua-8799	96	29	)	)	PUNCT
aiua-8799	96	30	.	.	PUNCT
aiua-8799	97	1	this	this	DET
aiua-8799	97	2	treatment	treatment	NOUN
aiua-8799	97	3	might	might	AUX
aiua-8799	97	4	be	be	AUX
aiua-8799	97	5	a	a	DET
aiua-8799	97	6	feasible	feasible	ADJ
aiua-8799	97	7	option	option	NOUN
aiua-8799	97	8	in	in	ADP
aiua-8799	97	9	bcg	bcg	PROPN
aiua-8799	97	10	unresponsive	unresponsive	ADJ
aiua-8799	97	11	nmibc	nmibc	ADJ
aiua-8799	97	12	patients	patient	NOUN
aiua-8799	97	13	,	,	PUNCT
aiua-8799	97	14	potentially	potentially	ADV
aiua-8799	97	15	avoiding	avoid	VERB
aiua-8799	97	16	or	or	CCONJ
aiua-8799	97	17	postponing	postpone	VERB
aiua-8799	97	18	the	the	DET
aiua-8799	97	19	need	need	NOUN
aiua-8799	97	20	for	for	ADP
aiua-8799	97	21	radical	radical	ADJ
aiua-8799	97	22	surgery	surgery	NOUN
aiua-8799	97	23	in	in	ADP
aiua-8799	97	24	a	a	DET
aiua-8799	97	25	proportion	proportion	NOUN
aiua-8799	97	26	of	of	ADP
aiua-8799	97	27	these	these	DET
aiua-8799	97	28	patients	patient	NOUN
aiua-8799	97	29	(	(	PUNCT
aiua-8799	97	30	3	3	NUM
aiua-8799	97	31	,	,	PUNCT
aiua-8799	97	32	10	10	NUM
aiua-8799	97	33	,	,	PUNCT
aiua-8799	97	34	11	11	NUM
aiua-8799	97	35	)	)	PUNCT
aiua-8799	97	36	.	.	PUNCT
aiua-8799	98	1	nevertheless	nevertheless	ADV
aiua-8799	98	2	,	,	PUNCT
aiua-8799	98	3	this	this	DET
aiua-8799	98	4	treatment	treatment	NOUN
aiua-8799	98	5	can	can	AUX
aiua-8799	98	6	increase	increase	VERB
aiua-8799	98	7	the	the	DET
aiua-8799	98	8	rate	rate	NOUN
aiua-8799	98	9	of	of	ADP
aiua-8799	98	10	local	local	ADJ
aiua-8799	98	11	adverse	adverse	ADJ
aiua-8799	98	12	events	event	NOUN
aiua-8799	98	13	than	than	ADP
aiua-8799	98	14	passive	passive	ADJ
aiua-8799	98	15	mitomycin	mitomycin	NOUN
aiua-8799	98	16	-	-	PUNCT
aiua-8799	98	17	c	c	NOUN
aiua-8799	98	18	like	like	ADP
aiua-8799	98	19	urinary	urinary	ADJ
aiua-8799	98	20	frequency	frequency	NOUN
aiua-8799	98	21	,	,	PUNCT
aiua-8799	98	22	haematuria	haematuria	NOUN
aiua-8799	98	23	and	and	CCONJ
aiua-8799	98	24	bladder	bladder	NOUN
aiua-8799	98	25	spasm	spasm	NOUN
aiua-8799	98	26	(	(	PUNCT
aiua-8799	98	27	4	4	NUM
aiua-8799	98	28	)	)	PUNCT
aiua-8799	98	29	.	.	PUNCT
aiua-8799	99	1	protopine	protopine	PROPN
aiua-8799	99	2	has	have	VERB
aiua-8799	99	3	a	a	DET
aiua-8799	99	4	demonstrated	demonstrate	VERB
aiua-8799	99	5	anti179archivio	anti179archivio	NOUN
aiua-8799	99	6	italiano	italiano	NOUN
aiua-8799	99	7	di	di	X
aiua-8799	99	8	urologia	urologia	PROPN
aiua-8799	99	9	e	e	PROPN
aiua-8799	99	10	andrologia	andrologia	NOUN
aiua-8799	99	11	2020	2020	NUM
aiua-8799	99	12	;	;	PUNCT
aiua-8799	99	13	92	92	NUM
aiua-8799	99	14	,	,	PUNCT
aiua-8799	99	15	3	3	NUM
aiua-8799	99	16	protopine	protopine	NOUN
aiua-8799	99	17	and	and	CCONJ
aiua-8799	99	18	nuciferin	nuciferin	ADJ
aiua-8799	99	19	for	for	ADP
aiua-8799	99	20	hyperthermic	hyperthermic	ADJ
aiua-8799	99	21	intravesical	intravesical	ADJ
aiua-8799	99	22	chemotherapy	chemotherapy	NOUN
aiua-8799	99	23	table	table	NOUN
aiua-8799	99	24	3	3	NUM
aiua-8799	99	25	.	.	PUNCT
aiua-8799	99	26	comparison	comparison	NOUN
aiua-8799	99	27	of	of	ADP
aiua-8799	99	28	uroflowmetry	uroflowmetry	NOUN
aiua-8799	99	29	parameters	parameter	NOUN
aiua-8799	99	30	and	and	CCONJ
aiua-8799	99	31	questionnaires	questionnaire	NOUN
aiua-8799	99	32	from	from	ADP
aiua-8799	99	33	baseline	baseline	NOUN
aiua-8799	99	34	and	and	CCONJ
aiua-8799	99	35	between	between	ADP
aiua-8799	99	36	one	one	NUM
aiua-8799	99	37	and	and	CCONJ
aiua-8799	99	38	six	six	NUM
aiua-8799	99	39	weeks	week	NOUN
aiua-8799	99	40	of	of	ADP
aiua-8799	99	41	treatment	treatment	NOUN
aiua-8799	99	42	(	(	PUNCT
aiua-8799	99	43	controls	control	NOUN
aiua-8799	99	44	)	)	PUNCT
aiua-8799	99	45	.	.	PUNCT
aiua-8799	100	1	variable	variable	ADJ
aiua-8799	100	2	value	value	NOUN
aiua-8799	100	3	(	(	PUNCT
aiua-8799	100	4	baseline	baseline	NOUN
aiua-8799	100	5	)	)	PUNCT
aiua-8799	100	6	value	value	NOUN
aiua-8799	100	7	(	(	PUNCT
aiua-8799	100	8	one	one	NUM
aiua-8799	100	9	-	-	PUNCT
aiua-8799	100	10	week	week	NOUN
aiua-8799	100	11	)	)	PUNCT
aiua-8799	100	12	value	value	NOUN
aiua-8799	100	13	(	(	PUNCT
aiua-8799	100	14	six	six	NUM
aiua-8799	100	15	-	-	PUNCT
aiua-8799	100	16	weeks	week	NOUN
aiua-8799	100	17	)	)	PUNCT
aiua-8799	100	18	uroflow	uroflow	NOUN
aiua-8799	100	19	-	-	PUNCT
aiua-8799	100	20	qmax	qmax	NOUN
aiua-8799	100	21	(	(	PUNCT
aiua-8799	100	22	ml	ml	PROPN
aiua-8799	100	23	/	/	SYM
aiua-8799	100	24	s	s	NOUN
aiua-8799	100	25	)	)	PUNCT
aiua-8799	100	26	17.39	17.39	NUM
aiua-8799	100	27	±	±	NUM
aiua-8799	100	28	2.21	2.21	NUM
aiua-8799	100	29	17.06	17.06	NUM
aiua-8799	100	30	±	±	NUM
aiua-8799	100	31	2.25	2.25	NUM
aiua-8799	100	32	17.02	17.02	NUM
aiua-8799	100	33	±	±	NUM
aiua-8799	100	34	2.15	2.15	NUM
aiua-8799	100	35	p	p	NOUN
aiua-8799	100	36	(	(	PUNCT
aiua-8799	100	37	from	from	ADP
aiua-8799	100	38	baseline	baseline	NOUN
aiua-8799	100	39	)	)	PUNCT
aiua-8799	101	1	p	p	NOUN
aiua-8799	101	2	=	=	PUNCT
aiua-8799	101	3	0.4611	0.4611	NUM
aiua-8799	101	4	p	p	X
aiua-8799	101	5	=	=	X
aiua-8799	101	6	0.3982	0.3982	NUM
aiua-8799	101	7	p	p	NOUN
aiua-8799	101	8	(	(	PUNCT
aiua-8799	101	9	from	from	ADP
aiua-8799	101	10	1	1	NUM
aiua-8799	101	11	and	and	CCONJ
aiua-8799	101	12	6	6	NUM
aiua-8799	101	13	weeks	week	NOUN
aiua-8799	101	14	)	)	PUNCT
aiua-8799	101	15	p	p	X
aiua-8799	101	16	=	=	PUNCT
aiua-8799	101	17	0.9278	0.9278	NUM
aiua-8799	101	18	uroflow	uroflow	NOUN
aiua-8799	101	19	-	-	PUNCT
aiua-8799	101	20	voided	void	VERB
aiua-8799	101	21	volume	volume	NOUN
aiua-8799	101	22	(	(	PUNCT
aiua-8799	101	23	ml	ml	NOUN
aiua-8799	101	24	)	)	PUNCT
aiua-8799	101	25	242.2	242.2	NUM
aiua-8799	101	26	±	±	NUM
aiua-8799	101	27	41.22	41.22	NUM
aiua-8799	101	28	220.4	220.4	NUM
aiua-8799	101	29	±	±	NOUN
aiua-8799	101	30	43.66	43.66	NUM
aiua-8799	101	31	218.8	218.8	NUM
aiua-8799	101	32	±	±	NOUN
aiua-8799	101	33	43.21	43.21	NUM
aiua-8799	101	34	p	p	NOUN
aiua-8799	101	35	(	(	PUNCT
aiua-8799	101	36	from	from	ADP
aiua-8799	101	37	baseline	baseline	NOUN
aiua-8799	101	38	)	)	PUNCT
aiua-8799	102	1	p	p	NOUN
aiua-8799	102	2	=	=	PUNCT
aiua-8799	103	1	0.0118	0.0118	NUM
aiua-8799	103	2	p	p	X
aiua-8799	103	3	=	=	PROPN
aiua-8799	103	4	0.0067	0.0067	NUM
aiua-8799	103	5	p	p	NOUN
aiua-8799	103	6	(	(	PUNCT
aiua-8799	103	7	from	from	ADP
aiua-8799	103	8	1	1	NUM
aiua-8799	103	9	and	and	CCONJ
aiua-8799	103	10	6	6	NUM
aiua-8799	103	11	weeks	week	NOUN
aiua-8799	103	12	)	)	PUNCT
aiua-8799	103	13	p	p	NOUN
aiua-8799	103	14	=	=	NOUN
aiua-8799	103	15	0.8543	0.8543	NUM
aiua-8799	103	16	uroflow	uroflow	ADJ
aiua-8799	103	17	-	-	PUNCT
aiua-8799	103	18	pvr	pvr	NOUN
aiua-8799	103	19	(	(	PUNCT
aiua-8799	103	20	ml	ml	NOUN
aiua-8799	103	21	)	)	PUNCT
aiua-8799	103	22	14.9	14.9	NUM
aiua-8799	103	23	±	±	NUM
aiua-8799	103	24	10.13	10.13	NUM
aiua-8799	103	25	13.8	13.8	NUM
aiua-8799	103	26	±	±	NUM
aiua-8799	103	27	10.08	10.08	NUM
aiua-8799	103	28	15.9	15.9	NUM
aiua-8799	103	29	±	±	NUM
aiua-8799	103	30	9.98	9.98	NUM
aiua-8799	103	31	p	p	NOUN
aiua-8799	103	32	(	(	PUNCT
aiua-8799	103	33	from	from	ADP
aiua-8799	103	34	baseline	baseline	NOUN
aiua-8799	103	35	)	)	PUNCT
aiua-8799	103	36	p	p	X
aiua-8799	103	37	=	=	PUNCT
aiua-8799	103	38	0.5875	0.5875	NUM
aiua-8799	103	39	p	p	X
aiua-8799	103	40	=	=	PUNCT
aiua-8799	103	41	0.6201	0.6201	NUM
aiua-8799	103	42	p	p	NOUN
aiua-8799	103	43	(	(	PUNCT
aiua-8799	103	44	from	from	ADP
aiua-8799	103	45	1	1	NUM
aiua-8799	103	46	and	and	CCONJ
aiua-8799	103	47	6	6	NUM
aiua-8799	103	48	weeks	week	NOUN
aiua-8799	103	49	)	)	PUNCT
aiua-8799	103	50	p	p	X
aiua-8799	103	51	=	=	PUNCT
aiua-8799	103	52	0.2977	0.2977	NUM
aiua-8799	103	53	ipss	ipss	PROPN
aiua-8799	103	54	total	total	NOUN
aiua-8799	103	55	7.79	7.79	NUM
aiua-8799	103	56	±	±	NUM
aiua-8799	103	57	4.55	4.55	NUM
aiua-8799	103	58	13.64	13.64	NUM
aiua-8799	103	59	±	±	NUM
aiua-8799	103	60	5.71	5.71	NUM
aiua-8799	103	61	14.62	14.62	NUM
aiua-8799	103	62	±	±	NUM
aiua-8799	103	63	5.92	5.92	NUM
aiua-8799	103	64	p	p	NOUN
aiua-8799	103	65	(	(	PUNCT
aiua-8799	103	66	from	from	ADP
aiua-8799	103	67	baseline	baseline	NOUN
aiua-8799	103	68	)	)	PUNCT
aiua-8799	104	1	p	p	X
aiua-8799	104	2	<	<	X
aiua-8799	104	3	0.001	0.001	NUM
aiua-8799	104	4	p	p	X
aiua-8799	104	5	<	<	X
aiua-8799	104	6	0.001	0.001	NUM
aiua-8799	104	7	p	p	NOUN
aiua-8799	104	8	(	(	PUNCT
aiua-8799	104	9	from	from	ADP
aiua-8799	104	10	1	1	NUM
aiua-8799	104	11	and	and	CCONJ
aiua-8799	104	12	6	6	NUM
aiua-8799	104	13	weeks	week	NOUN
aiua-8799	104	14	)	)	PUNCT
aiua-8799	104	15	p	p	NOUN
aiua-8799	105	1	=	=	PUNCT
aiua-8799	105	2	0.4016	0.4016	NUM
aiua-8799	105	3	oab	oab	PROPN
aiua-8799	105	4	-	-	PROPN
aiua-8799	105	5	q	q	PROPN
aiua-8799	105	6	sf	sf	PROPN
aiua-8799	105	7	6	6	NUM
aiua-8799	105	8	11.92	11.92	NUM
aiua-8799	105	9	±	±	NUM
aiua-8799	105	10	5.3	5.3	NUM
aiua-8799	105	11	20.58	20.58	NUM
aiua-8799	105	12	±	±	NUM
aiua-8799	105	13	6.29	6.29	NUM
aiua-8799	105	14	24.34	24.34	NUM
aiua-8799	105	15	±	±	NUM
aiua-8799	105	16	6.3	6.3	NUM
aiua-8799	105	17	p	p	NOUN
aiua-8799	105	18	(	(	PUNCT
aiua-8799	105	19	from	from	ADP
aiua-8799	105	20	baseline	baseline	NOUN
aiua-8799	105	21	)	)	PUNCT
aiua-8799	105	22	p	p	X
aiua-8799	105	23	<	<	X
aiua-8799	105	24	0.001	0.001	NUM
aiua-8799	105	25	p	p	X
aiua-8799	105	26	<	<	X
aiua-8799	105	27	0.001	0.001	NUM
aiua-8799	105	28	p	p	NOUN
aiua-8799	105	29	(	(	PUNCT
aiua-8799	105	30	from	from	ADP
aiua-8799	105	31	1	1	NUM
aiua-8799	105	32	and	and	CCONJ
aiua-8799	105	33	6	6	NUM
aiua-8799	105	34	weeks	week	NOUN
aiua-8799	105	35	)	)	PUNCT
aiua-8799	106	1	p	p	NOUN
aiua-8799	107	1	=	=	PUNCT
aiua-8799	107	2	0.0036	0.0036	NUM
aiua-8799	107	3	oab	oab	PROPN
aiua-8799	107	4	-	-	PROPN
aiua-8799	107	5	q	q	PROPN
aiua-8799	107	6	sf	sf	PROPN
aiua-8799	107	7	13	13	NUM
aiua-8799	107	8	26.02	26.02	NUM
aiua-8799	107	9	±	±	NUM
aiua-8799	107	10	11.39	11.39	NUM
aiua-8799	107	11	43.78	43.78	NUM
aiua-8799	107	12	±	±	NUM
aiua-8799	107	13	13.02	13.02	NUM
aiua-8799	107	14	49.44	49.44	NUM
aiua-8799	107	15	±	±	NUM
aiua-8799	107	16	12.65	12.65	NUM
aiua-8799	107	17	p	p	NOUN
aiua-8799	107	18	(	(	PUNCT
aiua-8799	107	19	from	from	ADP
aiua-8799	107	20	baseline	baseline	NOUN
aiua-8799	107	21	)	)	PUNCT
aiua-8799	107	22	p	p	X
aiua-8799	107	23	<	<	X
aiua-8799	107	24	0.001	0.001	NUM
aiua-8799	107	25	p	p	X
aiua-8799	107	26	<	<	X
aiua-8799	107	27	0.001	0.001	NUM
aiua-8799	107	28	p	p	NOUN
aiua-8799	107	29	(	(	PUNCT
aiua-8799	107	30	from	from	ADP
aiua-8799	107	31	1	1	NUM
aiua-8799	107	32	and	and	CCONJ
aiua-8799	107	33	6	6	NUM
aiua-8799	107	34	weeks	week	NOUN
aiua-8799	107	35	)	)	PUNCT
aiua-8799	107	36	p	p	X
aiua-8799	107	37	=	=	SYM
aiua-8799	107	38	0.0298	0.0298	NUM
aiua-8799	107	39	ppius	ppius	NOUN
aiua-8799	107	40	0.96	0.96	NUM
aiua-8799	107	41	±	±	NUM
aiua-8799	107	42	0.78	0.78	NUM
aiua-8799	107	43	2.12	2.12	NUM
aiua-8799	107	44	±	±	NUM
aiua-8799	107	45	0.69	0.69	NUM
aiua-8799	107	46	2.54	2.54	NUM
aiua-8799	107	47	±	±	NUM
aiua-8799	107	48	0.64	0.64	NUM
aiua-8799	107	49	p	p	NOUN
aiua-8799	107	50	(	(	PUNCT
aiua-8799	107	51	from	from	ADP
aiua-8799	107	52	baseline	baseline	NOUN
aiua-8799	107	53	)	)	PUNCT
aiua-8799	108	1	p	p	X
aiua-8799	108	2	<	<	X
aiua-8799	108	3	0.001	0.001	NUM
aiua-8799	108	4	p	p	X
aiua-8799	108	5	<	<	X
aiua-8799	108	6	0.001	0.001	NUM
aiua-8799	108	7	p	p	NOUN
aiua-8799	108	8	(	(	PUNCT
aiua-8799	108	9	from	from	ADP
aiua-8799	108	10	1	1	NUM
aiua-8799	108	11	and	and	CCONJ
aiua-8799	108	12	6	6	NUM
aiua-8799	108	13	weeks	week	NOUN
aiua-8799	108	14	)	)	PUNCT
aiua-8799	109	1	p	p	X
aiua-8799	109	2	=	=	PROPN
aiua-8799	109	3	0.0021	0.0021	NUM
aiua-8799	109	4	pgi	pgi	PROPN
aiua-8799	109	5	-	-	PUNCT
aiua-8799	109	6	i	i	PROPN
aiua-8799	109	7	4	4	NUM
aiua-8799	109	8	±	±	NUM
aiua-8799	109	9	0	0	NUM
aiua-8799	109	10	4.82	4.82	NUM
aiua-8799	109	11	±	±	NUM
aiua-8799	109	12	0.96	0.96	NUM
aiua-8799	109	13	5.22	5.22	NUM
aiua-8799	109	14	±	±	NUM
aiua-8799	109	15	1.02	1.02	NUM
aiua-8799	109	16	p	p	NOUN
aiua-8799	109	17	(	(	PUNCT
aiua-8799	109	18	from	from	ADP
aiua-8799	109	19	baseline	baseline	NOUN
aiua-8799	109	20	)	)	PUNCT
aiua-8799	109	21	p	p	X
aiua-8799	109	22	<	<	X
aiua-8799	109	23	0.001	0.001	NUM
aiua-8799	109	24	p	p	NOUN
aiua-8799	109	25	=	=	NOUN
aiua-8799	109	26	0.0462	0.0462	NUM
aiua-8799	109	27	p	p	NOUN
aiua-8799	109	28	(	(	PUNCT
aiua-8799	109	29	from	from	ADP
aiua-8799	109	30	1	1	NUM
aiua-8799	109	31	and	and	CCONJ
aiua-8799	109	32	6	6	NUM
aiua-8799	109	33	weeks	week	NOUN
aiua-8799	109	34	)	)	PUNCT
aiua-8799	110	1	p	p	NOUN
aiua-8799	110	2	=	=	SYM
aiua-8799	110	3	0.2719	0.2719	NUM
aiua-8799	110	4	vas	vas	NOUN
aiua-8799	110	5	scale	scale	NOUN
aiua-8799	110	6	0.08	0.08	NUM
aiua-8799	110	7	±	±	NUM
aiua-8799	110	8	0.27	0.27	NUM
aiua-8799	110	9	3.68	3.68	NUM
aiua-8799	110	10	±	±	NUM
aiua-8799	110	11	1.88	1.88	NUM
aiua-8799	110	12	3.92	3.92	NUM
aiua-8799	110	13	±	±	NUM
aiua-8799	110	14	1.93	1.93	NUM
aiua-8799	110	15	p	p	NOUN
aiua-8799	110	16	(	(	PUNCT
aiua-8799	110	17	from	from	ADP
aiua-8799	110	18	baseline	baseline	NOUN
aiua-8799	110	19	)	)	PUNCT
aiua-8799	111	1	p	p	X
aiua-8799	111	2	<	<	X
aiua-8799	111	3	0.001	0.001	NUM
aiua-8799	111	4	p	p	X
aiua-8799	111	5	<	<	X
aiua-8799	111	6	0.001	0.001	NUM
aiua-8799	111	7	p	p	NOUN
aiua-8799	111	8	(	(	PUNCT
aiua-8799	111	9	from	from	ADP
aiua-8799	111	10	1	1	NUM
aiua-8799	111	11	and	and	CCONJ
aiua-8799	111	12	6	6	NUM
aiua-8799	111	13	weeks	week	NOUN
aiua-8799	111	14	)	)	PUNCT
aiua-8799	111	15	p	p	X
aiua-8799	111	16	=	=	PUNCT
aiua-8799	111	17	0.5302	0.5302	NUM
aiua-8799	111	18	pvr	pvr	NOUN
aiua-8799	111	19	:	:	PUNCT
aiua-8799	111	20	post	post	ADJ
aiua-8799	111	21	-	-	ADJ
aiua-8799	111	22	void	void	ADJ
aiua-8799	111	23	residual	residual	NOUN
aiua-8799	111	24	;	;	PUNCT
aiua-8799	111	25	ipss	ipss	PROPN
aiua-8799	111	26	:	:	PUNCT
aiua-8799	111	27	international	international	ADJ
aiua-8799	111	28	prostatic	prostatic	ADJ
aiua-8799	111	29	symptoms	symptom	NOUN
aiua-8799	111	30	score	score	VERB
aiua-8799	111	31	;	;	PUNCT
aiua-8799	111	32	oab	oab	PROPN
aiua-8799	111	33	:	:	PUNCT
aiua-8799	111	34	overactive	overactive	ADJ
aiua-8799	111	35	bladder	bladder	NOUN
aiua-8799	111	36	;	;	PUNCT
aiua-8799	111	37	ppius	ppius	NOUN
aiua-8799	111	38	:	:	PUNCT
aiua-8799	111	39	patient	patient	ADJ
aiua-8799	111	40	perception	perception	NOUN
aiua-8799	111	41	of	of	ADP
aiua-8799	111	42	intensity	intensity	NOUN
aiua-8799	111	43	of	of	ADP
aiua-8799	111	44	urgency	urgency	NOUN
aiua-8799	111	45	scale	scale	NOUN
aiua-8799	111	46	;	;	PUNCT
aiua-8799	111	47	pgi	pgi	PROPN
aiua-8799	111	48	-	-	PUNCT
aiua-8799	111	49	i	i	PROPN
aiua-8799	111	50	:	:	PUNCT
aiua-8799	111	51	patient	patient	ADJ
aiua-8799	111	52	global	global	ADJ
aiua-8799	111	53	impression	impression	NOUN
aiua-8799	111	54	of	of	ADP
aiua-8799	111	55	improvement	improvement	NOUN
aiua-8799	111	56	questionnaire	questionnaire	NOUN
aiua-8799	111	57	;	;	PUNCT
aiua-8799	111	58	vas	vas	X
aiua-8799	111	59	:	:	PUNCT
aiua-8799	111	60	visual	visual	ADJ
aiua-8799	111	61	analogue	analogue	NOUN
aiua-8799	111	62	scale	scale	NOUN
aiua-8799	111	63	.	.	PUNCT
aiua-8799	112	1	table	table	NOUN
aiua-8799	112	2	4	4	NUM
aiua-8799	112	3	.	.	PUNCT
aiua-8799	112	4	comparison	comparison	NOUN
aiua-8799	112	5	of	of	ADP
aiua-8799	112	6	uroflowmetry	uroflowmetry	NOUN
aiua-8799	112	7	parameters	parameter	NOUN
aiua-8799	112	8	and	and	CCONJ
aiua-8799	112	9	results	result	NOUN
aiua-8799	112	10	of	of	ADP
aiua-8799	112	11	questionnaires	questionnaire	NOUN
aiua-8799	112	12	between	between	ADP
aiua-8799	112	13	cases	case	NOUN
aiua-8799	112	14	and	and	CCONJ
aiua-8799	112	15	controls	control	NOUN
aiua-8799	112	16	at	at	ADP
aiua-8799	112	17	one	one	NUM
aiua-8799	112	18	and	and	CCONJ
aiua-8799	112	19	six	six	NUM
aiua-8799	112	20	weeks	week	NOUN
aiua-8799	112	21	.	.	PUNCT
aiua-8799	113	1	variable	variable	ADJ
aiua-8799	113	2	value	value	NOUN
aiua-8799	113	3	(	(	PUNCT
aiua-8799	113	4	group	group	NOUN
aiua-8799	113	5	a	a	DET
aiua-8799	113	6	value	value	NOUN
aiua-8799	113	7	(	(	PUNCT
aiua-8799	113	8	group	group	NOUN
aiua-8799	113	9	b	b	PROPN
aiua-8799	113	10	p	p	NOUN
aiua-8799	113	11	value	value	NOUN
aiua-8799	113	12	(	(	PUNCT
aiua-8799	113	13	group	group	NOUN
aiua-8799	113	14	a	a	DET
aiua-8799	113	15	value	value	NOUN
aiua-8799	113	16	(	(	PUNCT
aiua-8799	113	17	group	group	NOUN
aiua-8799	113	18	b	b	PROPN
aiua-8799	113	19	p	p	ADJ
aiua-8799	113	20	1	1	NUM
aiua-8799	113	21	-	-	PUNCT
aiua-8799	113	22	week	week	NOUN
aiua-8799	113	23	)	)	PUNCT
aiua-8799	113	24	1	1	NUM
aiua-8799	113	25	-	-	PUNCT
aiua-8799	113	26	week	week	NOUN
aiua-8799	113	27	)	)	PUNCT
aiua-8799	113	28	6	6	NUM
aiua-8799	113	29	-	-	PUNCT
aiua-8799	113	30	week	week	NOUN
aiua-8799	113	31	)	)	PUNCT
aiua-8799	113	32	6	6	NUM
aiua-8799	113	33	-	-	PUNCT
aiua-8799	113	34	week	week	NOUN
aiua-8799	113	35	)	)	PUNCT
aiua-8799	113	36	uroflow	uroflow	NOUN
aiua-8799	113	37	-	-	PUNCT
aiua-8799	113	38	qmax	qmax	NOUN
aiua-8799	113	39	(	(	PUNCT
aiua-8799	113	40	ml	ml	PROPN
aiua-8799	113	41	/	/	SYM
aiua-8799	113	42	s	s	NOUN
aiua-8799	113	43	)	)	PUNCT
aiua-8799	113	44	16.99	16.99	NUM
aiua-8799	113	45	±	±	NUM
aiua-8799	113	46	2.55	2.55	NUM
aiua-8799	113	47	17.06	17.06	NUM
aiua-8799	113	48	±	±	NUM
aiua-8799	113	49	2.25	2.25	NUM
aiua-8799	113	50	0.8846	0.8846	NUM
aiua-8799	113	51	16.62	16.62	NUM
aiua-8799	113	52	±	±	NUM
aiua-8799	113	53	2.43	2.43	NUM
aiua-8799	113	54	17.02	17.02	NUM
aiua-8799	113	55	±	±	NUM
aiua-8799	113	56	2.15	2.15	NUM
aiua-8799	113	57	0.3951	0.3951	NUM
aiua-8799	113	58	uroflow	uroflow	NOUN
aiua-8799	113	59	-	-	PUNCT
aiua-8799	113	60	voided	void	VERB
aiua-8799	113	61	volume	volume	NOUN
aiua-8799	113	62	(	(	PUNCT
aiua-8799	113	63	ml	ml	NOUN
aiua-8799	113	64	)	)	PUNCT
aiua-8799	113	65	239.7	239.7	NUM
aiua-8799	113	66	±	±	NUM
aiua-8799	113	67	40.10	40.10	NUM
aiua-8799	113	68	220.4	220.4	NUM
aiua-8799	113	69	±	±	NOUN
aiua-8799	113	70	43.66	43.66	NUM
aiua-8799	113	71	0.0234	0.0234	NUM
aiua-8799	113	72	250.9	250.9	NUM
aiua-8799	113	73	±	±	NUM
aiua-8799	113	74	39.22	39.22	NUM
aiua-8799	113	75	218.8	218.8	NUM
aiua-8799	113	76	±	±	NOUN
aiua-8799	113	77	43.21	43.21	NUM
aiua-8799	113	78	0.0002	0.0002	NUM
aiua-8799	113	79	uroflow	uroflow	ADJ
aiua-8799	113	80	-	-	PUNCT
aiua-8799	113	81	pvr	pvr	NOUN
aiua-8799	113	82	(	(	PUNCT
aiua-8799	113	83	ml	ml	NOUN
aiua-8799	113	84	)	)	PUNCT
aiua-8799	113	85	18.18	18.18	NUM
aiua-8799	113	86	±	±	NUM
aiua-8799	113	87	12.46	12.46	NUM
aiua-8799	113	88	13.8	13.8	NUM
aiua-8799	113	89	±	±	NUM
aiua-8799	113	90	10.08	10.08	NUM
aiua-8799	113	91	0.0562	0.0562	NUM
aiua-8799	113	92	19.7	19.7	NUM
aiua-8799	113	93	±	±	NUM
aiua-8799	113	94	12.01	12.01	NUM
aiua-8799	113	95	15.9	15.9	NUM
aiua-8799	113	96	±	±	NUM
aiua-8799	113	97	9.98	9.98	NUM
aiua-8799	113	98	0.0611	0.0611	NUM
aiua-8799	113	99	ipss	ipss	PROPN
aiua-8799	113	100	total	total	NOUN
aiua-8799	113	101	11.18	11.18	NUM
aiua-8799	113	102	±	±	NUM
aiua-8799	113	103	4.84	4.84	NUM
aiua-8799	113	104	13.64	13.64	NUM
aiua-8799	113	105	±	±	NUM
aiua-8799	113	106	5.71	5.71	NUM
aiua-8799	113	107	0.0222	0.0222	NUM
aiua-8799	113	108	8.35	8.35	NUM
aiua-8799	113	109	±	±	NUM
aiua-8799	113	110	3.81	3.81	NUM
aiua-8799	113	111	14.62	14.62	NUM
aiua-8799	113	112	±	±	NUM
aiua-8799	113	113	5.92	5.92	NUM
aiua-8799	113	114	<	<	NOUN
aiua-8799	113	115	0.001	0.001	NUM
aiua-8799	113	116	oab	oab	PROPN
aiua-8799	113	117	-	-	PROPN
aiua-8799	113	118	q	q	NOUN
aiua-8799	113	119	sf	sf	PROPN
aiua-8799	113	120	6	6	NUM
aiua-8799	113	121	17.16	17.16	NUM
aiua-8799	113	122	±	±	NUM
aiua-8799	113	123	4.82	4.82	NUM
aiua-8799	113	124	20.58	20.58	NUM
aiua-8799	113	125	±	±	NUM
aiua-8799	113	126	6.29	6.29	NUM
aiua-8799	113	127	0.0029	0.0029	NUM
aiua-8799	113	128	14.46	14.46	NUM
aiua-8799	113	129	±	±	NUM
aiua-8799	113	130	5.60	5.60	NUM
aiua-8799	113	131	24.34	24.34	NUM
aiua-8799	113	132	±	±	NUM
aiua-8799	113	133	6.3	6.3	NUM
aiua-8799	113	134	<	<	X
aiua-8799	113	135	0.001	0.001	NUM
aiua-8799	113	136	oab	oab	PROPN
aiua-8799	113	137	-	-	PROPN
aiua-8799	113	138	q	q	PROPN
aiua-8799	113	139	sf	sf	PROPN
aiua-8799	113	140	13	13	NUM
aiua-8799	113	141	36.42	36.42	NUM
aiua-8799	113	142	±	±	NUM
aiua-8799	113	143	10.67	10.67	NUM
aiua-8799	113	144	43.78	43.78	NUM
aiua-8799	113	145	±	±	NUM
aiua-8799	113	146	13.02	13.02	NUM
aiua-8799	113	147	0.0026	0.0026	NUM
aiua-8799	113	148	31.16	31.16	NUM
aiua-8799	113	149	±	±	NUM
aiua-8799	113	150	11.57	11.57	NUM
aiua-8799	113	151	49.44	49.44	NUM
aiua-8799	113	152	±	±	NUM
aiua-8799	113	153	12.65	12.65	NUM
aiua-8799	113	154	<	<	X
aiua-8799	113	155	0.001	0.001	NUM
aiua-8799	113	156	ppius	ppius	NOUN
aiua-8799	113	157	2.26	2.26	NUM
aiua-8799	113	158	±	±	NUM
aiua-8799	113	159	0.88	0.88	NUM
aiua-8799	113	160	2.12	2.12	NUM
aiua-8799	113	161	±	±	NUM
aiua-8799	113	162	0.69	0.69	NUM
aiua-8799	113	163	0.3782	0.3782	NUM
aiua-8799	113	164	1.66	1.66	NUM
aiua-8799	113	165	±	±	NUM
aiua-8799	113	166	0.66	0.66	NUM
aiua-8799	113	167	2.54	2.54	NUM
aiua-8799	113	168	±	±	NUM
aiua-8799	113	169	0.64	0.64	NUM
aiua-8799	113	170	<	<	X
aiua-8799	113	171	0.001	0.001	NUM
aiua-8799	113	172	pgi	pgi	PROPN
aiua-8799	113	173	-	-	PUNCT
aiua-8799	113	174	i	i	PROPN
aiua-8799	113	175	4.2	4.2	NUM
aiua-8799	113	176	±	±	NUM
aiua-8799	113	177	0.60	0.60	NUM
aiua-8799	113	178	4.82	4.82	NUM
aiua-8799	113	179	±	±	NUM
aiua-8799	113	180	0.96	0.96	NUM
aiua-8799	113	181	0.0002	0.0002	NUM
aiua-8799	113	182	2.46	2.46	NUM
aiua-8799	113	183	±	±	NUM
aiua-8799	113	184	0.86	0.86	NUM
aiua-8799	113	185	5.22	5.22	NUM
aiua-8799	113	186	±	±	NUM
aiua-8799	113	187	1.02	1.02	NUM
aiua-8799	113	188	<	<	X
aiua-8799	113	189	0.001	0.001	NUM
aiua-8799	113	190	vas	vas	NOUN
aiua-8799	113	191	scale	scale	NOUN
aiua-8799	113	192	3.38	3.38	NUM
aiua-8799	113	193	±	±	NUM
aiua-8799	113	194	1.35	1.35	NUM
aiua-8799	113	195	3.68	3.68	NUM
aiua-8799	113	196	±	±	NUM
aiua-8799	113	197	1.88	1.88	NUM
aiua-8799	113	198	0.3616	0.3616	NUM
aiua-8799	113	199	2.34	2.34	NUM
aiua-8799	113	200	±	±	NUM
aiua-8799	113	201	0.96	0.96	NUM
aiua-8799	113	202	3.92	3.92	NUM
aiua-8799	113	203	±	±	NUM
aiua-8799	113	204	1.93	1.93	NUM
aiua-8799	113	205	<	<	X
aiua-8799	113	206	0.001	0.001	NUM
aiua-8799	113	207	pvr	pvr	NOUN
aiua-8799	113	208	:	:	PUNCT
aiua-8799	113	209	post	post	ADJ
aiua-8799	113	210	-	-	ADJ
aiua-8799	113	211	void	void	ADJ
aiua-8799	113	212	residual	residual	NOUN
aiua-8799	113	213	;	;	PUNCT
aiua-8799	113	214	ipss	ipss	PROPN
aiua-8799	113	215	:	:	PUNCT
aiua-8799	113	216	international	international	ADJ
aiua-8799	113	217	prostatic	prostatic	ADJ
aiua-8799	113	218	symptoms	symptom	NOUN
aiua-8799	113	219	score	score	VERB
aiua-8799	113	220	;	;	PUNCT
aiua-8799	113	221	oab	oab	PROPN
aiua-8799	113	222	:	:	PUNCT
aiua-8799	113	223	overactive	overactive	ADJ
aiua-8799	113	224	bladder	bladder	NOUN
aiua-8799	113	225	;	;	PUNCT
aiua-8799	113	226	ppius	ppius	NOUN
aiua-8799	113	227	:	:	PUNCT
aiua-8799	113	228	patient	patient	ADJ
aiua-8799	113	229	perception	perception	NOUN
aiua-8799	113	230	of	of	ADP
aiua-8799	113	231	intensity	intensity	NOUN
aiua-8799	113	232	of	of	ADP
aiua-8799	113	233	urgency	urgency	NOUN
aiua-8799	113	234	scale	scale	NOUN
aiua-8799	113	235	;	;	PUNCT
aiua-8799	114	1	pgi	pgi	PROPN
aiua-8799	114	2	:	:	PUNCT
aiua-8799	114	3	patient	patient	ADJ
aiua-8799	114	4	global	global	ADJ
aiua-8799	114	5	impression	impression	NOUN
aiua-8799	114	6	of	of	ADP
aiua-8799	114	7	improvement	improvement	NOUN
aiua-8799	114	8	questionnaire	questionnaire	NOUN
aiua-8799	114	9	;	;	PUNCT
aiua-8799	114	10	vas	vas	X
aiua-8799	114	11	:	:	PUNCT
aiua-8799	114	12	visual	visual	ADJ
aiua-8799	114	13	analogue	analogue	NOUN
aiua-8799	114	14	scale	scale	NOUN
aiua-8799	114	15	.	.	PUNCT
aiua-8799	115	1	04chiancone_stesura	04chiancone_stesura	ADJ
aiua-8799	115	2	seveso	seveso	PROPN
aiua-8799	115	3	24/09/20	24/09/20	PROPN
aiua-8799	115	4	14:13	14:13	NUM
aiua-8799	115	5	pagina	pagina	NOUN
aiua-8799	115	6	179	179	NUM
aiua-8799	115	7	archivio	archivio	NOUN
aiua-8799	115	8	italiano	italiano	X
aiua-8799	115	9	di	di	X
aiua-8799	115	10	urologia	urologia	PROPN
aiua-8799	115	11	e	e	PROPN
aiua-8799	115	12	andrologia	andrologia	NOUN
aiua-8799	115	13	2020	2020	NUM
aiua-8799	115	14	;	;	PUNCT
aiua-8799	115	15	92	92	NUM
aiua-8799	115	16	,	,	PUNCT
aiua-8799	115	17	3	3	NUM
aiua-8799	115	18	f.	f.	PROPN
aiua-8799	115	19	chiancone	chiancone	PROPN
aiua-8799	115	20	,	,	PUNCT
aiua-8799	115	21	m.	m.	NOUN
aiua-8799	115	22	carrino	carrino	PROPN
aiua-8799	115	23	,	,	PUNCT
aiua-8799	115	24	m.	m.	NOUN
aiua-8799	115	25	fedelini	fedelini	PROPN
aiua-8799	115	26	,	,	PUNCT
aiua-8799	115	27	m.	m.	NOUN
aiua-8799	115	28	fabiano	fabiano	PROPN
aiua-8799	115	29	,	,	PUNCT
aiua-8799	115	30	f.	f.	PROPN
aiua-8799	115	31	persico	persico	PROPN
aiua-8799	115	32	,	,	PUNCT
aiua-8799	115	33	c.	c.	PROPN
aiua-8799	115	34	meccariello	meccariello	PROPN
aiua-8799	115	35	,	,	PUNCT
aiua-8799	115	36	p.	p.	NOUN
aiua-8799	115	37	fedelini	fedelini	PROPN
aiua-8799	115	38	180	180	NUM
aiua-8799	115	39	cholinergicantimuscarinic	cholinergicantimuscarinic	ADJ
aiua-8799	115	40	(	(	PUNCT
aiua-8799	115	41	11	11	NUM
aiua-8799	115	42	,	,	PUNCT
aiua-8799	115	43	12	12	NUM
aiua-8799	115	44	)	)	PUNCT
aiua-8799	115	45	and	and	CCONJ
aiua-8799	115	46	gabaergic	gabaergic	ADJ
aiua-8799	115	47	(	(	PUNCT
aiua-8799	115	48	1215	1215	NUM
aiua-8799	115	49	)	)	PUNCT
aiua-8799	115	50	action	action	NOUN
aiua-8799	115	51	and	and	CCONJ
aiua-8799	115	52	it	it	PRON
aiua-8799	115	53	is	be	AUX
aiua-8799	115	54	able	able	ADJ
aiua-8799	115	55	to	to	PART
aiua-8799	115	56	influence	influence	VERB
aiua-8799	115	57	some	some	DET
aiua-8799	115	58	neurological	neurological	ADJ
aiua-8799	115	59	systems	system	NOUN
aiua-8799	115	60	responsible	responsible	ADJ
aiua-8799	115	61	of	of	ADP
aiua-8799	115	62	bladder	bladder	NOUN
aiua-8799	115	63	functions	function	NOUN
aiua-8799	115	64	.	.	PUNCT
aiua-8799	116	1	moreover	moreover	ADV
aiua-8799	116	2	,	,	PUNCT
aiua-8799	116	3	its	its	PRON
aiua-8799	116	4	anti	anti	ADJ
aiua-8799	116	5	-	-	ADJ
aiua-8799	116	6	acetylcholinesterase	acetylcholinesterase	ADJ
aiua-8799	116	7	action	action	NOUN
aiua-8799	116	8	give	give	VERB
aiua-8799	116	9	it	it	PRON
aiua-8799	116	10	an	an	DET
aiua-8799	116	11	antiamnesic	antiamnesic	ADJ
aiua-8799	116	12	property	property	NOUN
aiua-8799	116	13	that	that	PRON
aiua-8799	116	14	may	may	AUX
aiua-8799	116	15	hold	hold	VERB
aiua-8799	116	16	significant	significant	ADJ
aiua-8799	116	17	therapeutic	therapeutic	ADJ
aiua-8799	116	18	value	value	NOUN
aiua-8799	116	19	in	in	ADP
aiua-8799	116	20	alleviating	alleviate	VERB
aiua-8799	116	21	certain	certain	ADJ
aiua-8799	116	22	memory	memory	NOUN
aiua-8799	116	23	impairments	impairment	NOUN
aiua-8799	116	24	observed	observe	VERB
aiua-8799	116	25	in	in	ADP
aiua-8799	116	26	dementia	dementia	NOUN
aiua-8799	116	27	(	(	PUNCT
aiua-8799	116	28	15	15	NUM
aiua-8799	116	29	,	,	PUNCT
aiua-8799	116	30	16	16	NUM
aiua-8799	116	31	)	)	PUNCT
aiua-8799	116	32	.	.	PUNCT
aiua-8799	117	1	protopine	protopine	PROPN
aiua-8799	117	2	increase	increase	VERB
aiua-8799	117	3	the	the	DET
aiua-8799	117	4	p53	p53	NOUN
aiua-8799	117	5	-	-	PUNCT
aiua-8799	117	6	mediated	mediate	VERB
aiua-8799	117	7	transcriptional	transcriptional	ADJ
aiua-8799	117	8	activity	activity	NOUN
aiua-8799	117	9	,	,	PUNCT
aiua-8799	117	10	resulting	result	VERB
aiua-8799	117	11	in	in	ADP
aiua-8799	117	12	stabilization	stabilization	NOUN
aiua-8799	117	13	of	of	ADP
aiua-8799	117	14	p53	p53	NOUN
aiua-8799	117	15	protein	protein	NOUN
aiua-8799	117	16	.	.	PUNCT
aiua-8799	118	1	it	it	PRON
aiua-8799	118	2	exerts	exert	VERB
aiua-8799	118	3	an	an	DET
aiua-8799	118	4	antiproliferative	antiproliferative	ADJ
aiua-8799	118	5	activity	activity	NOUN
aiua-8799	118	6	and	and	CCONJ
aiua-8799	118	7	may	may	AUX
aiua-8799	118	8	have	have	VERB
aiua-8799	118	9	potential	potential	ADJ
aiua-8799	118	10	effect	effect	NOUN
aiua-8799	118	11	as	as	ADP
aiua-8799	118	12	a	a	DET
aiua-8799	118	13	chemopreventive	chemopreventive	ADJ
aiua-8799	118	14	agent	agent	NOUN
aiua-8799	118	15	for	for	ADP
aiua-8799	118	16	human	human	ADJ
aiua-8799	118	17	colon	colon	NOUN
aiua-8799	118	18	cancer	cancer	NOUN
aiua-8799	118	19	(	(	PUNCT
aiua-8799	118	20	16	16	NUM
aiua-8799	118	21	,	,	PUNCT
aiua-8799	118	22	17	17	NUM
aiua-8799	118	23	)	)	PUNCT
aiua-8799	118	24	.	.	PUNCT
aiua-8799	119	1	nuciferin	nuciferin	PROPN
aiua-8799	119	2	is	be	AUX
aiua-8799	119	3	a	a	DET
aiua-8799	119	4	partial	partial	ADJ
aiua-8799	119	5	antagonist	antagonist	NOUN
aiua-8799	119	6	of	of	ADP
aiua-8799	119	7	d2	d2	NOUN
aiua-8799	119	8	-	-	PUNCT
aiua-8799	119	9	like	like	ADJ
aiua-8799	119	10	receptor	receptor	NOUN
aiua-8799	119	11	and	and	CCONJ
aiua-8799	119	12	has	have	VERB
aiua-8799	119	13	a	a	DET
aiua-8799	119	14	demonstrated	demonstrate	VERB
aiua-8799	119	15	regulatory	regulatory	ADJ
aiua-8799	119	16	action	action	NOUN
aiua-8799	119	17	on	on	ADP
aiua-8799	119	18	the	the	DET
aiua-8799	119	19	dopaminergic	dopaminergic	ADJ
aiua-8799	119	20	system	system	NOUN
aiua-8799	119	21	(	(	PUNCT
aiua-8799	119	22	responsible	responsible	ADJ
aiua-8799	119	23	of	of	ADP
aiua-8799	119	24	urination	urination	NOUN
aiua-8799	119	25	onset	onset	NOUN
aiua-8799	119	26	(	(	PUNCT
aiua-8799	119	27	17	17	NUM
aiua-8799	119	28	,	,	PUNCT
aiua-8799	119	29	18	18	NUM
aiua-8799	119	30	)	)	PUNCT
aiua-8799	119	31	and	and	CCONJ
aiua-8799	119	32	seems	seem	VERB
aiua-8799	119	33	to	to	PART
aiua-8799	119	34	reduce	reduce	VERB
aiua-8799	119	35	states	state	NOUN
aiua-8799	119	36	of	of	ADP
aiua-8799	119	37	tension	tension	NOUN
aiua-8799	119	38	and	and	CCONJ
aiua-8799	119	39	anxiety	anxiety	NOUN
aiua-8799	119	40	on	on	ADP
aiua-8799	119	41	a	a	DET
aiua-8799	119	42	psychological	psychological	ADJ
aiua-8799	119	43	level	level	NOUN
aiua-8799	119	44	(	(	PUNCT
aiua-8799	119	45	18	18	NUM
aiua-8799	119	46	-	-	SYM
aiua-8799	119	47	20	20	NUM
aiua-8799	119	48	)	)	PUNCT
aiua-8799	119	49	.	.	PUNCT
aiua-8799	120	1	nuciferine	nuciferine	PROPN
aiua-8799	120	2	significantly	significantly	ADV
aiua-8799	120	3	inhibited	inhibit	VERB
aiua-8799	120	4	the	the	DET
aiua-8799	120	5	lipopolysaccharide	lipopolysaccharide	NOUN
aiua-8799	120	6	(	(	PUNCT
aiua-8799	120	7	lps)-induced	lps)-induce	VERB
aiua-8799	120	8	inflammatory	inflammatory	ADJ
aiua-8799	120	9	cytokine	cytokine	NOUN
aiua-8799	120	10	il-6	il-6	NOUN
aiua-8799	120	11	and	and	CCONJ
aiua-8799	120	12	tnf	tnf	PROPN
aiua-8799	120	13	-	-	PUNCT
aiua-8799	120	14	a	a	DET
aiua-8799	120	15	production	production	NOUN
aiua-8799	120	16	in	in	ADP
aiua-8799	120	17	raw	raw	ADJ
aiua-8799	120	18	264.7	264.7	NUM
aiua-8799	120	19	cells	cell	NOUN
aiua-8799	120	20	having	have	VERB
aiua-8799	120	21	potential	potential	ADJ
aiua-8799	120	22	anti	anti	ADJ
aiua-8799	120	23	-	-	ADJ
aiua-8799	120	24	inflammatory	inflammatory	ADJ
aiua-8799	120	25	activities	activity	NOUN
aiua-8799	120	26	(	(	PUNCT
aiua-8799	120	27	20	20	NUM
aiua-8799	120	28	,	,	PUNCT
aiua-8799	120	29	21	21	NUM
aiua-8799	120	30	)	)	PUNCT
aiua-8799	120	31	.	.	PUNCT
aiua-8799	121	1	its	its	PRON
aiua-8799	121	2	use	use	NOUN
aiua-8799	121	3	significantly	significantly	ADV
aiua-8799	121	4	decrease	decrease	VERB
aiua-8799	121	5	the	the	DET
aiua-8799	121	6	expression	expression	NOUN
aiua-8799	121	7	of	of	ADP
aiua-8799	121	8	tlr4	tlr4	NOUN
aiua-8799	121	9	in	in	ADP
aiua-8799	121	10	a	a	DET
aiua-8799	121	11	dose	dose	NOUN
aiua-8799	121	12	-	-	PUNCT
aiua-8799	121	13	dependent	dependent	ADJ
aiua-8799	121	14	manner	manner	NOUN
aiua-8799	121	15	and	and	CCONJ
aiua-8799	121	16	potently	potently	ADV
aiua-8799	121	17	ameliorates	ameliorate	VERB
aiua-8799	121	18	lpsinduced	lpsinduce	VERB
aiua-8799	121	19	mastitis	mastitis	NOUN
aiua-8799	121	20	by	by	ADP
aiua-8799	121	21	inhibition	inhibition	NOUN
aiua-8799	121	22	of	of	ADP
aiua-8799	121	23	the	the	DET
aiua-8799	121	24	tlr4	tlr4	NOUN
aiua-8799	121	25	-	-	PUNCT
aiua-8799	121	26	nf	nf	NOUN
aiua-8799	121	27	-	-	PUNCT
aiua-8799	121	28	kb	kb	NOUN
aiua-8799	121	29	signaling	signal	VERB
aiua-8799	121	30	pathway	pathway	NOUN
aiua-8799	121	31	(	(	PUNCT
aiua-8799	121	32	21	21	NUM
aiua-8799	121	33	,	,	PUNCT
aiua-8799	121	34	22	22	NUM
aiua-8799	121	35	)	)	PUNCT
aiua-8799	121	36	.	.	PUNCT
aiua-8799	122	1	in	in	ADP
aiua-8799	122	2	addiction	addiction	NOUN
aiua-8799	122	3	nuciferine	nuciferine	NOUN
aiua-8799	122	4	alleviated	alleviate	VERB
aiua-8799	122	5	fructose	fructose	NOUN
aiua-8799	122	6	-	-	PUNCT
aiua-8799	122	7	induced	induce	VERB
aiua-8799	122	8	inflammation	inflammation	NOUN
aiua-8799	122	9	by	by	ADP
aiua-8799	122	10	inhibiting	inhibit	VERB
aiua-8799	122	11	tlr4	tlr4	NOUN
aiua-8799	122	12	/	/	SYM
aiua-8799	122	13	pi3k	pi3k	PROPN
aiua-8799	122	14	/	/	SYM
aiua-8799	122	15	nf	nf	NOUN
aiua-8799	122	16	-	-	PUNCT
aiua-8799	122	17	kb	kb	NOUN
aiua-8799	122	18	signaling	signal	VERB
aiua-8799	122	19	and	and	CCONJ
aiua-8799	122	20	nlrp3	nlrp3	NOUN
aiua-8799	122	21	inflammasome	inflammasome	NOUN
aiua-8799	122	22	activation	activation	NOUN
aiua-8799	122	23	in	in	ADP
aiua-8799	122	24	rat	rat	NOUN
aiua-8799	122	25	renal	renal	ADJ
aiua-8799	122	26	cortex	cortex	NOUN
aiua-8799	122	27	and	and	CCONJ
aiua-8799	122	28	hk-2	hk-2	NUM
aiua-8799	122	29	cells	cell	NOUN
aiua-8799	122	30	,	,	PUNCT
aiua-8799	122	31	which	which	PRON
aiua-8799	122	32	may	may	AUX
aiua-8799	122	33	contribute	contribute	VERB
aiua-8799	122	34	to	to	ADP
aiua-8799	122	35	the	the	DET
aiua-8799	122	36	improvement	improvement	NOUN
aiua-8799	122	37	of	of	ADP
aiua-8799	122	38	renal	renal	ADJ
aiua-8799	122	39	injury	injury	NOUN
aiua-8799	122	40	(	(	PUNCT
aiua-8799	122	41	22	22	NUM
aiua-8799	122	42	,	,	PUNCT
aiua-8799	122	43	23	23	NUM
aiua-8799	122	44	)	)	PUNCT
aiua-8799	122	45	.	.	PUNCT
aiua-8799	123	1	this	this	DET
aiua-8799	123	2	molecule	molecule	NOUN
aiua-8799	123	3	is	be	AUX
aiua-8799	123	4	an	an	DET
aiua-8799	123	5	aporphine	aporphine	ADJ
aiua-8799	123	6	alkaloid	alkaloid	NOUN
aiua-8799	123	7	of	of	ADP
aiua-8799	123	8	lotus	lotus	PROPN
aiua-8799	123	9	leaf	leaf	NOUN
aiua-8799	123	10	extract	extract	NOUN
aiua-8799	123	11	which	which	PRON
aiua-8799	123	12	can	can	AUX
aiua-8799	123	13	induce	induce	VERB
aiua-8799	123	14	relaxation	relaxation	NOUN
aiua-8799	123	15	in	in	ADP
aiua-8799	123	16	contracted	contract	VERB
aiua-8799	123	17	tracheal	tracheal	NOUN
aiua-8799	123	18	rings	ring	NOUN
aiua-8799	123	19	.	.	PUNCT
aiua-8799	124	1	it	it	PRON
aiua-8799	124	2	induce	induce	VERB
aiua-8799	124	3	relaxation	relaxation	NOUN
aiua-8799	124	4	in	in	ADP
aiua-8799	124	5	tracheal	tracheal	NOUN
aiua-8799	124	6	rings	ring	NOUN
aiua-8799	124	7	mainly	mainly	ADV
aiua-8799	124	8	by	by	ADP
aiua-8799	124	9	inhibition	inhibition	NOUN
aiua-8799	124	10	of	of	ADP
aiua-8799	124	11	extracellular	extracellular	ADJ
aiua-8799	124	12	ca2	ca2	PROPN
aiua-8799	124	13	+	+	PROPN
aiua-8799	124	14	influx	influx	VERB
aiua-8799	124	15	through	through	ADP
aiua-8799	124	16	the	the	DET
aiua-8799	124	17	blockade	blockade	NOUN
aiua-8799	124	18	of	of	ADP
aiua-8799	124	19	voltage	voltage	NOUN
aiua-8799	124	20	-	-	PUNCT
aiua-8799	124	21	dependent	dependent	ADJ
aiua-8799	124	22	l	l	NOUN
aiua-8799	124	23	-	-	PUNCT
aiua-8799	124	24	type	type	NOUN
aiua-8799	124	25	ca2	ca2	PROPN
aiua-8799	124	26	+	+	NOUN
aiua-8799	124	27	channels	channel	NOUN
aiua-8799	124	28	and/or	and/or	CCONJ
aiua-8799	124	29	nonselective	nonselective	ADJ
aiua-8799	124	30	cation	cation	NOUN
aiua-8799	124	31	channels	channel	NOUN
aiua-8799	124	32	,	,	PUNCT
aiua-8799	124	33	showing	show	VERB
aiua-8799	124	34	therapeutic	therapeutic	ADJ
aiua-8799	124	35	effect	effect	NOUN
aiua-8799	124	36	on	on	ADP
aiua-8799	124	37	respiratory	respiratory	ADJ
aiua-8799	124	38	diseases	disease	NOUN
aiua-8799	124	39	associated	associate	VERB
aiua-8799	124	40	with	with	ADP
aiua-8799	124	41	the	the	DET
aiua-8799	124	42	aberrant	aberrant	ADJ
aiua-8799	124	43	contraction	contraction	NOUN
aiua-8799	124	44	of	of	ADP
aiua-8799	124	45	airway	airway	NOUN
aiua-8799	124	46	smooth	smooth	ADJ
aiua-8799	124	47	muscles	muscle	NOUN
aiua-8799	124	48	and/or	and/or	CCONJ
aiua-8799	124	49	bronchospasm	bronchospasm	NOUN
aiua-8799	124	50	(	(	PUNCT
aiua-8799	124	51	23	23	NUM
aiua-8799	124	52	,	,	PUNCT
aiua-8799	124	53	24	24	NUM
aiua-8799	124	54	)	)	PUNCT
aiua-8799	124	55	.	.	PUNCT
aiua-8799	125	1	in	in	ADP
aiua-8799	125	2	our	our	PRON
aiua-8799	125	3	experience	experience	NOUN
aiua-8799	125	4	the	the	DET
aiua-8799	125	5	patients	patient	NOUN
aiua-8799	125	6	who	who	PRON
aiua-8799	125	7	underwent	undergo	VERB
aiua-8799	125	8	protopine	protopine	NOUN
aiua-8799	125	9	and	and	CCONJ
aiua-8799	125	10	nuciferine	nuciferine	VERB
aiua-8799	125	11	syrup	syrup	NOUN
aiua-8799	125	12	treatment	treatment	NOUN
aiua-8799	125	13	,	,	PUNCT
aiua-8799	125	14	showed	show	VERB
aiua-8799	125	15	a	a	DET
aiua-8799	125	16	better	well	ADJ
aiua-8799	125	17	ipss	ipss	PROPN
aiua-8799	125	18	score	score	NOUN
aiua-8799	125	19	,	,	PUNCT
aiua-8799	125	20	a	a	DET
aiua-8799	125	21	better	well	ADJ
aiua-8799	125	22	control	control	NOUN
aiua-8799	125	23	of	of	ADP
aiua-8799	125	24	urgency	urgency	NOUN
aiua-8799	125	25	symptoms	symptom	NOUN
aiua-8799	125	26	(	(	PUNCT
aiua-8799	125	27	ppius	ppius	NOUN
aiua-8799	125	28	)	)	PUNCT
aiua-8799	125	29	and	and	CCONJ
aiua-8799	125	30	tolerate	tolerate	VERB
aiua-8799	125	31	well	well	INTJ
aiua-8799	125	32	the	the	DET
aiua-8799	125	33	pain	pain	NOUN
aiua-8799	125	34	related	relate	VERB
aiua-8799	125	35	to	to	ADP
aiua-8799	125	36	the	the	DET
aiua-8799	125	37	chemo	chemo	NOUN
aiua-8799	125	38	-	-	PUNCT
aiua-8799	125	39	hyperthermia	hyperthermia	NOUN
aiua-8799	125	40	treatment	treatment	NOUN
aiua-8799	125	41	(	(	PUNCT
aiua-8799	125	42	vas	vas	X
aiua-8799	125	43	score	score	NOUN
aiua-8799	125	44	)	)	PUNCT
aiua-8799	125	45	compared	compare	VERB
aiua-8799	125	46	to	to	ADP
aiua-8799	125	47	control	control	PROPN
aiua-8799	125	48	group	group	NOUN
aiua-8799	125	49	.	.	PUNCT
aiua-8799	126	1	the	the	DET
aiua-8799	126	2	treatment	treatment	NOUN
aiua-8799	126	3	does	do	AUX
aiua-8799	126	4	n’t	not	PART
aiua-8799	126	5	modify	modify	VERB
aiua-8799	126	6	uroflow	uroflow	NOUN
aiua-8799	126	7	-	-	PUNCT
aiua-8799	126	8	qmax	qmax	NOUN
aiua-8799	126	9	at	at	ADP
aiua-8799	126	10	1	1	NUM
aiua-8799	126	11	and	and	CCONJ
aiua-8799	126	12	6	6	NUM
aiua-8799	126	13	weeks	week	NOUN
aiua-8799	126	14	and	and	CCONJ
aiua-8799	126	15	seems	seem	VERB
aiua-8799	126	16	to	to	PART
aiua-8799	126	17	improve	improve	VERB
aiua-8799	126	18	the	the	DET
aiua-8799	126	19	uroflow	uroflow	NOUN
aiua-8799	126	20	-	-	PUNCT
aiua-8799	126	21	voided	void	VERB
aiua-8799	126	22	volume	volume	NOUN
aiua-8799	126	23	(	(	PUNCT
aiua-8799	126	24	ml	ml	NOUN
aiua-8799	126	25	)	)	PUNCT
aiua-8799	126	26	withouth	withouth	NOUN
aiua-8799	126	27	influence	influence	NOUN
aiua-8799	126	28	the	the	DET
aiua-8799	126	29	uroflow	uroflow	NOUN
aiua-8799	126	30	-	-	PUNCT
aiua-8799	126	31	pvr	pvr	NOUN
aiua-8799	126	32	.	.	PUNCT
aiua-8799	127	1	moreover	moreover	ADV
aiua-8799	127	2	protopine	protopine	NOUN
aiua-8799	127	3	and	and	CCONJ
aiua-8799	127	4	nuciferine	nuciferine	VERB
aiua-8799	127	5	syrup	syrup	NOUN
aiua-8799	127	6	treatment	treatment	NOUN
aiua-8799	127	7	has	have	AUX
aiua-8799	127	8	been	be	AUX
aiua-8799	127	9	proven	prove	VERB
aiua-8799	127	10	to	to	PART
aiua-8799	127	11	be	be	AUX
aiua-8799	127	12	effective	effective	ADJ
aiua-8799	127	13	in	in	ADP
aiua-8799	127	14	the	the	DET
aiua-8799	127	15	treatment	treatment	NOUN
aiua-8799	127	16	of	of	ADP
aiua-8799	127	17	oab	oab	PROPN
aiua-8799	127	18	symptoms	symptom	NOUN
aiua-8799	127	19	with	with	ADP
aiua-8799	127	20	a	a	DET
aiua-8799	127	21	significant	significant	ADJ
aiua-8799	127	22	reduction	reduction	NOUN
aiua-8799	127	23	of	of	ADP
aiua-8799	127	24	the	the	DET
aiua-8799	127	25	symptoms	symptom	NOUN
aiua-8799	127	26	assessed	assess	VERB
aiua-8799	127	27	with	with	ADP
aiua-8799	127	28	overactive	overactive	ADJ
aiua-8799	127	29	bladder	bladder	NOUN
aiua-8799	127	30	symptoms	symptom	NOUN
aiua-8799	127	31	score	score	VERB
aiua-8799	127	32	questionnaire	questionnaire	NOUN
aiua-8799	127	33	(	(	PUNCT
aiua-8799	127	34	oab	oab	PROPN
aiua-8799	127	35	-	-	PROPN
aiua-8799	127	36	q	q	PROPN
aiua-8799	127	37	sf6	sf6	PROPN
aiua-8799	127	38	,	,	PUNCT
aiua-8799	127	39	oab	oab	PROPN
aiua-8799	127	40	-	-	PUNCT
aiua-8799	127	41	q	q	PROPN
aiua-8799	127	42	sf13	sf13	PROPN
aiua-8799	127	43	)	)	PUNCT
aiua-8799	127	44	after	after	ADP
aiua-8799	127	45	six	six	NUM
aiua-8799	127	46	weeks	week	NOUN
aiua-8799	127	47	of	of	ADP
aiua-8799	127	48	treatment	treatment	NOUN
aiua-8799	127	49	but	but	CCONJ
aiua-8799	127	50	not	not	PART
aiua-8799	127	51	after	after	ADP
aiua-8799	127	52	one	one	NUM
aiua-8799	127	53	week	week	NOUN
aiua-8799	127	54	of	of	ADP
aiua-8799	127	55	treatment	treatment	NOUN
aiua-8799	127	56	.	.	PUNCT
aiua-8799	128	1	this	this	PRON
aiua-8799	128	2	underline	underline	NOUN
aiua-8799	128	3	the	the	DET
aiua-8799	128	4	need	need	NOUN
aiua-8799	128	5	to	to	PART
aiua-8799	128	6	start	start	VERB
aiua-8799	128	7	the	the	DET
aiua-8799	128	8	treatment	treatment	NOUN
aiua-8799	128	9	with	with	ADP
aiua-8799	128	10	protopine	protopine	NOUN
aiua-8799	128	11	and	and	CCONJ
aiua-8799	128	12	nuciferine	nuciferine	NOUN
aiua-8799	128	13	as	as	ADV
aiua-8799	128	14	soon	soon	ADV
aiua-8799	128	15	as	as	ADP
aiua-8799	128	16	possible	possible	ADJ
aiua-8799	128	17	in	in	ADP
aiua-8799	128	18	order	order	NOUN
aiua-8799	128	19	to	to	PART
aiua-8799	128	20	enhance	enhance	VERB
aiua-8799	128	21	the	the	DET
aiua-8799	128	22	effect	effect	NOUN
aiua-8799	128	23	of	of	ADP
aiua-8799	128	24	the	the	DET
aiua-8799	128	25	treatment	treatment	NOUN
aiua-8799	128	26	.	.	PUNCT
aiua-8799	129	1	patients	patient	NOUN
aiua-8799	129	2	’	'	PUNCT
aiua-8799	129	3	evaluation	evaluation	NOUN
aiua-8799	129	4	of	of	ADP
aiua-8799	129	5	the	the	DET
aiua-8799	129	6	two	two	NUM
aiua-8799	129	7	different	different	ADJ
aiua-8799	129	8	treatments	treatment	NOUN
aiua-8799	129	9	(	(	PUNCT
aiua-8799	129	10	protopine	protopine	NOUN
aiua-8799	129	11	and	and	CCONJ
aiua-8799	129	12	nuciferine	nuciferine	NOUN
aiua-8799	129	13	vs	vs	ADP
aiua-8799	129	14	placebo	placebo	NOUN
aiua-8799	129	15	)	)	PUNCT
aiua-8799	129	16	assessed	assess	VERB
aiua-8799	129	17	with	with	ADP
aiua-8799	129	18	pgi	pgi	PROPN
aiua-8799	129	19	-	-	PUNCT
aiua-8799	129	20	i	i	PROPN
aiua-8799	129	21	,	,	PUNCT
aiua-8799	129	22	demonstrated	demonstrate	VERB
aiua-8799	129	23	improvements	improvement	NOUN
aiua-8799	129	24	in	in	ADP
aiua-8799	129	25	the	the	DET
aiua-8799	129	26	group	group	NOUN
aiua-8799	129	27	of	of	ADP
aiua-8799	129	28	cases	case	NOUN
aiua-8799	129	29	with	with	ADP
aiua-8799	129	30	a	a	DET
aiua-8799	129	31	greater	great	ADJ
aiua-8799	129	32	satisfaction	satisfaction	NOUN
aiua-8799	129	33	expressed	express	VERB
aiua-8799	129	34	by	by	ADP
aiua-8799	129	35	patients	patient	NOUN
aiua-8799	129	36	at	at	ADP
aiua-8799	129	37	six	six	NUM
aiua-8799	129	38	weeks	week	NOUN
aiua-8799	129	39	,	,	PUNCT
aiua-8799	129	40	while	while	SCONJ
aiua-8799	129	41	the	the	DET
aiua-8799	129	42	control	control	NOUN
aiua-8799	129	43	group	group	NOUN
aiua-8799	129	44	showed	show	VERB
aiua-8799	129	45	a	a	DET
aiua-8799	129	46	lower	low	ADJ
aiua-8799	129	47	satisfaction	satisfaction	NOUN
aiua-8799	129	48	at	at	ADP
aiua-8799	129	49	one	one	NUM
aiua-8799	129	50	and	and	CCONJ
aiua-8799	129	51	six	six	NUM
aiua-8799	129	52	weeks	week	NOUN
aiua-8799	129	53	.	.	PUNCT
aiua-8799	130	1	moreover	moreover	ADV
aiua-8799	130	2	,	,	PUNCT
aiua-8799	130	3	the	the	DET
aiua-8799	130	4	treatment	treatment	NOUN
aiua-8799	130	5	with	with	ADP
aiua-8799	130	6	protopine	protopine	NOUN
aiua-8799	130	7	and	and	CCONJ
aiua-8799	130	8	nuciferine	nuciferine	NOUN
aiua-8799	130	9	syrup	syrup	NOUN
aiua-8799	130	10	was	be	AUX
aiua-8799	130	11	well	well	ADV
aiua-8799	130	12	tolerated	tolerate	VERB
aiua-8799	130	13	by	by	ADP
aiua-8799	130	14	all	all	DET
aiua-8799	130	15	patients	patient	NOUN
aiua-8799	130	16	,	,	PUNCT
aiua-8799	130	17	none	none	NOUN
aiua-8799	130	18	of	of	ADP
aiua-8799	130	19	them	they	PRON
aiua-8799	130	20	showing	show	VERB
aiua-8799	130	21	any	any	DET
aiua-8799	130	22	side	side	ADJ
aiua-8799	130	23	effect	effect	NOUN
aiua-8799	130	24	during	during	ADP
aiua-8799	130	25	the	the	DET
aiua-8799	130	26	period	period	NOUN
aiua-8799	130	27	study	study	NOUN
aiua-8799	130	28	.	.	PUNCT
aiua-8799	131	1	the	the	DET
aiua-8799	131	2	study	study	NOUN
aiua-8799	131	3	is	be	AUX
aiua-8799	131	4	a	a	DET
aiua-8799	131	5	double	double	ADJ
aiua-8799	131	6	-	-	PUNCT
aiua-8799	131	7	blind	blind	ADJ
aiua-8799	131	8	randomized	randomized	ADJ
aiua-8799	131	9	study	study	NOUN
aiua-8799	131	10	but	but	CCONJ
aiua-8799	131	11	is	be	AUX
aiua-8799	131	12	limited	limit	VERB
aiua-8799	131	13	by	by	ADP
aiua-8799	131	14	the	the	DET
aiua-8799	131	15	small	small	ADJ
aiua-8799	131	16	number	number	NOUN
aiua-8799	131	17	of	of	ADP
aiua-8799	131	18	patients	patient	NOUN
aiua-8799	131	19	and	and	CCONJ
aiua-8799	131	20	monocentric	monocentric	ADJ
aiua-8799	131	21	nature	nature	NOUN
aiua-8799	131	22	.	.	PUNCT
aiua-8799	132	1	conclusions	conclusion	NOUN
aiua-8799	132	2	protopine	protopine	NOUN
aiua-8799	132	3	and	and	CCONJ
aiua-8799	132	4	nuciferine	nuciferine	VERB
aiua-8799	132	5	syrup	syrup	NOUN
aiua-8799	132	6	can	can	AUX
aiua-8799	132	7	be	be	AUX
aiua-8799	132	8	an	an	DET
aiua-8799	132	9	interesting	interesting	ADJ
aiua-8799	132	10	alternative	alternative	NOUN
aiua-8799	132	11	to	to	PART
aiua-8799	132	12	antinflammatory	antinflammatory	VERB
aiua-8799	132	13	and	and	CCONJ
aiua-8799	132	14	antimuscarinic	antimuscarinic	ADJ
aiua-8799	132	15	agents	agent	NOUN
aiua-8799	132	16	to	to	PART
aiua-8799	132	17	treat	treat	VERB
aiua-8799	132	18	irritative	irritative	ADJ
aiua-8799	132	19	and	and	CCONJ
aiua-8799	132	20	pain	pain	NOUN
aiua-8799	132	21	related	relate	VERB
aiua-8799	132	22	symptoms	symptom	NOUN
aiua-8799	132	23	of	of	ADP
aiua-8799	132	24	intravesical	intravesical	ADJ
aiua-8799	132	25	chemo	chemo	NOUN
aiua-8799	132	26	/	/	SYM
aiua-8799	132	27	immunotherapy	immunotherapy	NOUN
aiua-8799	132	28	.	.	PUNCT
aiua-8799	133	1	more	more	ADJ
aiua-8799	133	2	studies	study	NOUN
aiua-8799	133	3	should	should	AUX
aiua-8799	133	4	be	be	AUX
aiua-8799	133	5	carried	carry	VERB
aiua-8799	133	6	out	out	ADP
aiua-8799	133	7	to	to	PART
aiua-8799	133	8	clarify	clarify	VERB
aiua-8799	133	9	the	the	DET
aiua-8799	133	10	precise	precise	ADJ
aiua-8799	133	11	role	role	NOUN
aiua-8799	133	12	of	of	ADP
aiua-8799	133	13	the	the	DET
aiua-8799	133	14	active	active	ADJ
aiua-8799	133	15	ingredients	ingredient	NOUN
aiua-8799	133	16	of	of	ADP
aiua-8799	133	17	protopine	protopine	NOUN
aiua-8799	133	18	and	and	CCONJ
aiua-8799	133	19	nuciferine	nuciferine	NOUN
aiua-8799	133	20	syrup	syrup	NOUN
aiua-8799	133	21	and	and	CCONJ
aiua-8799	133	22	their	their	PRON
aiua-8799	133	23	interactions	interaction	NOUN
aiua-8799	133	24	.	.	PUNCT
aiua-8799	134	1	references	reference	NOUN
aiua-8799	134	2	1	1	NUM
aiua-8799	134	3	.	.	PUNCT
aiua-8799	134	4	sousa	sousa	PROPN
aiua-8799	134	5	a	a	PROPN
aiua-8799	134	6	,	,	PUNCT
aiua-8799	134	7	inman	inman	PROPN
aiua-8799	134	8	ba	ba	PROPN
aiua-8799	134	9	,	,	PUNCT
aiua-8799	134	10	piñeiro	piñeiro	PROPN
aiua-8799	135	1	i	i	PRON
aiua-8799	135	2	,	,	PUNCT
aiua-8799	135	3	et	et	PROPN
aiua-8799	135	4	al	al	PROPN
aiua-8799	135	5	.	.	PUNCT
aiua-8799	136	1	a	a	DET
aiua-8799	136	2	clinical	clinical	ADJ
aiua-8799	136	3	trial	trial	NOUN
aiua-8799	136	4	of	of	ADP
aiua-8799	136	5	neoadjuvant	neoadjuvant	ADJ
aiua-8799	136	6	hyperthermic	hyperthermic	ADJ
aiua-8799	136	7	intravesical	intravesical	ADJ
aiua-8799	136	8	chemotherapy	chemotherapy	NOUN
aiua-8799	136	9	(	(	PUNCT
aiua-8799	136	10	hivec	hivec	PROPN
aiua-8799	136	11	)	)	PUNCT
aiua-8799	136	12	for	for	ADP
aiua-8799	136	13	treating	treat	VERB
aiua-8799	136	14	intermediate	intermediate	ADJ
aiua-8799	136	15	and	and	CCONJ
aiua-8799	136	16	high	high	ADJ
aiua-8799	136	17	-	-	PUNCT
aiua-8799	136	18	risk	risk	NOUN
aiua-8799	136	19	non	non	ADJ
aiua-8799	136	20	-	-	ADJ
aiua-8799	136	21	muscle	muscle	ADJ
aiua-8799	136	22	invasive	invasive	ADJ
aiua-8799	136	23	bladder	bladder	NOUN
aiua-8799	136	24	cancer	cancer	NOUN
aiua-8799	136	25	.	.	PUNCT
aiua-8799	137	1	int	int	PROPN
aiua-8799	137	2	j	j	PROPN
aiua-8799	137	3	hyperthermia	hyperthermia	NOUN
aiua-8799	137	4	.	.	PUNCT
aiua-8799	138	1	2014	2014	NUM
aiua-8799	138	2	;	;	PUNCT
aiua-8799	138	3	30:166	30:166	NUM
aiua-8799	138	4	-	-	SYM
aiua-8799	138	5	70	70	NUM
aiua-8799	138	6	.	.	PUNCT
aiua-8799	139	1	2	2	X
aiua-8799	139	2	.	.	X
aiua-8799	139	3	sousa	sousa	PROPN
aiua-8799	139	4	a	a	PRON
aiua-8799	139	5	,	,	PUNCT
aiua-8799	139	6	piñeiro	piñeiro	PROPN
aiua-8799	139	7	i	i	PRON
aiua-8799	139	8	,	,	PUNCT
aiua-8799	139	9	rodríguez	rodríguez	NOUN
aiua-8799	139	10	s	s	PROPN
aiua-8799	139	11	,	,	PUNCT
aiua-8799	139	12	et	et	PROPN
aiua-8799	139	13	al	al	PROPN
aiua-8799	139	14	.	.	PROPN
aiua-8799	140	1	recirculant	recirculant	PROPN
aiua-8799	140	2	hyperthermic	hyperthermic	PROPN
aiua-8799	140	3	intravesical	intravesical	ADJ
aiua-8799	140	4	chemotherapy	chemotherapy	NOUN
aiua-8799	140	5	(	(	PUNCT
aiua-8799	140	6	hivec	hivec	PROPN
aiua-8799	140	7	)	)	PUNCT
aiua-8799	140	8	in	in	ADP
aiua-8799	140	9	intermediate	intermediate	ADJ
aiua-8799	140	10	-	-	PUNCT
aiua-8799	140	11	high	high	ADJ
aiua-8799	140	12	-	-	PUNCT
aiua-8799	140	13	risk	risk	NOUN
aiua-8799	140	14	non	non	ADJ
aiua-8799	140	15	-	-	ADJ
aiua-8799	140	16	muscle	muscle	ADJ
aiua-8799	140	17	-	-	PUNCT
aiua-8799	140	18	invasive	invasive	ADJ
aiua-8799	140	19	bladder	bladder	NOUN
aiua-8799	140	20	cancer	cancer	NOUN
aiua-8799	140	21	.	.	PUNCT
aiua-8799	141	1	int	int	PROPN
aiua-8799	141	2	j	j	PROPN
aiua-8799	141	3	hyperthermia	hyperthermia	NOUN
aiua-8799	141	4	.	.	PUNCT
aiua-8799	142	1	2016	2016	NUM
aiua-8799	142	2	;	;	PUNCT
aiua-8799	142	3	32:374	32:374	NUM
aiua-8799	142	4	-	-	SYM
aiua-8799	142	5	80	80	NUM
aiua-8799	142	6	.	.	PUNCT
aiua-8799	143	1	3	3	X
aiua-8799	143	2	.	.	X
aiua-8799	143	3	de	de	PROPN
aiua-8799	143	4	jong	jong	PROPN
aiua-8799	143	5	jj	jj	PROPN
aiua-8799	143	6	,	,	PUNCT
aiua-8799	143	7	hendricksen	hendricksen	PROPN
aiua-8799	143	8	k	k	PROPN
aiua-8799	143	9	,	,	PUNCT
aiua-8799	143	10	rosier	rosier	X
aiua-8799	143	11	m	m	PROPN
aiua-8799	143	12	,	,	PUNCT
aiua-8799	143	13	et	et	PROPN
aiua-8799	143	14	al	al	PROPN
aiua-8799	143	15	.	.	PROPN
aiua-8799	144	1	hyperthermic	hyperthermic	PROPN
aiua-8799	144	2	intravesical	intravesical	ADJ
aiua-8799	144	3	chemotherapy	chemotherapy	NOUN
aiua-8799	144	4	for	for	ADP
aiua-8799	144	5	bcg	bcg	PROPN
aiua-8799	144	6	unresponsive	unresponsive	ADJ
aiua-8799	144	7	non	non	ADJ
aiua-8799	144	8	-	-	ADJ
aiua-8799	144	9	muscle	muscle	ADJ
aiua-8799	144	10	invasive	invasive	ADJ
aiua-8799	144	11	bladder	bladder	NOUN
aiua-8799	144	12	cancer	cancer	NOUN
aiua-8799	144	13	patients	patient	NOUN
aiua-8799	144	14	.	.	PUNCT
aiua-8799	145	1	bladder	bladder	NOUN
aiua-8799	145	2	cancer	cancer	NOUN
aiua-8799	145	3	.	.	PUNCT
aiua-8799	146	1	2018	2018	NUM
aiua-8799	146	2	;	;	PUNCT
aiua-8799	146	3	4:35	4:35	NUM
aiua-8799	146	4	-	-	SYM
aiua-8799	146	5	401	401	NUM
aiua-8799	146	6	.	.	PUNCT
aiua-8799	147	1	4	4	X
aiua-8799	147	2	.	.	X
aiua-8799	147	3	tan	tan	PROPN
aiua-8799	147	4	ws	ws	PROPN
aiua-8799	147	5	,	,	PUNCT
aiua-8799	147	6	palou	palou	PROPN
aiua-8799	147	7	j	j	PROPN
aiua-8799	147	8	,	,	PUNCT
aiua-8799	147	9	kelly	kelly	PROPN
aiua-8799	147	10	j.	j.	PROPN
aiua-8799	147	11	safety	safety	PROPN
aiua-8799	147	12	and	and	CCONJ
aiua-8799	147	13	tolerability	tolerability	NOUN
aiua-8799	147	14	analysis	analysis	NOUN
aiua-8799	147	15	of	of	ADP
aiua-8799	147	16	hyperthermic	hyperthermic	ADJ
aiua-8799	147	17	intravesical	intravesical	ADJ
aiua-8799	147	18	mitomycin	mitomycin	PROPN
aiua-8799	147	19	to	to	ADP
aiua-8799	147	20	mitomycin	mitomycin	NOUN
aiua-8799	147	21	alone	alone	ADV
aiua-8799	147	22	in	in	ADP
aiua-8799	147	23	hivec	hivec	PROPN
aiua-8799	147	24	i	i	PRON
aiua-8799	147	25	and	and	CCONJ
aiua-8799	147	26	hivec	hivec	PROPN
aiua-8799	147	27	ii	ii	PROPN
aiua-8799	147	28	:	:	PUNCT
aiua-8799	147	29	an	an	DET
aiua-8799	147	30	interim	interim	ADJ
aiua-8799	147	31	analysis	analysis	NOUN
aiua-8799	147	32	of	of	ADP
aiua-8799	147	33	307	307	NUM
aiua-8799	147	34	patients	patient	NOUN
aiua-8799	147	35	eur	eur	PROPN
aiua-8799	147	36	urol	urol	NOUN
aiua-8799	147	37	.	.	PUNCT
aiua-8799	147	38	2017	2017	NUM
aiua-8799	147	39	;	;	PUNCT
aiua-8799	147	40	16;e1150	16;e1150	NUM
aiua-8799	147	41	.	.	PUNCT
aiua-8799	148	1	5.colombo	5.colombo	NUM
aiua-8799	148	2	r	r	NOUN
aiua-8799	148	3	,	,	PUNCT
aiua-8799	148	4	da	da	PROPN
aiua-8799	148	5	pozzo	pozzo	X
aiua-8799	148	6	lf	lf	PROPN
aiua-8799	148	7	,	,	PUNCT
aiua-8799	148	8	lev	lev	NOUN
aiua-8799	148	9	a	a	X
aiua-8799	148	10	,	,	PUNCT
aiua-8799	148	11	et	et	PROPN
aiua-8799	148	12	al	al	PROPN
aiua-8799	148	13	.	.	PROPN
aiua-8799	148	14	neoadjuvant	neoadjuvant	ADJ
aiua-8799	148	15	combined	combine	VERB
aiua-8799	148	16	microwave	microwave	NOUN
aiua-8799	148	17	induced	induce	VERB
aiua-8799	148	18	local	local	ADJ
aiua-8799	148	19	hyperthermia	hyperthermia	NOUN
aiua-8799	148	20	and	and	CCONJ
aiua-8799	148	21	topical	topical	ADJ
aiua-8799	148	22	chemotherapy	chemotherapy	NOUN
aiua-8799	148	23	versus	versus	ADP
aiua-8799	148	24	chemotherapy	chemotherapy	NOUN
aiua-8799	148	25	alone	alone	ADV
aiua-8799	148	26	for	for	ADP
aiua-8799	148	27	superficial	superficial	ADJ
aiua-8799	148	28	bladder	bladder	NOUN
aiua-8799	148	29	cancer	cancer	NOUN
aiua-8799	148	30	.	.	PUNCT
aiua-8799	149	1	j	j	PROPN
aiua-8799	149	2	urol	urol	PROPN
aiua-8799	149	3	.	.	PUNCT
aiua-8799	149	4	1996	1996	NUM
aiua-8799	149	5	;	;	PUNCT
aiua-8799	149	6	155:1227	155:1227	NUM
aiua-8799	149	7	-	-	SYM
aiua-8799	149	8	32	32	NUM
aiua-8799	149	9	.	.	PUNCT
aiua-8799	150	1	6.lammers	6.lammers	NUM
aiua-8799	150	2	rj	rj	PROPN
aiua-8799	150	3	,	,	PUNCT
aiua-8799	150	4	witjes	witjes	PROPN
aiua-8799	150	5	ja	ja	PROPN
aiua-8799	150	6	,	,	PUNCT
aiua-8799	150	7	inman	inman	PROPN
aiua-8799	150	8	ba	ba	PROPN
aiua-8799	150	9	,	,	PUNCT
aiua-8799	150	10	et	et	PROPN
aiua-8799	150	11	al	al	PROPN
aiua-8799	150	12	.	.	PUNCT
aiua-8799	151	1	the	the	DET
aiua-8799	151	2	role	role	NOUN
aiua-8799	151	3	of	of	ADP
aiua-8799	151	4	a	a	DET
aiua-8799	151	5	combined	combine	VERB
aiua-8799	151	6	regimen	regiman	NOUN
aiua-8799	151	7	with	with	ADP
aiua-8799	151	8	intravesical	intravesical	ADJ
aiua-8799	151	9	chemotherapy	chemotherapy	NOUN
aiua-8799	151	10	and	and	CCONJ
aiua-8799	151	11	hyperthermia	hyperthermia	NOUN
aiua-8799	151	12	in	in	ADP
aiua-8799	151	13	the	the	DET
aiua-8799	151	14	management	management	NOUN
aiua-8799	151	15	of	of	ADP
aiua-8799	151	16	nonmuscle	nonmuscle	PROPN
aiua-8799	151	17	-	-	PUNCT
aiua-8799	151	18	invasive	invasive	ADJ
aiua-8799	151	19	bladder	bladder	NOUN
aiua-8799	151	20	cancer	cancer	NOUN
aiua-8799	151	21	:	:	PUNCT
aiua-8799	151	22	a	a	DET
aiua-8799	151	23	systematic	systematic	ADJ
aiua-8799	151	24	review	review	NOUN
aiua-8799	151	25	.	.	PUNCT
aiua-8799	152	1	eur	eur	PROPN
aiua-8799	152	2	urol	urol	PROPN
aiua-8799	152	3	.	.	PUNCT
aiua-8799	153	1	2011	2011	NUM
aiua-8799	153	2	;	;	PUNCT
aiua-8799	153	3	60:81	60:81	NUM
aiua-8799	153	4	-	-	SYM
aiua-8799	153	5	93	93	NUM
aiua-8799	153	6	.	.	PUNCT
aiua-8799	154	1	7	7	X
aiua-8799	154	2	.	.	PUNCT
aiua-8799	154	3	ahmed	ahmed	PROPN
aiua-8799	154	4	k	k	PROPN
aiua-8799	154	5	,	,	PUNCT
aiua-8799	154	6	zaidi	zaidi	PROPN
aiua-8799	154	7	sf	sf	PROPN
aiua-8799	154	8	.	.	PUNCT
aiua-8799	154	9	treating	treat	VERB
aiua-8799	154	10	cancer	cancer	NOUN
aiua-8799	154	11	with	with	ADP
aiua-8799	154	12	heat	heat	NOUN
aiua-8799	154	13	:	:	PUNCT
aiua-8799	154	14	hyperthermia	hyperthermia	NOUN
aiua-8799	154	15	as	as	ADP
aiua-8799	154	16	promising	promise	VERB
aiua-8799	154	17	strategy	strategy	NOUN
aiua-8799	154	18	to	to	PART
aiua-8799	154	19	enhance	enhance	VERB
aiua-8799	154	20	apoptosis	apoptosis	NOUN
aiua-8799	154	21	.	.	PUNCT
aiua-8799	155	1	j	j	PROPN
aiua-8799	155	2	pak	pak	PROPN
aiua-8799	155	3	med	med	PROPN
aiua-8799	155	4	assoc	assoc	PROPN
aiua-8799	155	5	.	.	PUNCT
aiua-8799	155	6	2013	2013	NUM
aiua-8799	155	7	;	;	PUNCT
aiua-8799	155	8	63:504	63:504	NUM
aiua-8799	155	9	-	-	SYM
aiua-8799	155	10	8	8	NUM
aiua-8799	155	11	.	.	NOUN
aiua-8799	155	12	8	8	NUM
aiua-8799	155	13	.	.	PUNCT
aiua-8799	155	14	kampinga	kampinga	PROPN
aiua-8799	155	15	hh	hh	PROPN
aiua-8799	155	16	.	.	PROPN
aiua-8799	155	17	cell	cell	NOUN
aiua-8799	155	18	biological	biological	ADJ
aiua-8799	155	19	effects	effect	NOUN
aiua-8799	155	20	of	of	ADP
aiua-8799	155	21	hyperthermia	hyperthermia	NOUN
aiua-8799	155	22	alone	alone	ADV
aiua-8799	155	23	or	or	CCONJ
aiua-8799	155	24	combined	combine	VERB
aiua-8799	155	25	with	with	ADP
aiua-8799	155	26	radiation	radiation	NOUN
aiua-8799	155	27	or	or	CCONJ
aiua-8799	155	28	drugs	drug	NOUN
aiua-8799	155	29	:	:	PUNCT
aiua-8799	155	30	a	a	DET
aiua-8799	155	31	short	short	ADJ
aiua-8799	155	32	introduction	introduction	NOUN
aiua-8799	155	33	to	to	ADP
aiua-8799	155	34	newcomers	newcomer	NOUN
aiua-8799	155	35	in	in	ADP
aiua-8799	155	36	the	the	DET
aiua-8799	155	37	field	field	NOUN
aiua-8799	155	38	.	.	PUNCT
aiua-8799	156	1	int	int	NOUN
aiua-8799	156	2	j	j	PROPN
aiua-8799	156	3	hyperthermia	hyperthermia	NOUN
aiua-8799	156	4	.	.	PUNCT
aiua-8799	157	1	2006	2006	NUM
aiua-8799	157	2	;	;	PUNCT
aiua-8799	157	3	22:191	22:191	NUM
aiua-8799	157	4	-	-	SYM
aiua-8799	157	5	6	6	NUM
aiua-8799	157	6	.	.	NOUN
aiua-8799	157	7	9	9	NUM
aiua-8799	157	8	.	.	X
aiua-8799	158	1	hildebrandt	hildebrandt	PROPN
aiua-8799	158	2	b	b	NUM
aiua-8799	158	3	,	,	PUNCT
aiua-8799	158	4	wust	wust	ADJ
aiua-8799	158	5	p	p	X
aiua-8799	158	6	,	,	PUNCT
aiua-8799	158	7	ahlers	ahler	NOUN
aiua-8799	158	8	o	o	NOUN
aiua-8799	158	9	,	,	PUNCT
aiua-8799	158	10	et	et	PROPN
aiua-8799	158	11	al	al	PROPN
aiua-8799	158	12	.	.	PUNCT
aiua-8799	159	1	the	the	DET
aiua-8799	159	2	cellular	cellular	ADJ
aiua-8799	159	3	and	and	CCONJ
aiua-8799	159	4	molecular	molecular	ADJ
aiua-8799	159	5	basis	basis	NOUN
aiua-8799	159	6	of	of	ADP
aiua-8799	159	7	hyperthermia	hyperthermia	NOUN
aiua-8799	159	8	.	.	PUNCT
aiua-8799	160	1	crit	crit	PROPN
aiua-8799	160	2	rev	rev	VERB
aiua-8799	160	3	oncol	oncol	ADJ
aiua-8799	160	4	hematol	hematol	NOUN
aiua-8799	160	5	.	.	PUNCT
aiua-8799	161	1	2002	2002	NUM
aiua-8799	161	2	;	;	PUNCT
aiua-8799	161	3	43:33	43:33	NUM
aiua-8799	161	4	-	-	SYM
aiua-8799	161	5	56	56	NUM
aiua-8799	161	6	.	.	NOUN
aiua-8799	161	7	10	10	NUM
aiua-8799	161	8	.	.	PUNCT
aiua-8799	162	1	babjuk	babjuk	PROPN
aiua-8799	162	2	m	m	PROPN
aiua-8799	162	3	,	,	PUNCT
aiua-8799	162	4	burger	burger	PROPN
aiua-8799	162	5	m	m	PROPN
aiua-8799	162	6	,	,	PUNCT
aiua-8799	162	7	compérat	compérat	NOUN
aiua-8799	162	8	e	e	NOUN
aiua-8799	162	9	,	,	PUNCT
aiua-8799	162	10	et	et	PROPN
aiua-8799	162	11	al	al	PROPN
aiua-8799	162	12	.	.	PUNCT
aiua-8799	163	1	eau	eau	PROPN
aiua-8799	163	2	guidelines	guideline	NOUN
aiua-8799	163	3	on	on	ADP
aiua-8799	163	4	non	non	ADJ
aiua-8799	163	5	-	-	ADJ
aiua-8799	163	6	muscle	muscle	ADJ
aiua-8799	163	7	-	-	PUNCT
aiua-8799	163	8	invasive	invasive	ADJ
aiua-8799	163	9	bladder	bladder	NOUN
aiua-8799	163	10	cancer	cancer	NOUN
aiua-8799	163	11	,	,	PUNCT
aiua-8799	163	12	2019	2019	NUM
aiua-8799	163	13	.	.	PUNCT
aiua-8799	164	1	11	11	NUM
aiua-8799	164	2	.	.	PUNCT
aiua-8799	165	1	gözen	gözen	NOUN
aiua-8799	165	2	as	as	ADP
aiua-8799	165	3	,	,	PUNCT
aiua-8799	165	4	umari	umari	PROPN
aiua-8799	165	5	p	p	X
aiua-8799	165	6	,	,	PUNCT
aiua-8799	165	7	scheitlin	scheitlin	PROPN
aiua-8799	165	8	w	w	PROPN
aiua-8799	165	9	,	,	PUNCT
aiua-8799	165	10	et	et	PROPN
aiua-8799	165	11	al	al	PROPN
aiua-8799	165	12	.	.	PROPN
aiua-8799	165	13	effectivity	effectivity	NOUN
aiua-8799	165	14	of	of	ADP
aiua-8799	165	15	intravescical	intravescical	ADJ
aiua-8799	165	16	thermo	thermo	NOUN
aiua-8799	165	17	-	-	PUNCT
aiua-8799	165	18	chemotherapy	chemotherapy	NOUN
aiua-8799	165	19	prophylaxis	prophylaxis	NOUN
aiua-8799	165	20	for	for	ADP
aiua-8799	165	21	patients	patient	NOUN
aiua-8799	165	22	with	with	ADP
aiua-8799	165	23	high	high	ADJ
aiua-8799	165	24	recurrence	recurrence	NOUN
aiua-8799	165	25	and	and	CCONJ
aiua-8799	165	26	progression	progression	NOUN
aiua-8799	165	27	risk	risk	NOUN
aiua-8799	165	28	for	for	ADP
aiua-8799	165	29	non	non	ADJ
aiua-8799	165	30	-	-	ADJ
aiua-8799	165	31	muscle	muscle	ADJ
aiua-8799	165	32	invasive	invasive	ADJ
aiua-8799	165	33	bladder	bladder	NOUN
aiua-8799	165	34	cancer	cancer	NOUN
aiua-8799	165	35	.	.	PUNCT
aiua-8799	166	1	arch	arch	PROPN
aiua-8799	166	2	ital	ital	PROPN
aiua-8799	166	3	urol	urol	PROPN
aiua-8799	166	4	androl	androl	PROPN
aiua-8799	166	5	.	.	PROPN
aiua-8799	166	6	2017	2017	NUM
aiua-8799	166	7	;	;	PUNCT
aiua-8799	166	8	89:102	89:102	NUM
aiua-8799	166	9	-	-	SYM
aiua-8799	166	10	105	105	NUM
aiua-8799	166	11	.	.	PUNCT
aiua-8799	166	12	12	12	NUM
aiua-8799	166	13	.	.	PUNCT
aiua-8799	167	1	ustunes	ustunes	PROPN
aiua-8799	167	2	l.	l.	PROPN
aiua-8799	167	3	,	,	PUNCT
aiua-8799	167	4	laekeman	laekeman	NOUN
aiua-8799	167	5	gm	gm	PROPN
aiua-8799	167	6	,	,	PUNCT
aiua-8799	167	7	gözler	gözler	NOUN
aiua-8799	167	8	b	b	NOUN
aiua-8799	167	9	,	,	PUNCT
aiua-8799	167	10	et	et	PROPN
aiua-8799	167	11	al	al	PROPN
aiua-8799	167	12	.	.	PROPN
aiua-8799	168	1	in	in	ADP
aiua-8799	168	2	vitro	vitro	X
aiua-8799	168	3	study	study	NOUN
aiua-8799	168	4	of	of	ADP
aiua-8799	168	5	the	the	DET
aiua-8799	168	6	anticholinergic	anticholinergic	ADJ
aiua-8799	168	7	and	and	CCONJ
aiua-8799	168	8	antihistaminic	antihistaminic	NOUN
aiua-8799	168	9	activities	activity	NOUN
aiua-8799	168	10	of	of	ADP
aiua-8799	168	11	protopine	protopine	NOUN
aiua-8799	168	12	and	and	CCONJ
aiua-8799	168	13	some	some	DET
aiua-8799	168	14	derivatives	derivative	NOUN
aiua-8799	168	15	.	.	PUNCT
aiua-8799	169	1	j	j	PROPN
aiua-8799	169	2	nat	nat	PROPN
aiua-8799	169	3	prod	prod	NOUN
aiua-8799	169	4	.	.	PUNCT
aiua-8799	169	5	1988	1988	NUM
aiua-8799	169	6	;	;	PUNCT
aiua-8799	169	7	51:1021	51:1021	PROPN
aiua-8799	169	8	-	-	SYM
aiua-8799	169	9	2	2	NUM
aiua-8799	169	10	13	13	NUM
aiua-8799	169	11	.	.	PUNCT
aiua-8799	170	1	kardos	kardos	PROPN
aiua-8799	170	2	j	j	PROPN
aiua-8799	170	3	,	,	PUNCT
aiua-8799	170	4	blaskó	blaskó	PROPN
aiua-8799	170	5	g	g	PROPN
aiua-8799	170	6	,	,	PUNCT
aiua-8799	170	7	simonyi	simonyi	NOUN
aiua-8799	170	8	m.	m.	NOUN
aiua-8799	170	9	enhancement	enhancement	NOUN
aiua-8799	170	10	of	of	ADP
aiua-8799	170	11	gammaaminobutyric	gammaaminobutyric	ADJ
aiua-8799	170	12	acid	acid	NOUN
aiua-8799	170	13	receptor	receptor	NOUN
aiua-8799	170	14	binding	bind	VERB
aiua-8799	170	15	by	by	ADP
aiua-8799	170	16	protopine	protopine	NOUN
aiua-8799	170	17	-	-	PUNCT
aiua-8799	170	18	type	type	NOUN
aiua-8799	170	19	alkaloids	alkaloid	NOUN
aiua-8799	170	20	.	.	PUNCT
aiua-8799	170	21	arzneimittelforschung	arzneimittelforschung	PROPN
aiua-8799	170	22	.	.	PUNCT
aiua-8799	171	1	1986	1986	NUM
aiua-8799	171	2	;	;	PUNCT
aiua-8799	171	3	36:939	36:939	NUM
aiua-8799	171	4	-	-	SYM
aiua-8799	171	5	40	40	NUM
aiua-8799	171	6	.	.	PUNCT
aiua-8799	172	1	04chiancone_stesura	04chiancone_stesura	NOUN
aiua-8799	172	2	seveso	seveso	PROPN
aiua-8799	172	3	24/09/20	24/09/20	PROPN
aiua-8799	172	4	14:13	14:13	NUM
aiua-8799	172	5	pagina	pagina	NOUN
aiua-8799	172	6	180	180	NUM
aiua-8799	172	7	181archivio	181archivio	PROPN
aiua-8799	172	8	italiano	italiano	NOUN
aiua-8799	172	9	di	di	NOUN
aiua-8799	172	10	urologia	urologia	PROPN
aiua-8799	172	11	e	e	PROPN
aiua-8799	172	12	andrologia	andrologia	NOUN
aiua-8799	172	13	2020	2020	NUM
aiua-8799	172	14	;	;	PUNCT
aiua-8799	172	15	92	92	NUM
aiua-8799	172	16	,	,	PUNCT
aiua-8799	172	17	3	3	NUM
aiua-8799	172	18	protopine	protopine	NOUN
aiua-8799	172	19	and	and	CCONJ
aiua-8799	172	20	nuciferin	nuciferin	ADJ
aiua-8799	172	21	for	for	ADP
aiua-8799	172	22	hyperthermic	hyperthermic	ADJ
aiua-8799	172	23	intravesical	intravesical	ADJ
aiua-8799	172	24	chemotherapy	chemotherapy	NOUN
aiua-8799	172	25	14	14	NUM
aiua-8799	172	26	.	.	PUNCT
aiua-8799	173	1	fedurco	fedurco	PROPN
aiua-8799	173	2	mj	mj	PROPN
aiua-8799	173	3	,	,	PUNCT
aiua-8799	173	4	gregorová	gregorová	PROPN
aiua-8799	173	5	k	k	PROPN
aiua-8799	173	6	,	,	PUNCT
aiua-8799	173	7	šebrlová	šebrlová	PROPN
aiua-8799	173	8	j	j	PROPN
aiua-8799	173	9	,	,	PUNCT
aiua-8799	173	10	et	et	PROPN
aiua-8799	173	11	al	al	PROPN
aiua-8799	173	12	.	.	PROPN
aiua-8799	173	13	modulatory	modulatory	ADJ
aiua-8799	173	14	effects	effect	NOUN
aiua-8799	173	15	of	of	ADP
aiua-8799	173	16	eschscholzia	eschscholzia	PROPN
aiua-8799	173	17	californica	californica	NOUN
aiua-8799	173	18	alkaloids	alkaloid	NOUN
aiua-8799	173	19	on	on	ADP
aiua-8799	173	20	recombinant	recombinant	ADJ
aiua-8799	173	21	gabaa	gabaa	NOUN
aiua-8799	173	22	receptors	receptor	NOUN
aiua-8799	173	23	.	.	PUNCT
aiua-8799	174	1	biochem	biochem	PROPN
aiua-8799	174	2	res	re	VERB
aiua-8799	174	3	int	int	NOUN
aiua-8799	174	4	.	.	PUNCT
aiua-8799	175	1	2015	2015	NUM
aiua-8799	175	2	;	;	PUNCT
aiua-8799	175	3	2015:617620	2015:617620	NUM
aiua-8799	175	4	.	.	PUNCT
aiua-8799	175	5	15,häberlein	15,häberlein	NUM
aiua-8799	175	6	h	h	NOUN
aiua-8799	175	7	,	,	PUNCT
aiua-8799	175	8	tschiersch	tschiersch	PROPN
aiua-8799	175	9	kp	kp	PROPN
aiua-8799	175	10	,	,	PUNCT
aiua-8799	175	11	boonen	boonen	PROPN
aiua-8799	175	12	g	g	PROPN
aiua-8799	175	13	,	,	PUNCT
aiua-8799	175	14	et	et	PROPN
aiua-8799	175	15	al	al	PROPN
aiua-8799	175	16	.	.	PUNCT
aiua-8799	175	17	chelidonium	chelidonium	PROPN
aiua-8799	175	18	majus	maju	VERB
aiua-8799	175	19	l.	l.	PROPN
aiua-8799	175	20	:	:	PUNCT
aiua-8799	175	21	components	component	NOUN
aiua-8799	175	22	with	with	ADP
aiua-8799	175	23	in	in	ADP
aiua-8799	175	24	vitro	vitro	X
aiua-8799	175	25	affinity	affinity	NOUN
aiua-8799	175	26	for	for	ADP
aiua-8799	175	27	the	the	DET
aiua-8799	175	28	gabaa	gabaa	NOUN
aiua-8799	175	29	receptor	receptor	NOUN
aiua-8799	175	30	.	.	PUNCT
aiua-8799	176	1	positive	positive	ADJ
aiua-8799	176	2	cooperation	cooperation	NOUN
aiua-8799	176	3	of	of	ADP
aiua-8799	176	4	alkaloids	alkaloid	NOUN
aiua-8799	176	5	.	.	PROPN
aiua-8799	176	6	planta	planta	PROPN
aiua-8799	176	7	med	med	PROPN
aiua-8799	176	8	.	.	PUNCT
aiua-8799	176	9	1996	1996	NUM
aiua-8799	176	10	;	;	PUNCT
aiua-8799	176	11	62:227	62:227	NUM
aiua-8799	176	12	-	-	SYM
aiua-8799	176	13	31	31	NUM
aiua-8799	176	14	.	.	PUNCT
aiua-8799	177	1	16	16	NUM
aiua-8799	177	2	.	.	PUNCT
aiua-8799	178	1	kim	kim	PROPN
aiua-8799	178	2	sr	sr	PROPN
aiua-8799	178	3	,	,	PUNCT
aiua-8799	178	4	hwang	hwang	PROPN
aiua-8799	178	5	sy	sy	PROPN
aiua-8799	178	6	,	,	PUNCT
aiua-8799	178	7	jang	jang	PROPN
aiua-8799	178	8	yp	yp	PROPN
aiua-8799	178	9	,	,	PUNCT
aiua-8799	178	10	et	et	PROPN
aiua-8799	178	11	al	al	PROPN
aiua-8799	178	12	.	.	PROPN
aiua-8799	178	13	protopine	protopine	PROPN
aiua-8799	179	1	from	from	ADP
aiua-8799	179	2	corydalis	corydalis	PROPN
aiua-8799	179	3	ternata	ternata	PROPN
aiua-8799	179	4	has	have	AUX
aiua-8799	179	5	anticholinesterase	anticholinesterase	VERB
aiua-8799	179	6	and	and	CCONJ
aiua-8799	179	7	antiamnesic	antiamnesic	ADJ
aiua-8799	179	8	activities	activity	NOUN
aiua-8799	179	9	.	.	PUNCT
aiua-8799	180	1	planta	planta	PROPN
aiua-8799	180	2	med	med	PROPN
aiua-8799	180	3	.	.	PUNCT
aiua-8799	180	4	1999	1999	NUM
aiua-8799	180	5	;	;	PUNCT
aiua-8799	180	6	65:218	65:218	NUM
aiua-8799	180	7	-	-	SYM
aiua-8799	180	8	21	21	NUM
aiua-8799	180	9	.	.	PUNCT
aiua-8799	180	10	17	17	NUM
aiua-8799	180	11	.	.	PUNCT
aiua-8799	181	1	son	son	PROPN
aiua-8799	181	2	y	y	PROPN
aiua-8799	181	3	,	,	PUNCT
aiua-8799	181	4	an	an	DET
aiua-8799	181	5	y	y	PROPN
aiua-8799	181	6	,	,	PUNCT
aiua-8799	181	7	jung	jung	PROPN
aiua-8799	181	8	j	j	PROPN
aiua-8799	181	9	,	,	PUNCT
aiua-8799	181	10	et	et	PROPN
aiua-8799	181	11	al	al	PROPN
aiua-8799	181	12	.	.	PROPN
aiua-8799	181	13	protopine	protopine	PROPN
aiua-8799	181	14	isolated	isolate	VERB
aiua-8799	181	15	from	from	ADP
aiua-8799	181	16	nandina	nandina	PROPN
aiua-8799	181	17	domestica	domestica	PROPN
aiua-8799	181	18	induces	induce	VERB
aiua-8799	181	19	apoptosis	apoptosis	NOUN
aiua-8799	181	20	and	and	CCONJ
aiua-8799	181	21	autophagy	autophagy	NOUN
aiua-8799	181	22	in	in	ADP
aiua-8799	181	23	colon	colon	NOUN
aiua-8799	181	24	cancer	cancer	NOUN
aiua-8799	181	25	cells	cell	NOUN
aiua-8799	181	26	by	by	ADP
aiua-8799	181	27	stabilizing	stabilize	VERB
aiua-8799	181	28	p53	p53	NOUN
aiua-8799	181	29	.	.	PUNCT
aiua-8799	182	1	phytother	phytother	PROPN
aiua-8799	182	2	res	re	NOUN
aiua-8799	182	3	.	.	PROPN
aiua-8799	182	4	2019	2019	NUM
aiua-8799	182	5	;	;	PUNCT
aiua-8799	182	6	33:1689	33:1689	NUM
aiua-8799	182	7	-	-	SYM
aiua-8799	182	8	1696	1696	NUM
aiua-8799	182	9	.	.	PUNCT
aiua-8799	183	1	18	18	NUM
aiua-8799	183	2	.	.	X
aiua-8799	184	1	fowler	fowler	PROPN
aiua-8799	184	2	cj	cj	PROPN
aiua-8799	184	3	,	,	PUNCT
aiua-8799	184	4	griffiths	griffiths	PROPN
aiua-8799	184	5	d	d	PROPN
aiua-8799	184	6	,	,	PUNCT
aiua-8799	184	7	de	de	PROPN
aiua-8799	184	8	groat	groat	PROPN
aiua-8799	184	9	wc	wc	PROPN
aiua-8799	184	10	.	.	PUNCT
aiua-8799	185	1	the	the	DET
aiua-8799	185	2	neural	neural	ADJ
aiua-8799	185	3	control	control	NOUN
aiua-8799	185	4	of	of	ADP
aiua-8799	185	5	micturition	micturition	NOUN
aiua-8799	185	6	.	.	PUNCT
aiua-8799	186	1	nat	nat	PROPN
aiua-8799	186	2	rev	rev	PROPN
aiua-8799	186	3	neurosci	neurosci	PROPN
aiua-8799	186	4	.	.	PUNCT
aiua-8799	186	5	2008	2008	NUM
aiua-8799	186	6	;	;	PUNCT
aiua-8799	186	7	9:453	9:453	NUM
aiua-8799	186	8	-	-	SYM
aiua-8799	186	9	466	466	NUM
aiua-8799	186	10	.	.	NOUN
aiua-8799	187	1	19	19	NUM
aiua-8799	187	2	.	.	PUNCT
aiua-8799	188	1	kang	kang	PROPN
aiua-8799	188	2	m	m	PROPN
aiua-8799	188	3	,	,	PUNCT
aiua-8799	188	4	shin	shin	PROPN
aiua-8799	189	1	d	d	NOUN
aiua-8799	189	2	,	,	PUNCT
aiua-8799	189	3	oh	oh	INTJ
aiua-8799	189	4	jw	jw	PROPN
aiua-8799	189	5	,	,	PUNCT
aiua-8799	189	6	et	et	PROPN
aiua-8799	189	7	al	al	PROPN
aiua-8799	189	8	.	.	PUNCT
aiua-8799	190	1	the	the	DET
aiua-8799	190	2	anti	anti	ADJ
aiua-8799	190	3	-	-	ADJ
aiua-8799	190	4	depressant	depressant	ADJ
aiua-8799	190	5	effect	effect	NOUN
aiua-8799	190	6	of	of	ADP
aiua-8799	190	7	nelumbinis	nelumbinis	NOUN
aiua-8799	190	8	semen	semen	NOUN
aiua-8799	190	9	on	on	ADP
aiua-8799	190	10	rats	rat	NOUN
aiua-8799	190	11	under	under	ADP
aiua-8799	190	12	chronic	chronic	ADJ
aiua-8799	190	13	mild	mild	ADJ
aiua-8799	190	14	stress	stress	NOUN
aiua-8799	190	15	induced	induce	VERB
aiua-8799	190	16	depression	depression	NOUN
aiua-8799	190	17	-	-	PUNCT
aiua-8799	190	18	like	like	ADJ
aiua-8799	190	19	symptoms	symptom	NOUN
aiua-8799	190	20	.	.	PUNCT
aiua-8799	191	1	am	be	AUX
aiua-8799	191	2	j	j	PROPN
aiua-8799	191	3	chin	chin	PROPN
aiua-8799	191	4	med	med	PROPN
aiua-8799	191	5	.	.	PUNCT
aiua-8799	191	6	2005	2005	NUM
aiua-8799	191	7	;	;	PUNCT
aiua-8799	191	8	33:205	33:205	NUM
aiua-8799	191	9	-	-	SYM
aiua-8799	191	10	13	13	NUM
aiua-8799	191	11	.	.	NOUN
aiua-8799	191	12	20	20	NUM
aiua-8799	191	13	.	.	PUNCT
aiua-8799	192	1	farrel	farrel	PROPN
aiua-8799	192	2	ms	ms	PROPN
aiua-8799	192	3	,	,	PUNCT
aiua-8799	192	4	mccorvy	mccorvy	PROPN
aiua-8799	192	5	jd	jd	PROPN
aiua-8799	192	6	,	,	PUNCT
aiua-8799	192	7	huang	huang	PROPN
aiua-8799	192	8	xp	xp	PROPN
aiua-8799	192	9	,	,	PUNCT
aiua-8799	192	10	et	et	PROPN
aiua-8799	192	11	al	al	PROPN
aiua-8799	192	12	.	.	PROPN
aiua-8799	193	1	in	in	ADP
aiua-8799	193	2	vitro	vitro	X
aiua-8799	193	3	and	and	CCONJ
aiua-8799	193	4	in	in	ADP
aiua-8799	193	5	vivo	vivo	ADJ
aiua-8799	193	6	characterization	characterization	NOUN
aiua-8799	193	7	of	of	ADP
aiua-8799	193	8	the	the	DET
aiua-8799	193	9	alkaloid	alkaloid	PROPN
aiua-8799	193	10	nuciferine	nuciferine	NOUN
aiua-8799	193	11	.	.	PUNCT
aiua-8799	194	1	plos	plos	PROPN
aiua-8799	194	2	one	one	NUM
aiua-8799	194	3	.	.	PROPN
aiua-8799	194	4	2016	2016	NUM
aiua-8799	194	5	;	;	PUNCT
aiua-8799	194	6	11	11	NUM
aiua-8799	194	7	:	:	PUNCT
aiua-8799	194	8	e0150602	e0150602	VERB
aiua-8799	194	9	.	.	PUNCT
aiua-8799	195	1	21	21	NUM
aiua-8799	195	2	.	.	X
aiua-8799	196	1	zhang	zhang	PROPN
aiua-8799	196	2	c	c	PROPN
aiua-8799	196	3	,	,	PUNCT
aiua-8799	196	4	deng	deng	PROPN
aiua-8799	196	5	j	j	PROPN
aiua-8799	196	6	,	,	PUNCT
aiua-8799	196	7	liu	liu	PROPN
aiua-8799	196	8	d	d	PROPN
aiua-8799	196	9	,	,	PUNCT
aiua-8799	197	1	et	et	PROPN
aiua-8799	197	2	al	al	PROPN
aiua-8799	197	3	.	.	PROPN
aiua-8799	197	4	nuciferine	nuciferine	PROPN
aiua-8799	197	5	inhibits	inhibit	VERB
aiua-8799	197	6	proinflammatory	proinflammatory	ADJ
aiua-8799	197	7	cytokines	cytokine	NOUN
aiua-8799	197	8	via	via	ADP
aiua-8799	197	9	the	the	DET
aiua-8799	197	10	ppars	ppar	NOUN
aiua-8799	197	11	in	in	ADP
aiua-8799	197	12	lps	lps	PROPN
aiua-8799	197	13	-	-	PUNCT
aiua-8799	197	14	induced	induce	VERB
aiua-8799	197	15	raw264.7	raw264.7	NOUN
aiua-8799	197	16	cells	cell	NOUN
aiua-8799	197	17	.	.	PUNCT
aiua-8799	198	1	molecules	molecule	NOUN
aiua-8799	198	2	2018;23	2018;23	NUM
aiua-8799	198	3	:	:	PUNCT
aiua-8799	198	4	pii	pii	NOUN
aiua-8799	198	5	:	:	PUNCT
aiua-8799	198	6	e2723	e2723	VERB
aiua-8799	198	7	.	.	PUNCT
aiua-8799	199	1	22	22	NUM
aiua-8799	199	2	.	.	PUNCT
aiua-8799	200	1	chen	chen	PROPN
aiua-8799	200	2	x	x	PROPN
aiua-8799	200	3	,	,	PUNCT
aiua-8799	200	4	zheng	zheng	PROPN
aiua-8799	200	5	x	x	PROPN
aiua-8799	200	6	,	,	PUNCT
aiua-8799	200	7	zhang	zhang	PROPN
aiua-8799	200	8	m	m	PROPN
aiua-8799	200	9	,	,	PUNCT
aiua-8799	200	10	et	et	PROPN
aiua-8799	200	11	al	al	PROPN
aiua-8799	200	12	.	.	PROPN
aiua-8799	200	13	nuciferine	nuciferine	PROPN
aiua-8799	200	14	alleviates	alleviate	VERB
aiua-8799	200	15	lpsinduced	lpsinduce	VERB
aiua-8799	200	16	mastitis	mastitis	NOUN
aiua-8799	200	17	in	in	ADP
aiua-8799	200	18	mice	mouse	NOUN
aiua-8799	200	19	via	via	ADP
aiua-8799	200	20	suppressing	suppress	VERB
aiua-8799	200	21	the	the	DET
aiua-8799	200	22	tlr4	tlr4	NOUN
aiua-8799	200	23	-	-	PUNCT
aiua-8799	200	24	nf	nf	NOUN
aiua-8799	200	25	-	-	PUNCT
aiua-8799	200	26	kb	kb	NOUN
aiua-8799	200	27	signaling	signal	VERB
aiua-8799	200	28	pathway	pathway	NOUN
aiua-8799	200	29	.	.	PUNCT
aiua-8799	201	1	inflamm	inflamm	PROPN
aiua-8799	201	2	res	re	NOUN
aiua-8799	201	3	.	.	PROPN
aiua-8799	201	4	2018	2018	NUM
aiua-8799	201	5	;	;	PUNCT
aiua-8799	201	6	67:903	67:903	NUM
aiua-8799	201	7	-	-	SYM
aiua-8799	201	8	911	911	NUM
aiua-8799	201	9	.	.	PUNCT
aiua-8799	202	1	23	23	NUM
aiua-8799	202	2	.	.	PUNCT
aiua-8799	203	1	wang	wang	PROPN
aiua-8799	203	2	mx	mx	PROPN
aiua-8799	203	3	,	,	PUNCT
aiua-8799	203	4	zhao	zhao	PROPN
aiua-8799	203	5	xj	xj	PROPN
aiua-8799	203	6	,	,	PUNCT
aiua-8799	203	7	chen	chen	PROPN
aiua-8799	203	8	ty	ty	PROPN
aiua-8799	203	9	,	,	PUNCT
aiua-8799	203	10	et	et	PROPN
aiua-8799	203	11	al	al	PROPN
aiua-8799	203	12	.	.	PROPN
aiua-8799	203	13	nuciferine	nuciferine	PROPN
aiua-8799	203	14	alleviates	alleviate	VERB
aiua-8799	203	15	renal	renal	ADJ
aiua-8799	203	16	injury	injury	NOUN
aiua-8799	203	17	by	by	ADP
aiua-8799	203	18	inhibiting	inhibit	VERB
aiua-8799	203	19	inflammatory	inflammatory	ADJ
aiua-8799	203	20	responses	response	NOUN
aiua-8799	203	21	in	in	ADP
aiua-8799	203	22	fructose	fructose	NOUN
aiua-8799	203	23	-	-	PUNCT
aiua-8799	203	24	fed	feed	VERB
aiua-8799	203	25	rats	rat	NOUN
aiua-8799	203	26	.	.	PUNCT
aiua-8799	204	1	j	j	PROPN
aiua-8799	204	2	agric	agric	PROPN
aiua-8799	204	3	food	food	PROPN
aiua-8799	204	4	chem	chem	NOUN
aiua-8799	204	5	.	.	PUNCT
aiua-8799	205	1	2016	2016	NUM
aiua-8799	205	2	;	;	PUNCT
aiua-8799	205	3	64:7899	64:7899	NOUN
aiua-8799	205	4	-	-	SYM
aiua-8799	205	5	7910	7910	NUM
aiua-8799	205	6	.	.	PUNCT
aiua-8799	206	1	24	24	NUM
aiua-8799	206	2	.	.	PUNCT
aiua-8799	207	1	yang	yang	PROPN
aiua-8799	207	2	x	x	PROPN
aiua-8799	207	3	,	,	PUNCT
aiua-8799	207	4	yu	yu	PROPN
aiua-8799	207	5	mf	mf	PROPN
aiua-8799	207	6	,	,	PUNCT
aiua-8799	207	7	lei	lei	PROPN
aiua-8799	207	8	j	j	PROPN
aiua-8799	207	9	,	,	PUNCT
aiua-8799	207	10	et	et	PROPN
aiua-8799	207	11	al	al	PROPN
aiua-8799	207	12	.	.	PROPN
aiua-8799	208	1	nuciferine	nuciferine	PROPN
aiua-8799	208	2	relaxes	relax	VERB
aiua-8799	208	3	tracheal	tracheal	NOUN
aiua-8799	208	4	rings	ring	NOUN
aiua-8799	208	5	via	via	ADP
aiua-8799	208	6	the	the	DET
aiua-8799	208	7	blockade	blockade	NOUN
aiua-8799	208	8	of	of	ADP
aiua-8799	208	9	vdlcc	vdlcc	NOUN
aiua-8799	208	10	and	and	CCONJ
aiua-8799	208	11	nscc	nscc	ADJ
aiua-8799	208	12	channels	channel	NOUN
aiua-8799	208	13	.	.	PUNCT
aiua-8799	209	1	planta	planta	PROPN
aiua-8799	209	2	med	med	PROPN
aiua-8799	209	3	.	.	PUNCT
aiua-8799	209	4	2018	2018	NUM
aiua-8799	209	5	;	;	PUNCT
aiua-8799	209	6	84:83	84:83	NUM
aiua-8799	209	7	-	-	SYM
aiua-8799	209	8	90	90	NUM
aiua-8799	209	9	.	.	PUNCT
aiua-8799	210	1	correspondence	correspondence	NOUN
aiua-8799	210	2	francesco	francesco	PROPN
aiua-8799	210	3	chiancone	chiancone	PROPN
aiua-8799	210	4	,	,	PUNCT
aiua-8799	210	5	md	md	PROPN
aiua-8799	210	6	(	(	PUNCT
aiua-8799	210	7	corresponding	correspond	VERB
aiua-8799	210	8	author	author	NOUN
aiua-8799	210	9	)	)	PUNCT
aiua-8799	210	10	francescok86@gmail.com	francescok86@gmail.com	X
aiua-8799	210	11	maurizio	maurizio	NOUN
aiua-8799	210	12	carrino	carrino	PROPN
aiua-8799	210	13	,	,	PUNCT
aiua-8799	210	14	md	md	PROPN
aiua-8799	210	15	maurizio	maurizio	PROPN
aiua-8799	210	16	fedelini	fedelini	PROPN
aiua-8799	210	17	,	,	PUNCT
aiua-8799	210	18	md	md	PROPN
aiua-8799	210	19	marco	marco	PROPN
aiua-8799	210	20	fabiano	fabiano	PROPN
aiua-8799	210	21	,	,	PUNCT
aiua-8799	210	22	md	md	PROPN
aiua-8799	210	23	francesco	francesco	PROPN
aiua-8799	210	24	persico	persico	PROPN
aiua-8799	210	25	,	,	PUNCT
aiua-8799	210	26	md	md	PROPN
aiua-8799	210	27	clemente	clemente	PROPN
aiua-8799	210	28	meccariello	meccariello	PROPN
aiua-8799	210	29	,	,	PUNCT
aiua-8799	210	30	md	md	PROPN
aiua-8799	210	31	paolo	paolo	PROPN
aiua-8799	210	32	fedelini	fedelini	PROPN
aiua-8799	210	33	,	,	PUNCT
aiua-8799	210	34	md	md	PROPN
aiua-8799	210	35	urology	urology	PROPN
aiua-8799	210	36	department	department	PROPN
aiua-8799	210	37	,	,	PUNCT
aiua-8799	210	38	a.	a.	PROPN
aiua-8799	210	39	cardarelli	cardarelli	PROPN
aiua-8799	210	40	hospital	hospital	NOUN
aiua-8799	210	41	,	,	PUNCT
aiua-8799	210	42	via	via	ADP
aiua-8799	210	43	antonio	antonio	PROPN
aiua-8799	210	44	cardarelli	cardarelli	PROPN
aiua-8799	210	45	9	9	NUM
aiua-8799	210	46	,	,	PUNCT
aiua-8799	210	47	80131	80131	NUM
aiua-8799	210	48	napoli	napoli	PROPN
aiua-8799	210	49	(	(	PUNCT
aiua-8799	210	50	italy	italy	PROPN
aiua-8799	210	51	)	)	PUNCT
aiua-8799	210	52	04chiancone_stesura	04chiancone_stesura	PROPN
aiua-8799	210	53	seveso	seveso	NOUN
aiua-8799	211	1	24/09/20	24/09/20	PROPN
aiua-8799	211	2	14:13	14:13	NUM
aiua-8799	211	3	pagina	pagina	NOUN
aiua-8799	211	4	181	181	NUM